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Abstract
The renin angiotensin system (RAS) is highly conserved across vertebrates. How-
ever, until recently it has not been extensively explored in zebrafish, an important
model organism suitable for developmental studies, high-resolution in vivo imag-
ing, and genetic and chemical screens. In common with mammals, the adult ze-
brafish kidney contains specialised renin-expressing mural cells that contain gran-
ules indicative of the processing and regulated secretion of active renin. Due to the
translucent nature of zebrafish larvae, the functional pronephros is easily accessi-
ble for real-time imaging and in vivo studies of the RAS.
The primary aim of this project was to develop novel tools to help elucidate the
function of renin and the role of the RAS in zebrafish. I designed a zebrafish renin-
luciferase reporter transgene using a previously published promoter sequence to
investigate the transcriptional regulation of renin in real-time. The expression vec-
tor was injected into fertilised WIK zebrafish eggs and successful integration of
the plasmid into the zebrafish genome was demonstrated. An in vivo assay was
designed to select for highest luciferase expressers, but bioluminescent imaging
revealed that the high signal stemmed from the yolk sac of zebrafish. Yolk sac
expression appeared to originate from episomal transcription of the injected plas-
mid and, in the F0 fish, masked potential bona fide expression from the renin-
expressing cells of the pronephros. A new transgene was generated using two
reporters, driven by the same promoter sequence and the two reporters were
separated by a ’2A’ sequence which codes for a self-cleaving peptide. This ze-
brafish line was generated to permit selection of tg(ren:LUC-2A-mCherry) fish for
the strongest mCherry signal originating from renin expressing cells. However,
no expression was observed at the anterior mesenteric artery (AMA). Further in-
vestigation revealed that when generating novel transgenic zebrafish, the reporter
proteins are transiently expressed in the yolk sac of F0 founder fish and the ectopic
expression can influence studies relying on quantitative reporters.
Current studies largely rely on the transcriptional activity of RAS components
and are restricted to timepoint-specific observations. The lack of antibodies pre-
vents the measurement of RAS proteins in zebrafish. The amino acid sequence for
zebrafish angiotensinogen is known and by comparison to mammalian sequences,
I identified the amino acid sequences for angiotensin (Ang) I and II. The produc-
tion of zebrafish Ang I and II peptides by solid phase peptide synthesis provided
standards for the development of assays for zebrafish angiotensins. I used these
ii
assays to demonstrate that Captopril, which in mammals prevents the conversion
of Ang I to Ang II by inhibiting the Angiotensin Converting Enzyme (ACE), is active
in zebrafish, and that its administration leads to a dramatic decrease in Ang II. In
parallel I designed and synthesised a fluorescent resonant energy transfer (FRET)
probe to enable zebrafish renin activity to be measured. Using various zebrafish
models I was able to demonstrate dynamic changes in renin activity and measure
these using the first renin zebrafish FRET probe.
I characterised a renin knockout zebrafish, generated by CrispRCas9 gene edit-
ing. Knockouts were identified by DNA sequencing which identified an 8bp deletion
in exon 2 of the renin gene, causing a frameshift mutation and early termination
of renin translation. Renin knockout fish proved to be viable and were screened
for a phenotype using the high throughput automated screening system (VAST)
which permits the precise imaging of a large number of live fish. Imaging revealed
delayed development of the swim bladder and reduced fish length compared to
age-matched controls. This was indicative of an overall developmental delay. The
knockout fish were intercrossed with existing renal reporter lines to investigate phe-
notypes at a cellular level. Ren−/− tg(wt1b:EGFP) fish showed a delay in glomeru-
lar fusion of the pronephric kidney and a cross of the ren−/− with tg(ren:RFP-
LifeAct) fish indicated a dramatic increase in renin-expressing cell along the renal
mesonephric vasculature. Moreover, morphological examination revealed vacuola-
tion of proximal tubules in the mesonephric kidney. The intercrossing of the ren−/−
zebrafish to the tg(ren:RFP-LifeAct) and tg(acta2:EGFP) fluorescent reporters lead
to the optimisation of a FAC sorting protocol and resulted in the first zebrafish ren-
and acta2-expressing cells to be cultured and imaged using high-resolution mi-
croscopy imaging.
In summary, my work has led to the first successful measurement of zebrafish
AngI and AngII in mesonephric zebrafish tissue to demonstrate the effectiveness
of Captopril in zebrafish as well as the first development of a zebrafish renin FRET
probe to allow the measurement and quantification of renin activity in zebrafish,
enabling more accurate studies of the zebrafish RAS. Lastly, successful phenotypic
characterisation of the ren−/− fish will further our understanding of the role of renin
and the RAS in zebrafish.
iii
Lay Abstract
The renin-angiotensin system (RAS) is a hormonal system responsible for blood
pressure control and water regulation in the body. A vital component of that sys-
tem is the enzyme renin, which is produced by specialised cells located in the
kidney. Although various studies have investigated the function of renin, many
questions remain regarding its role in cardiovascular diseases and kidney devel-
opment. These studies have been performed predominantly in mammals, which
have a very complex kidney. Recently, zebrafish have become a crucial model or-
ganism for studying the kidney. The main reasons are that during the early stages
of zebrafish development, the zebrafish has a functional but simple kidney. Despite
its simplicity, the types of cells that make up the zebrafish kidney are also present
within the adult human kidney. Furthermore, the zebrafish is optically transparent
during the early stages of development, allowing imaging of the kidney in living ze-
brafish. Recent studies have shown that the zebrafish possesses the crucial RAS
enzyme renin, alongside other essential components. These studies have been
able to show that the cells expressing renin have a similar structure to the renin
cells found in the adult human kidney and respond to environmental stresses such
as low salt concentrations in a comparable manner. Most of these studies have
focused on the characterisation of these cells. However, there is a lack of tools to
permit studying the active component renin in zebrafish.
During this project, I have generated a new transgenic zebrafish, which utilises
bioluminescence instead of the commonly used fluorescence. Bioluminescence is
based on the chemistry that allows fireflies to produce light. By placing regulatory
elements required by renin in front of the gene coding for the bioluminescent protein
and inserting it into the genome of zebrafish, it can be used as a surrogate marker
for the renin gene. Due to the rapid bioluminescent reaction, the gene function can
be assessed in living fish. I have used qualitative as well as quantitative data to
asses whether bioluminescence can be used to measure renin activity in the larval
zebrafish.
I was also able to identify and synthesise two components of the RAS in ze-
brafish. Using a blood pressure lowering drug I was able to evoke a dynamic
change in the concentration of these components which were subsequently mea-
sured using a mass spectrometry assay provided by Attoquant Diagnostics. To
investigate the function of the renin protein, I have developed chemical probes that
can be injected or added to water to enter the fishes’ blood supply. The probes
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are designed by synthesising a sequence of amino acids which renin recognises
and interacts with by breaking the amino acid chain. On either end of the chain,
a fluorophore is attached. A fluorophore is a protein which fluoresces when it is
excited by the correct wavelength of light. On the opposite end, a further molecule
is attached which, when the amino acid chain is intact, inhibits the fluorescent pro-
tein from fluorescing. However, upon the interaction with renin, the probe is broken
up, restoring the fluorescent property of the fluorophore. The fluorescence can be
quantified and permits the investigation of renin activity. Similar probes have been
designed for human and rat renin, however, this is the first probe of its kind for
zebrafish renin. In this project, I describe the synthesis and also test the probe and
how well it interacts with zebrafish renin.
Lastly, to understand the function of a gene within an organism, gene editing
techniques are used to delete or disable a gene. The causes of the deletion can be
investigated and give insight into the mechanisms for which the gene is required. I
had the opportunity to characterise the first zebrafish with a mutation in the renin
gene, causing a complete lack of renin. Using a high-throughput imaging system, I
was able to determine that the growth of the zebrafish is delayed as well as severe
differences in kidney structure in the adult zebrafish. Combination of the zebrafish
line lacking renin with previous zebrafish lines used to characterise the renin ex-
pressing cells showed an increase in renin cells which is a response similar to that
seen in mammals.
In this project, I was able to measure accurately the first dynamic change of
RAS components and was able to synthesise these successfully. Furthermore, the
first renin fluorescent probe was designed and tested and results have indicated
that it is capable of recognising and reporting on zebrafish renin activity. Lastly,
the characterisation of the first zebrafish lacking active renin by various imaging
modalities has furthered the understanding of the function of renin in zebrafish.
All of the designed tools in this project will permit to design more accurate and
previously impossible experiments to further the understanding of the role of renin
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The renin-angiotensin system (RAS) is the primary hormonal system responsible
for blood pressure and water regulation. The RAS rate-limiting enzyme, renin, is
secreted and predominantly synthesised in specialised renal cells called the juxta-
glomerular (JG) cells. Renin is secreted in response to reduced blood flow and low
salt concentration and is required for the formation of angiotensin I (AngI) and ulti-
mately angiotensin II (Ang II), the main effector of the canonical RAS. Many stud-
ies have elucidated the different roles of renin and the RAS in mammalian model
systems. However, the role of renin and the RAS in the establishment of cardio-
vascular homeostasis and their involvement in cardiovascular and renal diseases
remain unclear. Recent work using transgenic zebrafish has shown that zebrafish
possess specialised renal mural cells expressing renin. Although there are many
similarities of the zebrafish RAS to the mammalian RAS, the zebrafish model still
lacks specific tools that allow investigation of the role of zebrafish renin. Develop-
ing tools such as new renin bioluminescent transgenic zebrafish lines, mutant RAS
knockout animals and chemical probes for measuring RAS activity will further the
zebrafish as a crucial model for kidney research.
1.2 Kidney Structure
The kidney is a highly complex multicellular organ. A nephron is the functional
unit of the kidney and constitutes of a glomerulus, where blood is filtered through
blood vessels and nutrients are reabsorbed in the tubule [1, 2]. Although the num-
ber of nephrons per kidney in humans varies strongly dependant on the size of
the human, it is estimated that on average, an adult kidney consists of 1,000,000
nephrons [3]. Afferent arterioles provide blood in into the renal corpuscle where
blood vessels form a knotted structure inside a capsule made up of epithelial cells.
This blood-filtering structure is known as the glomerulus. The glomerulus is the
main blood filtering structure, and the vessels inside the glomerular capsule are
enveloped by specialised epithelial cells called podocytes. Podocytes project foot-
like processes forming filtration slits which are bridged by the slit diaphragm. These
slits enable the passing of molecules and proteins up to a specific size to pass
through and into the urinary space of the tubule. The tubule is segmented by spe-
cialised cells with specific abilities to absorb and excrete different nutrients. The
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convoluted tubule, posterior to the glomerulus and the first segment of the proximal
tubule, specialises in the reabsorption of potassium, sodium and water, as well as
certain amino acids. The loop of Henle followed by the convoluted proximal tubule
predominantly reabsorbs water. The distal tubule, of which a small segment also
contains the macula densa cells further absorbs sodium and hydrogen ions and
senses the sodium concentration with the macula densa cells and is in contact
with the JG-cells. The tubule connects into a collecting tubule which transports the
remaining solutes into the bladder where they are excreted.
1.3 The Renin-Angiotensin System
The RAS is the primary regulator of blood pressure and fluid balance. Renin,
the rate limiting enzyme of the RAS, is almost exclusively synthesised within spe-
cialised perivascular mural cells of the kidney called the JG cells. JG cells are lo-
cated along the afferent arterioles, proximal to the glomerulus and comprise a cru-
cial anatomical and functional feature of the juxtaglomerular apparatus (JGA) [4].
The main effector of the RAS is AngII, which is generated by sequential cleavage
of peptides from the main substrate molecule angiotensinogen (Figure 1.1).
Angiotensinogen is freely secreted from the liver, and its C-terminus is cleaved
by renin to generate the biologically inactive decapeptide AngI [5]. Subsequent
cleavage of AngI by the angiotensin-converting enzyme (ACE) generates the bio-
logically active octapeptide, AngII [6]. Binding of AngII to the AT1 and AT2 receptors
triggers multiple systems affecting the heart, kidney, vasculature and the immune
system [7]. The two receptors differ in spatial distribution, physiological function
and signalling pathways. Most AngII effects occur via binding and activation of the
AT1 receptor which is highly present on vascular smooth muscle cells. Binding of
AngII to the AT1 receptor evokes an increase in intracellular calcium which induces
the contraction of vascular smooth muscle cells and ultimately leads to an increase
in blood pressure [8]. Furthermore, binding of AngII to the AT1 receptor stimulates
the production of aldosterone in the adrenal cortex, which acts on the principal
cells of the kidney, leading to an increase in sodium reabsorption [9]. More recent
studies have been investigating the function of the AT2 receptor. The AT2 receptor
is highly expressed during early development; however, its expression is reduced
postnatally in mammals [10]. Although the AT1 receptor is dominant in adult organ-
isms, an increase of AT2 expression has been observed in response to vascular
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Figure 1.1 | Schematic representation of the renin-angiotensin system An-
giotensinogen is freely secreted from the liver. Renin, secreted from specialised
cells within the kidney, cleaves angiotensinogen and converts it to angiotensin I.
Subsequent cleavage by ACE, released from the lung converts it to angiotensin II.
Angiotensin II acts via the AT1 and AT2 receptors.
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injury [11]. Mice lacking a gene coding for the AT2 receptor have increased blood
pressure, which was reversed using an AT1 receptor antagonists [12]. Further-
more, studies have suggested that the observed increase in blood pressure using
AT2 antagonists suggests that the AT2 might mediate vasodilatation [13, 14]. The
opposing functions of the AT2 receptor, to that of the AT1 receptor implicates that
the functions of the AT2 receptor may have a protective effect against the overstim-
ulation of the AT1 receptor. In addition to the classical RAS, many additional smaller
peptides have been described, which only recently gained pharmacological signif-
icance [15,16,17]. Besides the circulating RAS, several so-called ’local RAS’ have
been identified in different tissues such as the heart, brain and adrenal glands.
These tissues can express all components of the RAS, although, the functionality
of the RAS can differ to that of the circulating RAS [18].
1.4 Renin
Renin is the rate-limiting enzyme of the RAS, making it the central hormone for
controlling blood pressure and water balance. However, renin is also involved in
various other functions. Renin and the RAS were first discovered by Tigerstedt and
Bergman, who observed an increase in blood pressure when injecting rabbit kidney
extracts into rabbits [19]. The substance causing the raise in blood pressure was
named renin after the renal substance it derived from. Renin is a protein-coding
gene, which in humans encodes for 406 amino acids. Moreover, the enzyme renin
belongs to the class of aspartyl proteases and has a high affinity to its substrate an-
giotensinogen and studies have demonstrated that in many cases renin is unable
to cleave angiotensinogen from different species [20]. Synthesis of renin predom-
inantly occurs in specialised JG cells in the kidney, which are located along the
afferent arterioles, proximal to the glomerulus and comprise a crucial anatomical
and functional feature of the JGA [4]. Renin expression and secretion is regulated
by baroreceptors on JG cells sensing the perfusion in the afferent arteriole and
via the macula densa cells, which sense sodium chloride concentration and sig-
nal to JG cells [21, 22, 23, 24]. Renin is synthesised in the JG cells as an inactive
pre-pro-protein [25, 26]. The pre-segment acts as a signal peptide and removal of
the pre-peptide from the N-terminus of renin produces the inactive form of renin,
prorenin [26]. Prorenin is packed into vesicles, continuously in its inactive form as
prorenin [27]. However, a small subset of prorenin is glycosylated in the Golgi Ap-
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paratus and packaged into dense-core storage granules [28]. In those dense-core
storage granules, a still unknown mechanism removes the pro-segment, activat-
ing it to renin, before being secreted via a regulated secretory pathway. It is still
debated whether the precursor of renin, prorenin has a distinct physiological role.
Circulating prorenin levels are reported to be 10-fold higher than concentrations of
active renin [29, 30]. The recent identification of a prorenin receptor suggests that
binding of prorenin to the receptor leads to conformational changes of prorenin,
making it catalytically active, allowing it to produce AngII locally [31,32,33]. More-
over, there is evidence of prorenin uptake by cardiomyocytes, which subsequently
can activate prorenin to renin [34].
Renin is highly selective for its substrate angiotensinogen and the specific
amino acid sequence necessary for cleavage was first determined by isolation of a
14 amino acid sequence following trypsin digestion of horse plasma [35]. Although
the tetradeca peptide amino acid sequence has demonstrated the best affinity as
a substrate for renin, the shortest possible amino acid sequence, still cleaved by
renin, is that of 10 amino acids [36]. A study has investigated the requirement of
different amino acids in the decapeptide sequence using various alanine replace-
ments. This study was able to demonstrate that the three amino acid sequence
His6-Pro7-Phe8 is crucial for the cleavage of a substrate by renin [37]. Unsurpris-
ingly, this sequence is conserved across all species that express renin and an-
giotensinogen [37]. The actual amino acids of the peptide bond cleaved by renin,
however, vary dependant on species. In particular, the renin cleavage of human
angiotensinogen occurs at the peptide bond of Leu10-Leu11 whereas that of other
mammalian species including rat, mouse, horse and sheep including other mam-
malian species is cleaved at Leu10-Val11 [38]. Zebrafish angiotensinogen also
contains the His6-Pro7-Phe8 motif, which is essential for angiotensinogen cleavage
by renin, however the peptide is cleaved between the Leu10-Phe11 amino acids.
These studies investigating the renin cleavage further suggest that the Leucine on
the N-terminus of the renin cleaved amino acid is essential for the renin cleavage,
whereas the C-terminal amino acid is variable [39].
1.5 Zebrafish Renin
Liang et al. first showed the presence of a renin gene in two non-mammalian
species, the zebrafish, and the pufferfish [40]. Furthermore, Fournier et al. utilised
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the published gene and protein sequence databases to investigate the evolution of
the RAS [41]. During the analysis, Fournier identified multiple orthologous gene
sequences of human RAS proteins. The zebrafish was shown to contain eight out
of the nine sequences orthologous to the human genes: Ace1, Ace2, angiotensino-
gen, AT1, AT2, renin receptor, mineralocorticoid receptor, and renin. Zebrafish lack
an orthologous gene sequence for the Mas receptor [41]. Although the function of
the RAS in the zebrafish remains to be elucidated, the RAS in teleost has been
linked to the ability to survive in water of fluctuating osmolarity [42]. In zebrafish,
diluted salt water increases renin expression and circulating AngII levels in a com-
parable manner to the effect of low salt diets for mammals, suggesting an involve-
ment of the RAS in salt handling [43,44,45]. AngII, the main effector of the system,
acts via the AT1 receptor. Tucker et al. demonstrated the presence of an AT1 like
receptor in zebrafish tissues involved in ion regulation [46]. Although it is suggested
that the RAS is required for salt handling in zebrafish, the zebrafish has additional
mechanisms that permit the maintenance of salt and water balance. In particular,
the gills contain many specialised epithelial cells, ionicytes, which actively take up
ions from the environment.
The identification of a zebrafish renin gene permitted the development of a
novel transgenic fluorescent zebrafish reporter [47]. The fluorescent reporter plas-
mid to be injected into zebrafish to generate a transgenic line, utilised a 6.4kb
segment of the zebrafish renin promoter, driving the fluorescent reporter protein
RFP-LifeAct. The RFP-LifeAct fluorophore binds to intracellular actin, permitting
visualisation of actin filaments [48]. The fluorescent zebrafish renin reporter en-
abled visualisation of renin cells as early as 48 hours post fertilisation (hpf) in the
zebrafish pronephros. The cells first appear along the anterior mesenteric artery
(AMA) in a post-glomerular position and expand along the dorsal aorta (DA) (Fig-
ure 1.2).
There are also renin-expressing cells present along the proximal mesenteric
artery (PMA) that are not directly associated with the pronephric kidney [47]. The
cellular location of renin-expressing cells in the mesonephric zebrafish kidney re-
sembles that seen in the mammalian metanephros. Renin expressing cells are
located proximal to the glomerulus along afferent arterioles [49]. Furthermore, the
use of Lyostracker Green staining, which permits the intracellular labelling of acidic
structures, suggested the presence of acidic granules in the renin-expressing cells
[49]. Mammalian intrarenal renin cells contain a large number of acidic secretory
granules that store and process prorenin into the active renin form [50]. The cross-
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Figure 1.2 | Renin cells in the zebrafish pronephros Illustration of the larval
zebrafish vasculature at 5 days post fertilisation (dpf). Renin-expressing cells are
highlighted in yellow along the anterior mesenteric artery (AMA) and the dorsal
aorta (DA) and the posterior mesenteric arteries (PMA). CV, caudal vein; PA, pec-
toral artery; SBA, swim bladder artery; SIA, Supraintestinal artery. Taken from
Rider et al. [47].
ing of the tg(ren:RFP-LifeAct) zebrafish line to endothelial cell-deficient (cloche)
and notch pathway impaired mibta52b-/- mutants further demonstrated the require-
ment of a functional notch pathway and endothelium for the expression of renin
[47].
1.6 Zebrafish Salt Handling
Zebrafish live in a hypotonic environment, making them hyperosmotic and hyperi-
onic to their surroundings. Comparable with the mammalian kidney, the zebrafish
kidney reabsorbs ions through active transcellular actions. Zebrafish possess spe-
cialised epithelial cells, termed ionocytes, which are predominantly located in the
gills, that allow them to actively absorb electrolytes from the water. In addition to
the ionocytes located on the gills, zebrafish are also capable of taking up elec-
trolytes from food via epithelial cells located in the gut and subsequently through
specialised cells within their kidneys [51, 52, 53]. During early development and
prior proper establishment of the gills, zebrafish utilise ionocytes on their skin, al-
lowing them for proper salt handling during larval stages [54]. Studies investigating
the salt handling of freshwater fish have shown that zebrafish possess 4 differ-
ent types of ionocytes, which are analogous to the transporting cells found in the
different segments of the mammalian kidney tubules [55]. Namely, H+- ATPase-
rich(HR), Na+-K +- ATPase-rich(NaR), Na+-Cl−- element cotransporter-expressing
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(NCC) and K +-secreting cells are responsible for the sodium, calcium, and chlo-
ride uptake, respectively [56, 57]. A major difference between teleosts and mam-
mals is that terrestrial mammals are required to actively take up water in order to
prevent dehydration. However, teleosts live in an aquatic environment and con-
stantly excrete huge amounts of highly diluted urine, in order to maintain their os-
motic balance [58]. The main regulatory mechanisms, by which zebrafish main-
tain ion homeostasis, is via the endocrine system. The osmoregulation in verte-
brates by the endocrine system has been widely studied, however only few studies
have implicated several hormones that might be involved in osmoregulation in ze-
brafish [59]. These include the atrial natriuretic peptide (ANP), which is secreted
in response to an increase in blood volume and promotes excretion of water and
sodium, and the renin-angiotensin system, which is discussed in section 1.3 and
1.4. Lastly, prolactin the function of which includes promoting lactation in the mam-
mary gland, has been implicated in the involvement for osmoregulation in fish.
In particular in euryhaline fish, prolactin is required for the adaption to fresh wa-
ter by promoting the uptake of ions [60]. Zebrafish are particularly interesting for
the investigation of various endocrine responses as they are stenohaline, allowing
them to adapt to freshwater salinity changes. Despite many similarities between
zebrafish and mammals in endocrine responses to salinity changes, several dif-
ferences exist due to the relationship of the control of blood volume and sodium
concentration in the plasma. In terrestrial mammals, the blood volume control oc-
curs in the same direction as the plasma sodium. However, in teleost the direction
of blood volume control is opposite to that of the sodium plasma control. A great
example of this is that in mammals ANP and renin have opposing effects. ANP pro-
motes excretion of water and sodium, whereas renin promote reabsorption [61]. In
zebrafish, ANP and renin have been suggested to be regulated in the same di-
rection when exposed to low saltwater, suggesting that ANP may have a water
excretion role in zebrafish whilst renin is implicated in sodium reabsorption [43].
1.7 Renin Knockout Models
To elucidate the function of renin, various studies in different mammals using knock-
out strategies have been performed [62, 63, 64]. Mice, depending on the strain,
differ from other mammals and fish, as some strains have two renin genes, termed
Ren-1d and Ren-2, while other strains such as the C57BL/6 only have one renin
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gene, Ren-1c. The second renin gene is believed to have originated from a gene
duplication on chromosome 1 [65]. The Ren-2 gene sequence is highly homolo-
gous to Ren-1d, with differences in the glycosylation sites required for post-
translational modifications. Deletion of the Ren-2 gene in mouse strains with two
renin genes, leaving the Ren-1d gene intact, does not result in any distinct pheno-
type [64]. Ren-2 knockout mice are viable, do not display increased blood pressure,
although an increase in active plasma renin can be measured. Knocking out the
Ren-1d gene in mice with two copies of the renin gene, leaving only the Ren-2 as
a functioning renin gene, resulted in hypotension in female mice but no change in
blood pressure was observable in male mice [63]. Most interestingly, however, is
the complete absence of secretory electron-dense granules in the JG cells [63]. A
homozygous Ren-1c knockout presents a very similar phenotype to a complete Agt
knockout mouse [66]. Viability is significantly reduced, and daily saline injections
are required to prevent death shortly after birth. The Ren-1c knockout mice are
polyureic, severely hypotensive and morphological changes to the kidneys include
interstitial fibrosis, focal glomerulosclerosis and perivascular infiltration [62]. Prior
to my thesis there has been no report describing the generation of a renin knockout
zebrafish.
1.8 Renin Expressing Cells
Renin-expressing cells are specialised smooth muscle cells that are anatomically
restricted to the JGA in the mammalian and metanephros and have also been
characterised along the anterior mesenteric artery, dorsal aorta and the poste-
rior mesenteric artery in the larval zebrafish pronephros, and along afferent arte-
rioles in the zebrafish mesonephros [47, 67, 68]. Renin cells descend from Foxd1-
expressing stromal cells [69]. The precursor cell to the Foxd1-expressing cells also
gives rise to smooth muscle cells, mesangial cells, as well as interstitial pericytes.
It has been suggested that renin precursor cells are crucial for the development
of the kidney vasculature [70]. During kidney development in the mouse and rat,
renin cells are located at kidney vessel sprouting points [71]. A similar observation
has been made in the pronephric zebrafish kidney, where AMA angiogenesis was
inhibited with the VGEF inhibitor axitinib. Renin-expressing cells were observed
at the position of the expected initiation site of the AMA, suggesting a role in an-
giogenesis [47]. In rats and mice, the sprouting arteriolar vessels during kidney
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development are enveloped by renin cells, and with the maturation of the vessels
and the kidney, these cells lose their renin expressing identity and differentiate into
smooth muscle cells [72]. Renin cells are then restricted to the juxtaglomerular
position along the afferent arterioles in the metanephric mammalian kidney (Fig-
ure 1.3).
Figure 1.3 | Mammalian glomerulus Structure of the glomerulus. Afferent ar-
terioles provide the glomerulus with blood and create a knot like structure. The
juxtaglomerular apparatus constitutes of the granulated juxtaglomerular cells (spe-
cialised vascular cells in red) capable of renin expression and storage, extra
glomerular mesangial cells (purple), and the macula densa cells (specialised tubu-
lar cells in yellow). The glomerular vasculature is lined by podocytes which filter
small enough proteins into the lumen of the Bowman’s capsule, attached to the
tubule. Image from Lauralee Sherwood [73].
The smooth muscle cells along the afferent arterioles retain the ability to re-
express renin in response to physiological stress [74]. Although renin cells express
smooth muscle cell makers, as well as pericyte markers, the expression levels of
these appear to be variable. Reports have shown that in comparison to smooth
muscle cells along the afferent arterioles, which express high levels of α-smooth
muscle actin, renin-expressing cells have low expression [75]. Although the ex-
act mechanism for the transition of smooth muscle cells to renin cells in response
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to physiological stress remains to be described, recent findings have suggested
that the cAMP pathway involving CBP and p300 are essential for the induction of
renin expression during development. Furthermore, as renin cells originate from a
vascular progenitor cell, it remains to be elucidated whether renin-expressing cells
are required for, and directly involved in the angiogenesis of the renal vascula-
ture. RAS inhibition during kidney development or knockout of RAS genes results
in renal vascular defects [76, 77, 78]. Renin-expressing cells release renin in re-
sponse to various signals, which include the renal baroreceptors located on the
JG cells, the macula densa mechanism, and via the β-adrenergic receptor mech-
anism. Renal baroreceptors sense the decrease in perfusion, which results in the
release of renin. The cells of the macula densa sense the chloride concentration
of the tubular fluid [79]. In response to high chloride concentrations macula densa
cells release ATP, which induces vasoconstriction of the smooth muscle cells of the
juxtaglomerular apparatus via purinergic receptors [80]. Reports have suggested
that ATP may also be hydrolysed to adenosine before acting on the adenosine
A1 receptors expressed on the smooth muscle cells [23]. A1 receptors induce a
receptor-mediated inhibition of cAMP activity in renin cells, which is directly linked
to regulation of renin gene expression via the CERB on the renin promoter re-
gion [81]. In response to low tubular chloride concentrations the macula densa
cells have been shown to release prostaglandin E2 (PGE2) [82]. PGE acts via
the PGE receptors and binding to the EP2 and EP4 receptors activates adenylyl
cyclase which leads in an accumulation of intracellular cAMP, resulting in stimu-
lating renin release [81]. Lastly, renin cells can also release renin in response
to stimulation of their β2-receptors by cAMP [83]. Moreover, it has been shown
that an increase in the concentration of circulating renin is predominantly due to
an increase in renin-expressing cells rather than individual cells releasing more
renin [84]. cAMP is a potent regulator of renin transcription, and renin release
and the renin gene harbours a cAMP-responsive element which is required for
renin expression [85]. Renin secretion is a tightly regulated and complex process.
Activation of AT1 receptors by AngII inhibits renin secretion and forms the AngII-
mediated negative feedback loop of the RAS. The AngII inhibitory effect on renin
secretion has been demonstrated by using various RAS targeting drugs that inhibit
the formation of AngII. Application of these drugs as well as AT1 receptor targeting
drugs was shown to increase circulating renin, suggesting enhanced secretion of
renin from JG cells [86].
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1.9 The Zebrafish as a Model Organism
The zebrafish (Danio Rerio) is a bony (teleost) freshwater fish, native to South
Asia. The zebrafish has become an important model for understanding numerous
biological pathways and its applications extend well beyond developmental biology.
The zebrafish was first established as a model species by George Streisinger [87],
however research using the zebrafish for developmental and reproductive studies
dates back to the 1930s, when its benefits over mammalian models were recog-
nised [88]. Zebrafish are simpler to maintain and to manipulate compared to mice.
Further advantages include that zebrafish pairings can generate many offspring
(50-200 eggs) and many studies can be undertaken during the larval stage. The
high number of offspring permits large phenotypic and drug screens using fish with
the same genetic background. During early development, the zebrafish larvae are
optically transparent, and the use of chemical compounds can delay the develop-
ment of pigment at later stages. Zebrafish have high genetic similarity to humans
and 70% of zebrafish genes have a human orthologous gene [89]. This genetic
homology and the relative ease of using genetic editing techniques such as zinc
finger nucleases, transcription activator-like effector nucleases (TALENs), and the
’clustered regularly interspaced short palindromic repeat’ (CRISPR)-Cas9 system
in zebrafish, permits the efficient use of this species for the study of gene function.
Furthermore, the ability to easily generate transgenic zebrafish lines has permitted
cell labelling and cell lineage tracing. Fluorescent zebrafish reporters have genet-
ically incorporated fluorescent markers downstream of a promoter of a gene to be
studied. The fluorescent reporter then allows visual tracking of the cells expressing
the gene of interest.
Zebrafish transgenic lines are most commonly developed by using the tol2
transposon system. The tol2 transposon system utilises DNA transposons, which
are present and make up significant parts of many genomes. Transposons identify,
excise, and reinsert DNA that is tagged with inverted terminal repeats. The first
active DNA transposon (tol2) was identified in Medaka fish and permitted the char-
acterisation of its mRNA [90]. Its activity was further demonstrated by injecting a
non-autonomous element alongside tol2 mRNA into zebrafish eggs, generating a
germline transgenic zebrafish [90]. Generation of new transgenic lines still utilises
the co-injection of tol2 mRNA alongside a plasmid carrying the desired expression
cassette, placed between tol2 inverted terminal repeats [91]. The injection of tol2
mRNA ensures transient expression of the transposase due to mRNA degradation.
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Since the discovery of the tol2 transposase, further transposases have been iden-
tified and used for the generation of transgenic zebrafish lines. However, the tol2
system remains the most successful tool for generating novel transgenic zebrafish
lines. A crucial step for utilising the tol2 system is the cloning strategy used to place
the expression cassette between the two inverted tol2 terminal repeats, recognised
by the transposase.
Gateway Cloning multisite destination vectors are commercially available and
already contain a reporter cassette [92]. The Gateway Cloning system permits
DNA fragment transfer between different cloning vectors using a set of recombina-
tion sequences. DNA fragments initially are cloned between Gateway att sites to
generate a 5’-entry, middle-entry and 3’-entry clone. Each plasmid contains spe-
cific recombination sites. The 5’-entry clone commonly carries the promoter region
for the gene of interest, whereas the middle-entry clone contains the gene coding
for the desired fluorescent reporter protein. Lastly, the 3’-entry clone contains the
polyadenylation repeats. Specific enzyme mixes then allow recombination of the 3
plasmids into a destination vector while maintaining the reading frame. Although
the gateway cloning method is more expensive than the more commonly used re-
striction enzyme and ligase-based cloning, it permits for faster and more efficient
development of expression clones. Generation of transgenic zebrafish lines of-
ten utilises a dominant reporter cassette within the desired expression plasmid to
aid in identifying successful transgenic animals visually and for subsequent geno-
typing. Commonly the reporter cassette constitutes a promoter such as a gamma-
crystallin or the cardiac myosin light chain (cmlc2) promoter, driving the expression
of a fluorescent protein. Both reporters are expressed very early during embryonic
development, allowing for more accessible selection of transgenic carriers. Nowa-
days, the zebrafish is commonly employed for studying the nervous system due to
the ability of the zebrafish to regenerate its nervous system. However, a consider-
able amount of work has been performed on zebrafish for renal studies. There are
various advantages in using the species such as the simplicity of the pronephric
embryonic kidney, the regenerative mesonephric zebrafish kidney, and the ability
to generate fluorescent transgenic zebrafish lines and image the kidney function
and cells of interest in vivo.
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1.10 Transgenic Zebrafish for studying Zebrafish RAS
The ease of generating transgenic zebrafish has allowed the establishment of nu-
merous tissue-specific transgenic zebrafish lines. These have helped our under-
standing of zebrafish kidney development. The most notable lines, some of which
have been used as part of this project, are discussed below.
1.10.1 Tg(ren:RFP-LifeAct)
The ren:RFP-LifeAct was the first fluorescent transgenic zebrafish line that allowed
high-resolution imaging of renin cells in the in vivo pronephric, as well as the ex vivo
mesonephric zebrafish kidney. The transgenic zebrafish line was constructed by
cloning a 6.4kb promoter region of the zebrafish renin promoter, containing essen-
tial cAMP and RBP-J binding sites [47]. The cloned renin promoter region drives
the expression of the red fluorescent protein, RFP-LifeAct. This particular fluo-
rophore binds to intracellular actin filaments, visualising the structure of the renin
cells. Additionally, staining with dyes that bind to acidic compartments within cells,
confirmed the presence of acidic granules within these cells [49]. The ren:RFP-
LifeAct transgene also indicated the presence of renin cells at vascular sprouting
tips, further suggesting the involvement of renin and renin cells in renal angiogen-
esis. Moreover, the generation of this transgenic line enabled intercrossing of the
tg(ren:RFP-LifeAct) zebrafish to other existing lines such as the tg(acta2:EGFP)
zebrafish to demonstrate the co-expression of the smooth muscle cell marker in ze-
brafish renin cells, as as reported in mammalian organisms. Lastly, the tg(ren:RFP-
LifeAct) line visualised that the cells along the efferent arterioles, compared to the
cells along the afferent arterioles, are flatter suggesting that, similarly to mam-
malian organisms the renin cells along the efferent arterioles in the zebrafish are
not granulated [49,93].
1.10.2 Tg(wt1b:EGFP)
The Wilms’ tumor gene WT1 encodes a zinc finger transcription factor and is a
major regulator of mesenchymal progenitors in various organs including the heart,
kidney, spleen and gonads [94]. WT1b expression is required for proper kidney
development and maintenance of the glomerulus [95]. Dysregulation of the wt1b
gene is linked to abnormalities in the urogenital tract and a paediatric renal cancer
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[96]. Zebrafish have two homologues of the WT1 gene termed wt1a and wt1b [97].
Despite high sequence homology, studies using morpholinos to knockdown either
gene have suggested that the genes exert different roles. Knockdown of wt1a
induces oedemas in larval zebrafish, whereas knockdown of wt1b results in subtle
oedema and body curvature [98, 99]. A transgenic zebrafish line was generated
using the promoter region for wt1b to drive the enhanced green fluorescent protein
(EGFP) and studies showed that wt1b is strongly expressed during nephrogenesis
[97, 99]. Furthermore dysregulation of zebrafish wt1b results in the formation of
renal cysts which is similar to the wt1 deregulatory effects observed in humans
[99]. The transgenic zebrafish recapitulates the expression of wt1b during kidney
development and presents an powerful tool for studying kidney development and
nephrogenesis in vivo.
1.10.3 Tg(flk :EGFP)
The promoter for the endothelial-specific gene flk-1 has been used to drive ex-
pression of fluorescent reporters to visualise endothelial cells in zebrafish. Flk-1
encodes for a protein tyrosine kinase and is first expressed in hemangioblasts, a
precursor of endothelial cells, making Flk-1 one of the earliest markers of endothe-
lial cells [100]. The most commonly used reporters are mCherry and EGFP and
were chosen with consideration to the downstream application. Transgenic ze-
brafish expressing a fluorescent endothelial reporter have been used to study the
vasculature of the zebrafish but have also been used to investigate the distinction
between renin-expressing cells and the endothelium [49,100].
1.11 Zebrafish Pronephros
The pronephros is the first kidney structure to form across all vertebrates [101].
The pro-nephros lacks blood filtering ability in higher vertebrates, however it is
functional as a blood filtration organ in fish and amphibians [102, 103]. The use
of fluorescent dextran of different molecular sizes demonstrated that blood filtering
activity in the zebrafish pronephros commences from 3dpf and dextran smaller than
10kDa in size are filtered by the glomerulus [104,105]. The pronephros is a simple
structure consisting of two tubules fused at the glomerulus at the midline of the
zebrafish (Figure 1.4) [106].
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Figure 1.4 | Zebrafish pronephros Illustration of a 4dpf straightened zebrafish
larvae with the pronephric structure. (G) Glomerulus, (N) Neck, (PCT) Proximal
Convoluted Tubule, (PST) Proximal Straight Tubule, (DE) Distal Early, (DL) Distal
Late, (C) Cloaca. Specific segments of the pronephric kidney show conservation
of mammalian tubular kidney markers.
The zebrafish glomerular anatomy is comparable to that of the human glomeru-
lus, although a significant difference between the mammalian and zebrafish urinary
systems is the lack of a bladder in fish. The tubule segmentation is conserved with
that of the more complex metanephric mammalian tubule and gene expression
patterns within the segments are also conserved [107]. The zebrafish pronephros
consists of eight distinct regions, defined by specialised cells destined for the re-
absorption of nutrients [107, 108]. In comparison, the mammalian metanephric
nephron contains nine distinct regions [109]. A significant difference in tubular seg-
mentation between the mammalian and fish tubule is the lack of the loop of Henle in
zebrafish, which in mammals functions predominantly for the reabsorption of water.
The pronephric tubule contains a short neck segment expressing rfx2, a marker for
ciliated cells [4]. The tubular epithelium of the pronephros is subdivided into two
proximal and two distal segments. Similarly to mammals, the proximal segment is
defined by the expression of the gene coding for the sodium hydrogen exchanger,
slc9a3 [110,111]. The proximal segment is further subdivided into a proximal con-
voluted tubule (PCT) and proximal straight tubule (PST), expressing megalin and
slc13a3, respectively [108, 112]. In particular, the expression of slc13a3 further
suggests the presence of ciliated cells in this part of the tubule [107]. Despite gene
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conservation showing many similarities between the simple pronephric tubule and
the mammalian metanephros, the latter has developed a highly complex collecting
duct system into which the tubules drain. In the pronephros, the excretion system is
simplified with the two tubules coming together at the pronephric duct and draining
directly into the cloaca.
1.12 Zebrafish Mesonephros
Nephrogenesis proceeds through a series of phases marked by three different
kidney structures, each more advanced than the previous. Nephrogenesis com-
mences with the development of the pronephros, the most immature kidney struc-
ture, and progresses through a mesonephric structure to the metanephros, the
most advanced kidney structure and the final kidney structure persisting as the
definitive adult kidney in many vertebrates [113, 114]. The mesonephros in ze-
brafish develops at around 12dpf, following the thickening and convolution of the
pronephric duct, by the formation of a new pair of glomeruli on either side of the
pronephric duct [115] (Figure 1.5).
The nephrons fuse to the distal region of the existing pronephros [116]. The
mesonephric kidney development was carefully investigated using the tg(pod :EGFP)
and tg(cadherin17 :EGFP) transgenic zebrafish [115]. In the trunk region of the ze-
brafish mesonephros, nephrons contain secondary branching tubules which are
comparable to that seen in the metanephric mammalian kidney [71]. The meso-
nephros is a continually developing organ, maintaining the ability to form new
nephrons, contrary to the mammalian metanephros which is a final structure. How-
ever, the zebrafish contains approximately 150 nephrons, depending on the size of
the fish and new nephrons are formed to replenish damaged ones [115,117]. The
meso-nephros is capable of commencing regeneration within 48 hours following
gentamicin-based kidney injury [115]. This fast response to renal damage makes
the zebrafish mesonephros an incredibly useful model for studying kidney develop-
ment and disease without the complexity of the mammalian metanephric kidney.
1.13 Circadian Rhythm of Blood Pressure
The circadian clock evolved for organisms to adapt to the 24 hours cycles of light
and dark. The circadian rhythm has been identified to regulate physiological func-
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Figure 1.5 | Zebrafish mesonephros The mesonephros in the adult zebrafish is
located on the distal side against the spine. The Mesonephros is divided into three
anatomical different parts; head, trunk and tail. Top panel shows the mesonephros
highlighted by dashed white lines of a tg(ren:RFP-LifeAct) transgenic zebrafish.
tion in organisms of various complexity, from bacteria to humans. In higher verte-
brates, a master regulator is located within the suprachiasmatic nucleus of the brain
and oscillates with an approximately 24 hour period even in the absence of external
stimuli [118,119]. However, peripheral circadian clocks are present in most tissues
and cell types, regulating cell expression and are synchronised via hormonal and
neuronal signals. The circadian clock mechanism is regulated by a series tran-
scriptional, post-transcriptional and translatory feedback loops with a periodicity
of approximately 24 hours [120, 121]. The circadian mechanism is governed by
transcription factors, which function through a series of feedback loops, driving cir-
cadian gene expression of clock regulated genes. The transcription factors BMAL1
and CLOCK comprise the positive feedback loop of the circadian mechanism in
mammals. BMAL1 and CLOCK drive the expression of two further transcription
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factors, Period (Per) and Cryptochrome (Cry). Per and Cry form the negative feed-
back loop by antagonising the BMAL1/CLOCK transcriptional activity. This mecha-
nism is predominantly synchronised to the light dark cycle and BMAL/CLOCK are
highly expressed during the light cycle, whereas Per and Cry are high during the
low light/dark period. The circadian rhythm is crucial for the maintenance of body
function and homeostasis. Disruption of circadian rhythms is linked to various in-
flammatory diseases, cardiovascular diseases and cancer. It is well known that
the renin-angiotensin system has a circadian rhythm, which was predominantly as-
sessed by measuring the plasma renin activity at different time points [122, 123].
The study by Gordon et al. investigated patients that were placed on the same diet
and identified that the plasma renin activity was higher in the morning than in the
afternoon [123]. The study further revealed that the circadian rhythm of renin was
unaffected by changes in diet or posture. The circadian rhythmicity of the RAS was
further demonstrated by plasma concentration measurements of circulating AngII
which revealed that AngII, the main effector of the RAS, exhibits diurnal variation
with highest concentrations in the morning and lowest values in the evening [54].
Ultimately, the circadian rhythm of the RAS is linked with the blood pressure (BP)
variation. In humans, blood pressure decreases at night, increases strongly in the
morning and peaks in the late afternoon. In healthy individuals, BP drops by 10%
- 20% at night [124]. However, so-called non-dippers do not experience a mini-
mum decrease of 10% at night. This lack of blood pressure decrease is linked to
the activation of the RAS, and ultimately, these individuals are at increased risk of
chronic kidney disease [120,121]. Since, the circadian rhythm of the RAS has been
identified in various different species, however, not in zebrafish. Homologous gene
sequences to the mammalian clock genes have been identified in zebrafish [125].
Furthermore, the molecular mechanisms that govern the circadian rhythm are sim-
ilar to that in the more extensively studied mammalian systems. Most of the ze-
brafish clock genes are rhythmically expressed, however, there is a lack studies
investigating the circadian clock protein expression in zebrafish in vivo and their
regulation of tissue specific genes.
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Fluorescence Resonance Energy Transfer (FRET) peptides are a novel and excel-
lent tool for studying enzyme kinetics and for the investigation of enzyme kinetics
in vitro and in vivo. FRET peptides are commonly designed to encompass two
fluorophores that are separated by a peptide sequence which is recognised and
cleaved by an enzyme of interest. Foster first described the resonance mechanism,
and it occurs whenever the emission spectrum of the acceptor molecule overlaps
with that of the emission molecule [126]. FRET is highly dependent on the dis-
tance of the two molecules and distances greater than 10nm are too far for FRET
to occur [127]. For FRET probes, it is common to choose a fluorescent acceptor
molecule that is quenched by a non-fluorescent emission molecule (Figure 1.6).
A peptide sequence separates the two molecules and, when intact, the probe
exhibits internal fluorescent quenching. However, cleavage of the peptide se-
quence separates the two molecules and liberates the fluorescence property of
the acceptor molecule, allowing quantitative and qualitative measurement and as-
sessment of the enzyme activity. A significant advantage of FRET probes is that
they have low toxicity [128]. Many peptides and fluorophores are not toxic and, due
to the sensitivity of fluorophores, only low concentrations of the FRET probes are
required for most applications.
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Figure 1.6 | Schematic representation of the FRET peptide mechanism A)
Methyl red quenches the fluorescence of 5(6)-carboxyfluorescein when the pep-
tide sequence is intact. B) Renin recognises and cleaves the Ang1-14 peptide
sequence. C) Cleavage removes the N-terminus and C-terminus interrupting the
FRET and restoring the fluorescent property of the 5(6)-carboxyfluorescein.
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There is limited literature on the use of FRET probes to measure renin activity
although FRET probes for mouse, rat and human renins are commercially avail-
able. Briefly, FRET probes consist of two fluorophores connected by a peptide
sequence from angiotensinogen, which contains the renin cleavage site. In the ab-
sence of renin activity, the acceptor molecule on one end of the peptide sequence
quenches the fluorophore activity of the fluorescent molecule on the opposing end
of the peptide sequence, due to the fluorescent energy transfer between the two
molecules. Cleavage by renin separates the two molecules and the inter-molecule
distance becomes too great for FRET to occur and thus preventing quenching.
This fluorescence-based technique is, in principle, an excellent alternative to the
previously commonly-used radioimmuno method of assaying renin as it directly
measures renin activity rather than measuring angiotensinogen conversion to AngI
by renin. Noteworthy is the work conducted by Peter-Peterdi, which uses a com-
mercially available FRET probe to measure and image renin release in vitro [129].
The FRET probe uses a 10 amino acid angiotensinogen sequence containing the
renin cleavage site with the EDANS fluorophore, which is quenched by DABCYL
when the peptide sequence is intact in the absence of renin. Renin release was
stimulated by administration of isoproterenol, a β-adrenoreceptor stimulant, and
an increase in EDANS fluorescence was observed. Other attempts to use the
renin FRET probe have been for renin quantification in the plasma of rats and hu-
mans [130]. The problem with peptide based FRET probes is that the amino acid
sequence is often recognised and cleaved by proteolytic enzymes such as trypsin
and proteinase K. Dissection of arterioles reduces the background activity of the
FRET by protecting it from cleavage through other enzymes however, there are
no publications of using FRET probes in vivo. Common strategies to reduce the
background of FRET probes is to remove single amino acids in the FRET probe
peptide sequence without affecting the enzyme of interest. Due to the translucent
nature of larval zebrafish, there is potential scope for imaging renin release in vivo
in larval zebrafish.
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Solid-phase peptide synthesis (SPPS) is the most commonly used strategy to build
short peptides synthetically [131, 132]. Most biological regulatory processes are
dependent on peptides and proteins deriving from α-amino acids, and hence there
was a need to develop a simple lab-based technique to produce pure peptides.
Amino acids are organic compounds that contain two key functional groups, a car-
boxylic acid (–COOH) and an amine (–NH2) and SPPS is a step-by-step construc-
tion of a peptide built on a solid support (Figure 1.7).
Although peptide synthesis in solution is possible, it requires lengthy recovery
and purification of the product after every addition of a new amino acid [131]. The
solid support in SPPS permits wash out of unreacted reagents without loss of the
actual product. SPPS depends on the covalent attachment of a protected amino
acid to a solid support and uses either a Boc (tert-butyloxycarbonyl) or Fmoc (9-
fluorenylmethoxycarbony) strategy as the protection group for the reactive amino
group of the amino acid. The two strategies differ mainly in the deprotection con-
ditions. Fmoc is a more refined and requires moderate bases for deprotection
compared to the acid-liable Boc protecting group. In a first step, a Fmoc protected
amino acid is covalently bound to a solid support. Removal of the Fmoc protecting
group permits a further Fmoc protected amino acid to react only with its carboxylic
acid group to the free amine group of the covalently bound amino acid, preventing
side reactions. Amino acids with side protecting groups have these deprotected
during the final cleavage step of removing the final peptide from the solid support.
1.17 VAST Imaging System
Zebrafish is an ideal model for various diseases. Their in vitro development, translu-
cent nature and small size allow for using microscopy to investigate organ and tis-
sue function at high spatial resolution. A significant drawback of using microscopy
systems is the time-consuming nature of mounting single fish in a correct orien-
tation for reproducible images while minimising damage to permit recovery and
re-imaging of the same fish [133]. First attempts at developing an automated ze-
brafish imaging system used simple capillary tubes and a fluidics system, which
allowed the loading of larval zebrafish into a glass capillary, which was mounted
under a microscope and was attached to rotary segments for proper orientation of
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Figure 1.7 | Fmoc-Chemistry for peptide synthesis An Fmoc protected amino
acid is coupled onto a solid support (SS). Deprotection removes the Fmoc pro-
tecting group, exposing an amino reactive group which can be coupled with an
activated, further Fmoc protected amino acid. The Fmoc protection ensures that
only the carboxyl group can react with the amine group of the deprotected amino
acid. Cleavage of the final peptide from the solid support results in complete de-
protection.
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the fish [134, 135]. This system was further developed into the Vertebrate Auto-
mated Screening Technology (VAST) system. The VAST system contains a Large
Particle sampler (LP sampler) which gently aspirates larvae from multi-well plates,
transporting these to a rotary glass capillary (Figure 1.8).
Figure 1.8 | Vertebrate Automated Screening Technology (VAST) system
Photo of the VAST system linked to the Large Particle (LP) sampler. The LP sam-
pler is connected to the VAST by plastic capillary tubing. Pumps operate the LP
sampler, enabling suction of fish into the plastic tubing. Fish are transported to the
microscope where a rotatable glass capillary is mounted. The fish is arrested in
the glass capillary and a live image permits correct orientation of the fish. After
imaging the fish is returned to the LP sampler and with fresh medium placed in the
same well on a new multi-well plate. Image taken from Pulak et al. [135].
The glass capillary is held in place between two rotating components, capable
of rotating the fish by 360°. Installed software recognises the fish entering the cap-
illary and can orientate the fish with highly reproducible accuracy every time. The
LP sampler system is then able to return the fish to a separate multi-well plate into
the equivalent well, thereby retaining the identity of the fish for future imaging. This
automation and handling of larvae permit for high-throughput phenotypic screen-
ing and generation of large dataset images. It also minimises the number of fish





Bioluminescence and fluorescence differ in that fluorescence is a type of light stem-
ming from a fluorophore, which is a molecule that is excited by the energy from an
external light source. In an excited state, the fluorophore releases energy in the
form of light at a different wavelength to the excitation wavelength. Contrary, bio-
luminescence is not dependent on an external light source and requires excitation
from an enzymatic reaction. Both bioluminescence and fluorescence are com-
monly used in scientific research and their different properties have advantages
and disadvantages. Bioluminescence is known to have a highly sensitive detec-
tion capacity, and the lack of an external light source eliminates autofluorescence
during imaging. The light produced from the bioluminescent reaction is very faint
and hence it is not suitable for high-resolution imaging, however higher sensitivity
cameras have recently been developed enabling high-resolution bioluminescence
microscopy. Luciferase has no post-translational modification and is well-suited as
a real-time reporter for gene expression analysis. For the bioluminescent reaction
to occur two agents are required: the enzyme luciferase and its substrate luciferin.
The oxidative decarboxylation of the luciferin in the presence of oxygen yields en-
ergy in form of light which can be measured and imaged (Figure 1.9).
Depending on the luciferase enzyme used, different wavelengths of light and
length of light emission can be achieved. When luciferase is expressed its activity
can be assayed by addition of the substrate and measuring its light-producing ac-
tivity using a plate reader or a highly sensitive CCD camera capable of detecting
photons. The photon signal can then be superimposed onto a brightfield image
in order to localise the source of the signal. Addition of the luciferin can be per-
formed by injection into the fish or addition to the water. Luciferase-based imaging
has been widely used in mice for monitoring cell expression and migration [136].
Although less common, the luciferase system has also been used to study various
systems in the zebrafish [137, 138, 139, 140, 141]. However, previous zebrafish lu-
ciferase work was predominately focused on larval zebrafish, such as the study by
Chen et al. used bioluminescent imaging systems to investigate heart regenera-
tion in adult zebrafish [140]. There are currently no reports of the luciferase system
being used to investigate renal function in zebrafish.
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Figure 1.9 | Bioluminescent reaction Bioluminescent reaction catalysed by firefly




Although the zebrafish is a highly valuable model for investigating renin and the
RAS, many questions remain unanswered, in particular the role of renin in the
zebrafish. Previous studies have demonstrated the spatial expression of renin in
the pronephric and mesonephric zebrafish kidneys. However, there is a lack of
understanding of the temporal renin gene expression and the renin protein activity
in zebrafish due to a lack of tools to permit investigation of these.
I aim to develop a novel bioluminescent renin reporter zebrafish in order to
establish a real-time reporter of renin transcription. I hypothesise that the biolu-
minescent reporter luciferase will faithfully report for renin gene expression within
the zebrafish. This novel renin reporter will be validated by a plate-based assay
for the quantitative measurement of renin expression as well as bioluminescent mi-
croscopy to validate bona fide expression of the bioluminescent signal. Current ze-
brafish renin reporters allow to investigate the spatial distribution of renin express-
ing cells however, investigating renin gene expression is limited to time consuming
assessment of mRNA concentration. Furthermore, the small number of renin ex-
pressing cells during early development requires multiple larval fish in order to have
high enough mRNA concentration for accurate quantification. A bioluminescent re-
porter is expected to overcome these limitations due to highly sensitive nature of
the bioluminescent assay.
Furthermore, I will identify and synthesise the zebrafish AngI and AngII pep-
tides by SPPS. In collaboration with Attoquant Diagnostics, a mass spectrometry
assay will be developed to accurately measure the concentrations of AngI and
AngII in adult zebrafish serum and kidney from fish treated with the ACE inhibitor
Captopril, and compare it to untreated controls. This will allow to observe a dy-
namic change in the concentrations of AngI and AngII and demonstrate the ef-
fectiveness of Captopril in zebrafish. I will also design a novel zebrafish renin
FRET probe using SPPS. I hypothesise that the renin FRET probe will permit ac-
curate measurements of renin activity in zebrafish. There is a lack of antibodies
that permit the quantification and visualisation of zebrafish renin. By synthesising
the 14-amino acid sequence renin recognises and cleaves, and attaching a fluo-
rophore and quencher to the N- and C- terminal ends of the peptide, the probe will
be fluorescently inactive. When zebrafish renin cleaves the probe the fluorescent
signal will be recovered and renin activity will be quantifiable. Probe activity will be
validated and compared in mib−/− and ren−/− zebrafish, both lacking active renin
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and compared to mib+/+ and ren+/+ zebrafish. Moreover, assays will be designed
to show an increase of renin activity throughout zebrafish development, indicative
of the specificity of the FRET probe.
In order to measure renin enzyme kinetics, recombinant zebrafish renin will be
generated in cell based protein expression systems and purified. Western blot
analysis and using the FRET probe designed in this thesis, the protein activity will
be validated.
During this thesis, the first ren−/− zebrafish was generated by CrispRCas9
gene editing. I will use various methods to characterise the ren−/− zebrafish line.
Histological examination of the adult zebrafish kidney will reveal changes to the
kidney morphology. I will also use the VAST system to identify any changes in ze-
brafish development due to the absence of active renin. I hypothesise that renin is
crucial for development, and zebrafish lacking renin will have severe vascular and
renal defects. The fish will be exposed to low salt water concentrations to inves-
tigate their ability of salt handling in the absence of a functional RAS. I will also
use high resolution microscopy imaging on the ren−/− zebrafish crossed to exist-
ing transgenic zebrafish lines to visualise the cellular changes to renin-expressing
cells and possible changes to the pronephric and mesonephric renal vasculature.
I hypothesise that the lack of renin will dramatically
Lastly, the crossing of ren−/− to the tg(ren:RFP-LifeAct) and tg(acta2:EGFP)
and the development of a FAC sorting protocol has permitted the recovery of ren-
and acta2-expressing cells from ren−/− zebrafish kidneys. This permitted further
quantification of the number of ren- and acta2-expressing cells in the metanephros
of ren−/− and ren+/+ zebrafish.
This thesis and the tools that will be developed throughout this research will
further the understanding and permit future studies using the zebrafish as a model







A list of standard solutions and their recipes can be found in Table 2.1.
Medium Type Recipe
1×PBS 10 tablets, 1l ddH2O
0.5M EDTA 93.05 g EDTA in 500 ml H2O, pH 8
50×TAE
242 g Tris-base in 700 ml, 57.1 ml
acetic acid, 100 ml 0.5 M EDTA
1M Tris
121.14 g Tris base and adjusted to
pH 8 using concentrated HCl
4% PFA
4% w/v paraformaldehyde in PBS and
used 1M NaOH used to adjust to pH 7.2
Conditioned Water (CW) 6 mg/l marine salts, pH 7.4
1/20 CW 3 mg/l marine salts, pH 7.4
E3 Medium
34.8 g NaCl, 1.6 g KCl, 5.8 g CaCl2 · 2 H2O,
9.78 g MgCl2 · 6 H2O
10×TBS 24.2 g TRIS Base, 80 g NaCl, pH 7.6
1×TBST 50 ml 10x TBS, 450 ml H2O 500 µl Tween 20
1×TBST + Milk
5 g Semi skimmed dried milk,
100 ml 1×TBST






Experiments were approved by the local ethics committee and conducted in ac-
cordance with the Animals (Scientific Procedures) Act 1986 in a United Kingdom
Home Office-approved establishment. All zebrafish home office regulated work
was conducted under the Home office project licence 70/8886 and carried out by
myself, unless stated otherwise. Zebrafish were maintained in aquarium system
water at a constant water temperature of 28.5 ◦C on a 14 hour light/10 hour dark
cycle.
2.2.2 Zebrafish Pair Mating
Zebrafish pair mating was performed in breeding tanks consisting of a 500 ml main
tank containing an insert with small gaps, through which eggs can fall through
to prevent the fish from eating them. A male and female fish are placed in the
breeding tank in the evening and usually breed first thing in the morning. For time
sensitive breeding and to allow control over the egg age, a plastic insert can be
added keeping the male and female apart and is removed in the morning. Eggs
were collected mid-day by pouring contents of the tank through a sieve. Eggs were
washed with system water, mixed with methylene blue to prevent fungal growth and
kept in an incubator at 28.5 ◦C
2.2.3 Zebrafish Breeding by Marbling
For large fish egg numbers, marble boxes were placed directly into the fish tanks.
The marble boxes consist of two boxes placed within each other. The internal tank
contains a mesh bottom allowing for the eggs to fall through into the external tank
to prevent the fish from eating them. The internal tank contains several marbles
to encourage fish breeding. The marble box was placed in the fish tank in the
late afternoon for fish to breed the subsequent morning. Eggs were collected as




Fish were sacrificed by overdose of anaesthetic. Adult fish were placed in Tricaine
solution (MS–222, 4 mg/ml) until cessation of gill movement was observed and
there was no reaction to touch. Destruction of the brain was used as the secondary
method for the confirmation of death
2.2.5 N-phenylthiourea
N-phenylthiourea (PTU(Sigma Aldrich, P7629)) was used to inhibit the zebrafish
from developing pigment. Especially for visualising cells along the anterior mesen-
teric artery it is essential that the fish are PTU treated. At 4dpf and 5dpf the pig-
mentation prohibits the anterior mesenteric artery from being imaged accurately.
A non toxic option would be to breed the fish on a nacre or casper background,
however these are difficult to breed and have been avoided throughout this project.
3 mg/ml PTU was dissolved in Hank’s Balanced salt solution by heating the mix to
65 ◦C. The stock solution was kept for 1 month at 28.5 ◦C to avoid re-crystallisation
and precipitation. PTU was added to the petri dishes for a final concentration of
0.003% w/v. PTU was added approximately 6 hours post fertilisation (hpf) on the
same day of egg collection. PTU was changed with water everyday and left in the
petri-dishes with the eggs until imaging. Due to the toxic developmental effects of
PTU, all treated fish were terminated at 5dpf.
2.2.6 Zebrafish Strains
WIK was the only strain of wild-type zebrafish used in this project and was main-
tained by the BVS Aquatics Unit housed in the multi-centred Queen’s Medical Re-
search Institute in Edinburgh. Transgenic zebrafish used in this study which have




ren:RFP-LifeAct Dr Sebastien Rider Rider et al. [47]
acta2:EGFP Prof. Didier Stainier Whitesell et al. [142]
wt1b:EGFP BVS Facility Perner et al. [143]
flk :mCherry BVS Facility Choi et al. [100]
WIK BVS Facility Rauch et al. [144]
Table 2.2 | Table listing zebrafish lines used Origin and reference of the ze-
brafish lines used throughout this thesis. All transgenic fish are on a WIK back-
ground.
2.2.7 Dechorionating Zebrafish Embryos
Chorions were removed at 24hpf using two forceps. Using forceps the chorion was
held in place whilst using the an additional pair of forceps to tear the chorion open.
The embryo is gently pushed through the opening. Any damaged embryos were
discarded.
2.2.8 Zebrafish Anaesthesia
Zebrafish were placed under short-term anaesthesia for fin clipping and imaging
purposes. Anaesthetic comprised of 0.04 mg/L tricane diluted aquarium system
water.
2.2.9 Genotyping Fin Clip DNA Extraction
Zebrafish were genotyped from caudal fin clips of on fish aged 23dpf or adults
(>3 months old). Clipped fins were placed directly in eppendorf tubes containing
200 µl 50mM NaOH and kept on ice until DNA extraction or stored in the freezer at
−20 ◦C. Crude DNA extraction was performed by heating the samples in NaOH to
95 ◦C in a heat block for 10 minutes with occasional shaking of the tubes to disrupt
the tissue. Samples were subsequently cooled to 4 ◦C by placing them on ice and
adding 1/10th of the original NaOH volume of 1M Tris (pH=8) to neutralise the
NaOH. Samples were spun at maximum speed in a centrifuge to pellet the debris.
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Supernatant was transferred to a fresh 1.5 ml eppendorf tube and diluted 1:10 for
subsequent PCR reactions.
2.2.10 Genotyping PCR Reaction
DNA was extracted as described in Section 2.2.9. For the genotyping PCR Q5
High-Fidelity DNA polymerase (NEB, M0491) was used. The protocol was adapted
to minimise the use of the polymerase for one reaction. 3 µl of Q5 buffer was added,
0.3 µl of 10mM dNTP mix, 0.75 µl of forward and reverse primer at a concentration
of 10 µM was added respectively. Lastly, 0.075 µl of Q5 polymerase was added
resulting in 14.5 µl of reaction volume per tube. 0.5 µl of the fin clip DNA were
added and the PCR was run in a thermocycler (Applied Biosciences, Veriti 96-well)
on the program (Table 2.3).
Temperature Time Cycles
98 ◦C 3 seconds 1×
98 ◦C 5 seconds
68 ◦C 15 seconds 30×
72 ◦C 20 seconds
72 ◦C 7 minutes 1×
4 ◦C 2 minutes ∞
Table 2.3 | PCR temperature and cycles for genotyping zebrafish Genotyping
of zebrafish with DNA extracted from fin clips.
2.3 Plasmid Generation
2.3.1 Restriction Enzyme Digest
All restriction enzyme digests were performed using restriction enzymes supplied
by NewEngland Biolabs. 1 µg of DNA and for the restriction enzyme appropriate
10× buffer were combined and diluted to 19.5 µl using water. 0.5 µl of the restric-



























Table 2.4 | ren:LUC genotyping primers Table containing genotyping primer se-
quences and their amplicon product size.
before placing on ice. The resulting DNA products were analysed by DNA gel
electrophoresis (Section 2.3.2).
2.3.2 Agarose Gel Electrophoresis
For DNA product size determination or investigation of RNA quality an agarose
electrophoresis gel was used. The gel constituted of 0.8% agarose, and gel red
to stain nucleic acid. Unless stated otherwise the the agarose was dissolved in
1×TAE buffer. Gel was run in electrophoresis tanks at 80 V for 1.5 hours.
2.3.3 Vector Amplification
All vectors used in this project were amplified using One ShotTM TOP10 Chemically
Competent E. Coli (InvitrogenTM). E. Coli were grown on luria broth (LB) plates con-
taining an antibiotic for selection, dependent on the plasmids antibiotic resistance.
Glycerol stocks of all vectors were kept in 5% glycerol at −80 ◦C.
2.3.4 Plasmid and PCR Sequencing
DNA sequencing was performed by DNA Sequencing & Services (MRC I PPU,
School of Life Sciences, University of Dundee, Scotland, www.dnaseq.co.uk) using
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Applied Biosystems Big-Dye Ver 3.1 chemistry on an Applied Biosystems model
3730 automated capillary DNA sequencer.
2.3.5 Gateway Cloning
All transgenic fish were injected with plasmids generated via the gateway cloning
method [91]. Plasmids not generated in house were obtained from sources detailed
in Table 2.5.
Plasmid Origin
p5E-6.4kb-renin Dr Sebastien Rider
p5E-Luciferase Dr Calum A. MacRae






Table 2.5 | List of Plasmids List of entry clones and destination vectors used to
build expression vectors.
2.3.6 Generation of ren:LUC
The plasmid to create the tg(ren:LUC) zebrafish was generated using the following
3 entry clones and destination vector:
• 5’ entry clone: p5E-6.4kb-renin
• Middle entry clone: p5E-Luciferase
• 3’ entry clone: p3E-polyA
• Destination vector: pDestTol2CG2
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All entry clones and the destination vector were validated by restriction digest
(Section 2.3.1). In a 1.5 ml eppendorf tube all entry clones (20 fmol) were combined
with the destination vector (20 fmol) and TE buffer (4 µl). Gateway™LR Clonase™II
Enzyme Mix was thawed on ice and added to the mixture (2 µl). The reaction was
incubated at 25 ◦C for 26 hours. The reaction was stopped by addition of proteinase
K (2 µg and incubation at 37 ◦C for 10 minutes. The reaction was then transformed
into Top 10 One Shot E. Coli cells and amplified as described in Section 2.3.3
and verified by DNA sequencing and extensive restriction digest and DNA elec-
trophoresis.
2.3.7 Generation of ren:LUC-2A-mCherry
The plasmid to create the tg(ren:LUC-2A-mCherry) zebrafish was generated the
following 3 entry clones and destination vector:
• 5’-entry clone: p5E-6.4kb-renin
• Middle entry clone: p5E-LuciferaseNoStop
• 3’-entry clone: p3E-2A-mcherryp2A
• Destination vector: pDestTol2pACryCFP
The ’p5E-LuciferaseNoStop’ plasmid was generated by TOPO cloning and re-
moving the stop codon from the previous p5E-Luciferase clone using the PCR
product using the primers outlined in Table 2.6. All entry clones and the destina-
tion vector were validated by restriction digest (Section 2.3.1). In a 1.5 ml eppendorf
tube all entry clones (20 fmol) were combined with the destination vector (20 fmol)
and TE buffer (4 µl). Gateway™LR Clonase™II Enzyme Mix was thawed on ice
and added to the mixture (2 µl). The reaction was incubated at 25 ◦C for 26 hours.
The reaction was stopped by addition of proteinase K (2 µg and incubation at 37 ◦C
for 10 minutes. The reaction was then transformed into Top 10 One Shot E. Coli
cells and amplified as described in Section 2.3.3 and verified by DNA sequencing















Table 2.6 | Luciferase no stop cloning primers Primers used for the generation
of the luciferase gene cassette without the stop codon.
2.3.8 Transposase
Tol2 transposase mRNA for co-injection with the transgenic plasmid DNA was gen-
erated from the PCS2FA-transposase plasmid. The vector containing an ampi-
cillin resistance cassette was amplified by the vector amplification method in Sec-
tion 2.3.3. The plasmid PCS2FA-transposase was digested with NotI and puri-
fied by phenol:chloroform extraction and ethanol precipitation. DNA was extracted
and processed into mRNA using the InvitrogenTM mMESSAGE mMACHINETM SP6
Transcription Kit (InvitrogenTM AM1340). The synthesised mRNA was purified with
the RNA purification kit (Qiagen, 70042). The RNA precipitate was suspended in
distilled water and frozen at −80 ◦C.
2.3.9 Prorenin-Psec2C
For the expression of recombinant renin, the Gibco ExpiCHO Expression System
(ThermoFisherTM, A29133) was used. The pSecTag2c mammalian expression
vector was used as a receiving vector of the renin gene cassette. The vector
contains a large cloning site. Upstream of the cloning site, the vector contains
a cytomegalovirus (CMV) promoter for high-level constitutive expression. Down-
stream of the cloning site is a sequence coding for the c-terminal polyhistidine
(6×His) tag for rapid purification with nickel-chelating resin and detection with an
Anti-His (C-terminal) antibody. The prorenin coding sequence (Appendix A) was
synthesised by DC BIOSCIENCES Ltd. with a 5’ EcoRI and C-terminal TEV pro-
tease site followed by a 3’ XhoI restriction site. The TEV protease side enabled
removal of the 6×His tag if it were to interfere with the protein activity. The EcoRI
and XhoI restriction sites permit cloning by restriction digest while maintaining the
reading frame. The carrier vector of the renin coding sequence, as well as the
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pSecTag2c vector were digested using a double restriction enzyme digestion with
the restriction enzymes EcoRI and XhoI. The DNA fragments were separated by
DNA gel electrophoresis and extracted from the agarose gel. DNA was recovered
from the gel using the Macherey-NagelTM NucleoSpinTM Gel and PCR Clean-up Kit
(Macherey-Nagel, 12303368). Ligation of the the renin coding sequence into the
pSecTag2c expression vector was performed using a 1:3 expression vector (50 ng)
to renin coding sequence ratio (35 ng) and combining this with the Quickligase
(Quick LigationTM Kit, NEB, M2200S). The mixture was left at 24 ◦C for 1 hour. Af-
ter ligation the resulting plasmid was transformed and amplified. Restriction digest
analysis with subsequent DNA electrophoresis confirmed successful ligation and
maintenance of the reading frame was validated by DNA sequencing.
2.3.10 Renin-Psec2c
The renin-Psec2c plasmid was generated as described in Section 2.3.9. The
prorenin coding sequence (Appendix B) was synthesised by DC BIOSCIENCES
Ltd. with a 5’ EcoRI and C-terminal TEV protease site followed by a 3’ XhoI restric-
tion site. The EcoRI and XhoI restriction sites permit cloning by restriction digest
while maintaining the reading frame.
2.3.11 Injection Needles
Injection needles were pulled from filament-less glass capillaries (TW100-4, World
Precision Instruments (WPI), Sarasota FL, USA) using a Micropipette puller (P-
97, Sutter Instrument, Novato CA, USA). The needles were pulled using the fol-
lowing settings: heat 450, pull 85, velocity 55 and time 150. The needles were
loaded using EppendorfTM MicroloaderTM Pipette Tips (EppendorfTM, 5242956003)
and mounted onto a (YS-PV820 Pneumatic PicoPump). The needles were bro-
ken using fine forceps closest to the sealed end. Once it was possible to eject
liquid from the needle, a calibration injection into mineral oil placed over a gratic-
ule was performed allowing the measurement of the diameter of the liquid sphere
from which the injection volume could be calculated. The micro manipulator was
adjusted to reach an injection volume of 5 nl.
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2.3.12 Plasmid Injection
Plasmids were injected into WIK derived eggs unless stated otherwise. WIK eggs
were collected using the mass egg production system (MEPS) which was set up
in the morning to ensure control over the stage of egg development. For the in-
jection the eggs were required to be collected and injected at the one cell stage
to ensure the transgene to be present in all subsequent cells. Injection needles
were loaded with 3 µl of 1:1 linearised plasmid DNA (50 ng/ml) and transposase
mRNA (50 ng/ml) by using EppendorfTM MicroloaderTM Pipette Tips (EppendorfTM,
5242956003). Collected MEPS eggs were placed onto 2% agarose with grooves
and water was extracted for the duration of the injections. Once injected, the eggs
were transferred into a petri dish and left in the incubator at 28.5 ◦C. Approximately
6 hours after the injections, the dishes were cleaned and dead eggs and debris
were removed.
2.4 In Vivo Luciferase Assay
Injected fish eggs were kept at 28.5 ◦C in for 4 days before being tested for lu-
ciferase expression. Fish were washed using embryonic media (E3) twice before
transferring single fish into a black 96-well plate. For accurate and even water dis-
tribution between wells, the pipette tip was cut off and the fish were placed into
the wells with E3 media. A stock solution of luciferin was prepared in E3 (100mM)
and added directly into the wells for a final concentration of 10mM. The plate was
kept in the dark and left for 5 minutes in order for the fish to take up the luciferin.
The plate was placed in a preheated (28.5 ◦C) bioluminescence plate reader (Victor
3X). Each well was read for 30 seconds in order to maximise light detection.
2.5 Ribonucleic Acid Extraction
1 metal bead was placed into a 2 ml eppendorf tube containing the tissue sam-
ple alongside 1 ml lysis reagent (QIAzol Lysis Reagent, Qiagen, 79306). Tissue
was homogenised using a tissue lyser (TissueLyser II, Qiagen, 85300) at 30 Hz
for 1 minute. Next, the tissue was left to incubate in the lysis reagent at room
temperature for 15 minutes before centrifuging at maximum speed for 15 minutes
at 4 ◦C. The supernatant was transferred into heavy phase lock tubes (5PRIME
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Phase Lock GelTM, Quantabio, 2302830) for phase separation and 200 µl of bromo-
3-chloropropane was added. Tubes were shaken for 10 seconds and left to incu-
bate on bench at room temperature before spinning again at maximum speed for
15 minutes at 4 ◦C. The aqueous phase containing ribonucleic acid (RNA) was
collected and washed with an equal volume of 70% ethanol. The aqueous phase
and ethanol mix was then transferred into Qiagen RNeasy Mini Kit (Qiagen, 74106)
columns for further cleaning up following the manufacturer’s protocol. After the first
cleaning step in the Qiagen protocol, DNAse (Ambion – AM1906) was added to
remove any gDNA contamination and the column was incubated at 37 ◦C for 15
minutes before continuing with the provided Quiagen protocol.
Adult Kidney RNA Extraction
Adult kidneys were extracted as described in Section 2.6.1 and a single kidney
was placed inside a 2 ml eppendorf tube on and kept cold on dry ice. The RNA
extraction was then performed according to the description in Section 2.5.
Whole Embryo RNA Extraction
For larval zebrafish RNA extraction 10 fish were pooled together as one sample
to ensure enough RNA was extracted. If the embryos were <3dpf, chorion was
removed prior to collection as described in Section 2.2.7. Zebrafish were placed in
2 ml eppendorf tubes and frozen by placing the tubes directly on dry ice. Samples
were either processed immediately as described in Section 2.5 or stored at−80 ◦C.
RNA Quantification
The RNA was eluted from the columns using 42 µl of RNAse free water and 2 µl
were used on a NanoDrop (ThermoFisher™NanoDrop 1000 Spectrophotometer)
to determine RNA concentration and the absorption ratios at 260nm/280nm and
260nm/230nm ratios indicating possible protein or carbohydrate contaminants, re-
spectively. If the absorption ratio at 260nm and 280nm was approximately 2, a 1%
agarose gel was made up using 1×TAE. 500 µg of RNA were loaded on the gel.
Gel electrophoresis at 80 V for 1.5 hours was performed to investigate the quality
of the RNA. When clear separation of the visible 28 s and 18 s bands could be
seen the RNA was regarded as stable and used for downstream applications.
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2.5.1 RNA Reverse Transcription
RNA was reverse transcribed to produce cDNA using the High–Capacity cDNA Re-
verse Transcription Kit (Applied Biosystems™, 4387406). In accordance with the
manufacturer’s guidelines, a 2×RT Master Mix was prepared and 10 µl of the Mas-
ter Mix were combined with 10 µl RNA (0.5 µg). The samples included a RNA sam-
ple without the Multiscribe enzyme which was included in the subsequent, quantita-
tive polymerase chain reaction (QPCR) assay, to ensure no DNA contaminated the
RNA samples. The reverse transcription was performed in a thermocycler (Applied
Biosciences, Veriti 96-well) on the program outlined in Table 2.7.
Steps Time Temperature
Step 1 10 minutes 25 ◦C
Step 2 120 minutes 37 ◦C
Step 3 5 minutes 85 ◦C
Step 4 ∞ 4 ◦C
Table 2.7 | Reverse transcription cycle conditions Thermal cycler conditions for
the reverse transcription of RNA to cDNA.
2.5.2 Quantitative Polymerase Chain Reaction
Quantitative polymerase chain reaction (QPCR) was performed using the Roche
LightCycler® 480 system. cDNA used was generated as described in Section 2.5.1
and diluted 1:40 for further use. All standards and samples were run in triplicates
and the average concentration was selected for the analysis. The probes from
the Universal Probe Library (UPL, Roche Diagnostics Ltd., UK) used are outlined
together with the selected primer sequences in Table 2.8.
One reaction contained 8 µl Perfecta® QPCR FastMix® II (Quantabio, 733-2108)
made up according to the manufacturers guidelines containing; 100 nM probe,
20 µM forward and reverse primer, and 2.8 µl nuclease free water. The reactions
were plated onto 384 well plates (LightCycler® 480 Multiwell Plate 384, white) and
sealed with LightCycler® 480 sealing foil to prevent evaporation. The plates were
prepared in a clean fume cabinet and on ice. Prior to loading the plates into the
Roche LightCycler® 480 system they were briefly centrifuged to ensure all the sam-
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Table 2.8 | QPCR primers Primer sequences and Roche UPL probe numbers for
QPCR analysis.
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ples and cDNA were at the bottom of the well. The reactions were run on a Fam-
Hydrolysis program outlined in Table 2.9.
Triplicates were analysed and any samples with a standard deviation of the
triplicate Cp value higher than 0.5 was excluded. Furthermore, the standard curve
was analysed for error and efficiency, where <0.05 and 1.9 to 2.1, respectively
was acceptable. Gene concentrations were normalised to the concentration of the
selected housekeeper gene.
Temperature Time Cycles
95 ◦C 5 minutes 1
95 ◦C 10 seconds
60 ◦C 30 seconds 50
72 ◦C 1 seconds
40 ◦C 30 seconds 1
Table 2.9 | Fam-hydrolysis cycle conditions Fam-hydrolysis method used on the
Roche LightCycler® 480 system.
2.6 Cell and Tissue Culturing
2.6.1 Kidney Extraction
Zebrafish were sacrificed as described in Section 2.2.4. The fish were wiped with
an ethanol soaked cloth to prevent contamination during extraction. Using spring
dissection scissors (World Precision Instruments, WPI, 15906) the body of the fish
was opened by performing a long ventral incision from head to the base of the
caudal fin. The insides of the fish were removed by a single motion, removing the
swim bladder from the posterior to the anterior ends of the fish. Removal of the
swim bladder generally results in a successful removal of all internal organs and
exposes the kidney. The kidney can be identified by its faint pink colour and pres-
ence of pigments. The kidney is gently removed from the the spine and collected
in tissue collection medium (Table 2.10).
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Medium Type Recipe
Digestion Buffer
5 mM CaCl2, 10 mg/ml Bacillus Licheniformis
protease and 125 U/ml DNAse in PBS
Culture Medium
Leibowitz-15, 10% FCS, 100 U/ml penicillin
100 µg/ml penicillin and 50 µM
2–mercaptoethanol
FACS Buffer
Leibowitz-15, 2% FCS, 100 U/ml penicillin
100 µg/ml penicillin
Tissue Collection Medium
Leibowitz-15, 2% FCS, 100 U/ml penicillin
100 µg/ml penicillin
Table 2.10 | Cell culturing media Media containing all the cell culture media and
buffers.
2.6.2 Mesonephric Kidney Dissociation
Adult zebrafish kidneys were extracted as described in Section 2.6.1. Two kidneys
were placed in tissue collection media (Table 2.10) and kept on ice. Extracted
kidneys were processed in a clean tissue culture hood to avoid contamination.
Kidneys were washed 3× in collection medium to clear of any contaminants and
were placed in 100 µl of digestion buffer (Table 2.10). Kidneys were dissociated in
digestion buffer at 6 ◦C in a thermocycler for 15 minutes and triturated using a P200
Gilson pipette every 2 minutes. Next, the dissociated kidneys were passed through
a 40 µm cell strainer to remove undigested lumps and collected in a 50 ml falcon
tube. The cell strainer is washed with a further 2 ml of FACS buffer (Table 2.10).
The falcon tube containing the cells is spun at 400 g for 5 minutes to pellet the
cells. The cells are then resuspended in either 750 µl FACS buffer if taking them
for cell sorting or in 1 ml culture medium (Table 2.10) if to be seeded directly on in
a culturing plate, as described in Section 2.6.3).
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2.6.3 Kidney Cell Culturing
Zebrafish kidney cells were cultured in 96-well plates coated with fibronectin
(5 µg/cm2). 50 µl of fibronectin for a 96-well plate were placed inside the well and
left for 24 hours on a rocker. Fibronectin was removed right before seeding the
wells with cells. Cells were incubated at 28.5 ◦C in an CO2 incubator. The Cul-
ture Medium (Table2.10) was changed daily and the wells were inspected for any
infections.
2.7 Imaging Modalities
Different imaging modalities were used depending on the level of resolution and
quality of images required. With different imaging systems the mounting of the
samples varies.
Imaging Zebrafish Mesonephros
Zebrafish kidney was extracted as described in Section 2.6.1 and placed onto a
microscopy slide (Thermo Scientific, 11819022). A drop of PBS was added to
the kidney from drying out during imaging and a coverslip was applied on top and
pressure was applied to spread the kidney under the coverslip. Edges were sealed
with nail polish and the slide was imaged the same day using the Leica TCS SP8
confocal laser scanning microscope.
Epifluorescence Microscopy
All screening of zebrafish, injection of larval zebrafish and imaging that did not
require high resolution microscopy was performed on a Leica MZ16F stereomi-
croscope with top lighting. Prior to imaging, zebrafish were anaesthetised as de-
scribed in Section 2.2.8.
Bioluminescence Microscopy
Bioluminescence images were acquired using the Hamamatsu ORCA II BT 1024
mono-chrome camera (C4742-98-26-KWG2). The camera enables the detection
of luminescence signals at 16 bit depth and super cooling the detector to −75 ◦C
allows to acquire images without binning and maximising the signal to noise ratio.
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Images were sampled using the Hamamatsu Wasabi Software. Integration varied
between 12 and 20 minutes depending on signal strength. Larval zebrafish were
anaesthetised using Tricane (MS-222) before mounting them in agarose. 10mM
luciferin was added on top of the agarose 15 minutes prior to imaging, to permit
absorption by the agarose. Fluorescence images were acquired using the Leica
MZ16F stereomicroscope with a dipper lens and top lightning. The exposure time
was kept the same across different images when comparing fluorescence intensity.
Confocal Laser Scanning Microscopy
High resolution microscopy was performed on a Leica TCS SP8 confocal laser
scanning microscope using two highly sensitive HyD detectors. The microscope
was controlled via the Leica LAS X software.
2.8 Peptide Synthesis
2.8.1 Synthesis of Dde-OH
Dimedone (21.2 g, 151 mmol, 1 eq), DMAP (29 g, 156 mmol, 1 eq) and EDC hy-
drochloride (29.1 g, 152 mmol, 1 eq) were dissolved in DMF (400 ml). Acetic acid
(1.59 mmol, 1 eq) was added and the mixture was stirred overnight at room tem-
perature until fully dissolved. The solvent was removed in vacuo. The resulting
oily substance was dissolved in ethyl acetate (200 ml) and washed with 1M HCl
(2×200 ml) until fully dissolved, yielding crude Dde-OH. The crude substance was
analysed by TLC (ethyl acetate + 0.1% acetic acid). Purification was performed by
column chromatography (eluting with DCM) and the product analysed by analytical
HPLC.
2.8.2 Fmoc-Lys(Dde)-OH Synthesis
Fmoc-Lys-OH.HCL (14.12 g, 1 eq), with Dde-OH (9.52 g, 1 eq) was dissolved in
250 ml MeOH. DIPEA (8 ml) was added and using a stirrer the mixture was gently
agitated for 60 hours. The solvent was removed in vacuo and the crude product
was dissolved in ethyl acetate and washed twice with 1M KHSO4. The organic
layer was dried, filtered and concentrated yielding crude Fmoc-Lys(Dde)-OH. The
product was analysed TLC (ethyl acetate + 0.1% acetic acid) showing that it was
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not pure. The crude product was purified by column chromatography (eluting with
ethyl acetate + 0.1% acetic acid). Pure fractions were collected and analysed by
HPLC. The solvent was removed in vacuo and the product was recrystallised using
ethyl acetate/hexane. This resulted in crystalline Fmoc-Lys(Dde)-OH.
2.8.3 Rink Linker Polystyrene Resin
For all FRET probes, an aminomethyl polystyrene resin with a loading of 0.745
mmol/g was used. Poly-styrene resin (200 mg, 0.149 mmol, 1 eq) was swollen with
DCM for 30 minutes. Fmoc-Rink amide linker (241.19 mg, 0.447 mmol, 3 eq) was
dissolved in DMF. Oxyma (63.52 mg, 0.447 mmol, 3 eq) was added and the reaction
mixture was gently agitated for 10 minutes before DIC (69.21 µl, 0.447 mmol, 3
eq) was added and agitated for a further 5 minutes. The mixture was added to
the pre-swollen polystyrene resin. This reaction mixture was gently agitated at
room temperature for 50 minutes. Using the vacuum manifold, the supernatant
was removed and the resin was washed 3× with DMF, followed by 3×DCM and
3×MeOH. Quantitative ninhydrin tests were performed to confirm the lack of free
amines.
2.8.4 2-Chlorotrityl Linker Polystyrene Resin
For other peptides, the 2-chlorotrityl chloride resin with a loading of 1 mmol/g
was used. 2-chlorotrityl chloride resin (200 mg, 0.2 mmol, 1 eq) was washed and
swollen with dry DCM for 30 minutes. To the pre-swollen resin, SOCl2 (35 µl,
0.5mmol, 2.5 eq) dissolved in DCM was added with DIPEA (209.03 µl, 1.2 mmol,
6 eq). The reaction mixture was gently agitated using a stirrer at room temperature
for 1 hour. Supernatant was expelled using the vacuum manifold and the resin
was washed with dry DMF. A mixture of DCM:MeOH:DIPEA (80:10:10) was added
twice for 10 minutes each to cap all reactive groups. The resin was washed with
DMF.
2.8.5 Dde Deprotection
Removal of the Dde protection group was performed with 2% hydrazine in DMF. 2%
hydrazine was added to the resin 5 × 2 minutes and between each addition, the
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resin was thoroughly washed with DMF. Ninhydrin test was performed to confirm
the presence of free amine groups as described in Section 2.8.14.
2.8.6 Fmoc Deprotection
20% piperidine in DMF was added to the pre-swollen resin to remove the Fmoc
protecting group. The mixture was agitated for 10 minutes before removing the
supernatant using the vacuum manifold. Under vacuum the resin was washed
3× with DMF, 3× with DCM before adding a further 20% piperidine in DMF and
agitating for a further 10 minutes. Supernatant was removed using the vacuum
manifold and the resin was washed using 3×DMF, 3×DCM and 3×MeOH. The
quantitative ninhydrin test was used to confirm the presence of free primary amine
groups. For secondary amine groups the chloranil test was performed.
2.8.7 Amino Acid Addition
For all the peptides synthesised in this thesis, Fmoc protected amino acids were
used. Fmoc protected amino acids (3 eq) were dissolved in DMF. Oxyma (3 eq)
was added to the mixture and the solution was agitated for 10 minutes. DIC (3 eq)
was added and the mixture was agitated for a further 5 minutes. The resin was
swollen with DCM and the mixture was added and agitated for 1 hour to permit
binding of the amino acid to the free amine groups. After 1 hour the resin was
washed with 3×DMF, 3×DCM and 3×MeOH using the vacuum manifold. A quan-
titative ninhydrin test was performed to confirm the lack of free amine groups. If the
ninhydrin test indicated free amine groups the reaction was repeated.
2.8.8 Methyl Red Addition
Methyl red coupling was performed as described in Section 2.8.7. The ninhydrin
test was used to confirm the lack of free amine groups.
2.8.9 5(6)-Carboxyfluorescein Addition
Addition of the fluorophore 5(6)-carboxyfluorescein was performed as described




2.8.10 Peptide Cleavage from Resin
Resin was swollen in DCM and a mixture of TFA/TIS/DCM was added at a ratio
9:5:5, respectively. The cartridge with the resin and cleavage mixture was sealed
with parafilm as pressure buildup during the reaction can lead to leakage. The
mixture was shaken for a minimum of 3 hours to ensure that all side protecting
groups were also removed during this step and the peptide was collected via pre-
cipitation into cold ether. For determination of successful deprotection of all side
protecting groups, the final product was analysed by analytical HPLC described in
Section 2.8.13.
2.8.11 Probe Purification and Characterisation
All FRET probes synthesised were purified by semi-preparative HPLC and charac-
terised by analytical HPLC and MALDI mass spectrometry.
2.8.12 Matrix Assisted Laser Desorption Ionisation
Sample was prepared by dissolving the sample in 1 µl of 20 mg/ml sinapinic acid.
This was directly mixed on a 100 well gold Voyager™ matrix assisted laser desorp-
tion ionisation (MALDI) sample plate. MALDI time of flight (TOF) was measured on
a Voyager™ DE-STR MALDI-TOF (Applied Biosystems) mass spectrometer with
the laser scanning across the entire sample. Laser power was dependant on the
final sample concentration.
2.8.13 Analytical HPLC
Analytical high pressure liquid chromatography (HPLC) was performed on an Ag-
ilent 1100 coupled with a Polymer Lab PL-ELS 100 Evaporative Light Scattering
detector (ELSD). The ELSD had UV and also detection at 220, 254, 260, 282 and
450 nm. The column used was a Spelco’s Discovery C18 (50 mm × 2.1 mm ×
5 µm). Samples were dissolved in 1 ml 1:1 HPLC-grade MeCN:H2O. Elution was
performed with HPLC-grade deionised water with 0.1% formic acid and HPLC-
grade methanol with 0.1% formic acid at 1 ml/min with a gradient of 5% to 95% over
3 minutes, followed by 1 minute isocratic, 1 minute to 5% HPLC-grade methanol




• Reagent A: 430 mmol of phenol dissolved in absolute ethanol
• Reagent B: 14 mmol ninhydrin dissolved in absolute ethanol
In order to determine the presence or absence of primary amine groups a nin-
hydrin test was conducted. A small number of resin beads were placed in a glass
vial and reagent A was added to reagent B in a 1:3 ratio. The mixture is placed
in heating block pre-warmed to a 100 ◦C for 2 minutes. A blue colour indicates
primary free amine groups and a yellow test is indicative of protected or lack of
primary amine groups.
2.8.15 Chloranil Test
• Reagent A: 2% acetaldehyde in dimethylformamide (DMF)
• Reagent B: 2% chloranil in DMF
In order to test for secondary amine groups such as on proline, a chloranil test
was performed. Small number of beads were collected in a glass vial and solution
A and solution B were added to the beads at a ratio of 1:1. The mixture was briefly
mixed and left at room temperature for 1 minute. If the resin beads turned blue, it
indicated the presence of secondary amine groups and a negative test showed no
colour change and the beads remained yellow.
2.8.16 In Vitro FRET Assay
10 fish embryos or 1 zebrafish kidney were placed in a 2 ml eppendorf tube with 1
metal bead (Stainless Steel Beads, Quiagen, 69889) and 1M Tris-Buffer, and were
homogenised using a tissue lyser (TissueLyser II, Qiagen, 85300) for 1 minute at
30 Hz. Protein concentration was determined by BCA assay (PierceTM BCA Protein
Assay Kit, ThermoFisher, 23227). 50 µl of tissue homogenate was mixed with 50 µl
of FRET probe (10 µM) for a final concentration of 5 µM in a single well of a black
96-well plate (Nunchuck’s-ImmunoTM, Merck, P8741). After 1 minute of incubation,
the fluorescence intensity was analysed using a plate reader (VICTOR Multilabel
Plate Reader, PerkinElmer, 2030-0050). Wells were excited at a wavelength of
480 nm for 1 second and emission fluorescence intensity was measured at 520
nm from the top of the well. All measurements were conducted in triplicates.
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2.8.17 Western Blotting
Western blot analysis was performed to analyse recombinant proteins. 5 µg of
protein sample were denatured in SDS sample buffer on a heat block for 5 min-
utes at 90 ◦C before adding to a well of a 4-12% Bis-Tris gel (BoltTM, Invitrogen,
NW04120) and subjected to electrophoresis at 110 V for 2 hours to separate de-
pending on their molecular weights. The separated proteins were transferred by
semi-wet transfer onto a nitrocellulose membrane. Successful transfer of the pro-
tein was observed by staining the membrane with Ponceau Red, a protein detection
dye. The membrane was blocked with 1×TBST + 5% Milk at 4 ◦C for 1 hour. After
blocking, the membrane was washed 3× in 1×TBST. The membrane was incu-
bated overnight at 4 ◦C with primary mouse anti 6×His antibody (Anti-6×His tag,
Abcam, ab18184), diluted 1:2000 in 1×TBST + 5% Milk. The membrane was then
washed 3× in 1×TBST before application of the secondary fluorescent goat anti
mouse antibody (Goat Anti-Mouse IgG Alexa Fluor 488, Abcam, ab150113) for 1
hour. The membrane was then washed again 3× in 1×TBST before analysis using
the Licor Odyssey CLx imaging system (Odyssey CLx, Licor).
2.9 Data Analysis and Statistics
For analysis of two groups and continuous data the students t-test was used. Com-
parison of 3 or more samples was performed by 1-way ANOVA. All data analysis
was performed using GraphPad Prism 8 for MacOSX. All data are represented as
mean ± SD with p <0.05 considered to be statistically significant.
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The fluorescent zebrafish renin reporter line, established by Rider et al., permits
studies of the spatial distribution of renin-expression cells and their morphology. To
date it has been shown, using these reporter fish, that zebrafish renin can be modu-
lated by RAS inhibition and sodium challenges [45,47]. However these reporter fish
are not suitable for highly sensitive dynamic investigation of renin gene expression
in vivo, or studies of the response of the RAS to environmental challenges in real-
time. Like many fluorescent proteins, the RFP-LifeAct reporter for renin expression
used by Rider et al., undergoes many lengthy post translational modifications be-
fore they can be detected. This causes a significant lag from the initial gene expres-
sion to being able to detect the functional fluorescent reporter protein, and does not
permit investigation of changes in gene expression in real-time. However, firefly
luciferase is a monomer which does not require any post-translational modifica-
tions and becomes a functional mature enzyme after translation of its mRNA [145].
The use of a luciferase renin reporter would enable the investigation of the renin
transcription in ’real-time’, with the advantage of providing data on gene expres-
sion dynamics and spatial information of gene expression. Luciferase generates
bioluminescence through an oxygen- and ATP-dependant reaction, in which the
substrate luciferin is catalysed by luciferase, producing oxyluciferin and a photon
as a side product (see Figure 1.9). The sensitive and quantitative output of lu-
ciferase as a surrogate reporter for renin transcription, combined with the use of
pharmacological tools for the RAS, would allow the investigation of new regulatory
pathways and studies of the role of the RAS in early development. In this chapter
I will present the generation and validation of a renin-luciferase transgene, the de-
sign of a high-throughput bioluminescence assay, and the use of bioluminescence




3.2.1 Circadian Rhythm Regulating Renin Expression
Most mammals show a steep rise in blood pressure at the start of their active pe-
riod, i.e. daytime for humans and night time for rodents, where an increase in
plasma renin activity (PRA) and ultimately blood pressure increase is observed.
Although zebrafish have a low blood pressure system [146], they have a resting
phase during the dark cycle and an active phase during the light cycle [147]. In
order to determine the activity of clock genes in the zebrafish kidney, adult kidneys
were extracted early in the morning after the lights came on (9AM, n=7), the mid-
dle of the light cycle (3PM, n=5), immediately after lights went out (12AM, n=11),
and middle of the night (5AM, n=5). RNA from the kidneys was extracted and
subsequently reverse transcribed into cDNA and QPCR analysis was performed
(Figure 3.1). Bmal1 was significantly upregulated in the early afternoon compared
to all other time points. Clock1a, which is typically expressed in parallel with Bmal1
showed highest expression in the early morning. Clock1a was significantly lower
at all other time points, suggesting a delay in expression compared to mammalian
Clock expression. Cry1a, which is typically highly expressed in the evening and
lowest in the morning showed up-regulation throughout the day, with a significant
increase in expression between 12AM and 5AM (p=0.0009). Expression of Per2
was consistent with previous studies [148, 149], and was found to be lowest to-
wards the end of the dark cycle (5AM) and significantly higher at all other time
points. These data confirm activity of clock genes in the kidney and their 24 hour
cycles. However, the large gaps between the time-points and delay of gene ex-
pression of genes which are usually expressed in parallel suggest that more time
points or a more sensitive assay should be proposed. In contrast, the expression
of zebrafish renin showed a trend similar to that of its mammalian counterpart,
with peak expression at 9AM and reduced expression throughout the day. This
trend did not reach significance and these data do not suggest that renin is regu-
lated by the circadian rhythm. The relative renin gene expression data has a large
spread suggesting that individual fish might experience a delay in the regulation
of renin expression. The QPCR analysis is restrictive to a single time point and
labour intensive. Hence, to investigate more closely the dynamic renin expression
in the pronephric and mesonephric kidneys zebrafish, a more sensitive and more
accessible assay for transcriptional regulation is required.
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Figure 3.1 | QPCR analysis of clock gene expression and renin at varying
time points 9AM (n=7), 3PM (n=5), 12AM (n=11), 5AM (n=5). X-axis represents
the light/dark cycle in the zebrafish facility. Data normalised to housekeeper genes
(rsp18 and elfa). ANOVA with Bonferroni’s multiple comparisons test. Data are
mean ± SD.*=p<0.05, **=p<0.01, ***=p<0.001, ****=p<0.0001.
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3.2.2 Generation of a Novel Dynamic Renin Luciferase
Reporter Fish
In order to investigate whether renin expression is more transcriptional subtle than
that suggested by the previous experiments, I decided to use a luciferase reporter
as a surrogate readout for renin expression. The luciferase reaction is highly sensi-
tive and occurs almost instantaneously when luciferase breaks down the substrate
luciferin, which can be detected shortly after initial gene expression. One of the
side products emitted from this reaction is light, thereby permitting the detection
and quantification of the reaction [139, 150, 151]. Furthermore, in order to detect
the light, no external light source is required, eliminating autofluorescence.
For the design of the expression plasmid, the gateway cloning strategy was cho-
sen. Gateway cloning depends on the development of 3 individual plasmids knows
as 3’, middle, and 5’ entry clones [92]. These plasmids contain DNA cassettes
with a promoter, reporter and a polyA tail, respectively. Each DNA expression cas-
sette is flanked by specialised recombination sites, which will be recombined in a
single reaction into a destination vector while maintaining the reading frame. The
chosen destination vector was pDestTol2CG2, which contains the zebrafish cmlc2
promoter driving EGFP in cardiomyocytes of the heart, and is commonly used as
a marker of successful transgenesis in zebrafish [152]. A map of the final entry
clone can be seen in Figure 3.2. The destination vector contains tol2 sites. Trans-
posase mRNA, which is co-injected with the plasmid, recognises the tol2 sites and
integrates the plasmid into the chromosome. The transposon shows no specific
integration site, meaning that the plasmid can translocate anywhere on the chro-
mosome [90].
The 3’ entry clone, consisting of the 6.4kb renin promoter, had previously been
published Rider et al. [47]. To verify the plasmid, diagnostic NcoI and PstI restric-
tion enzyme digests were performed and analysed by DNA electrophoresis. The
predicted 9106bp fragment (representing the linearised plasmid) was observed fol-
lowing digestion by NcoI, whilst 7009bp and 2097bp fragments were obtained fol-
lowing digestion with PstI (Figure 3.3B). The commercially available pDestTOl2CG2




The middle entry clone, containing the firefly luciferase coding sequence, was
kindly provided by the MacRae Laboratory (Harvard) and restriction digestion with
ApaLI confirmed the correct size of the plasmid (3892bp) (Figure 3.3D). Lastly
the final insert, the polyA tail was used to fill for the 5’ entry clone which was
also assessed using a single restriction digest by EcoRI generating two fragments
(1911bp, 927bp).
All three entry clones were recombined with the destination vector using LR-
clonase. The reaction was left for 24 hours overnight and the product used for
transformation into E.coli bacteria generating 26 ampicillin-resistant colonies. Five
colonies were chosen and DNA was extracted and processed for extensive re-
striction digest analysis. Only 1 colony gave the expected DNA fragment sizes
(EcoRI=12752bp; PSTI=5152bp, 4743bp, 4622bp; NCOI=11312bp, 3096bp; NHEI
=14508bp). The colony was selected and a final restriction analysis was performed
followed by DNA sequencing (Figure 3.4). The plasmid was then co-injected into
the single cell-stage WIK eggs with transposase mRNA. After 24 hours EGFP
expression was observed in the larval zebrafish hearts, indicating successful ex-
pression of the cmlc2:EGFP transgene.
Mosaic expression is commonly seen in the F0 founders and is suggestive of
not all cells containing a copy of the transgene. In order to ensure expression in all
cells of interest, transgenic fish are outcrossed to a non-transgenic WIK fish once
sexual maturity is reached. This step is also necessary to determine if F0 animals
are capable of transgenic germline transmission. An illustration of the breeding
















Figure 3.2 | Plasmid map for the ren:LUC expression clone A previously pub-
lished 6.64kb renin promoter drives luciferase expression. To improve selection for
successful integration of the transgene, the backbone consists of a cmlc2 promoter
driving the fluorescent protein EGFP in the opposite direction.
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Figure 3.3 | Restriction enzyme verification of entry clones used for the con-
struction of the ren:LUC expression vector Restriction enzyme digestion and
and subsequent gel electrophoresis of entry entry clones. A) 6.64kb renin pro-
moter entry clones digested with restriction enzymes NcoI and PstI. Lane 1 and
2 represent analysis of two different clones. B) pDestTol2CG2 destination vector
digest with EcoRI and HindIII, yielding the correct fragment sizes. C) Middle en-
try clone luciferase reporter digested with Apal1 restriction enzyme D) Restriction
enzyme digest of polyA, 5’ entry clone with EcoRI.
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Figure 3.4 | Restriction enzyme digest and subsequent gel electrophoresis of
the ren:LUC entry clone A) 1% agarose gel DNA electrophoresis with restriction
enzyme digest analysis of expression clone. Restriction enzymes used were: NheI,
NcoI, PstI, and EcoRI. B) 2% agarose gel DNA electrophoresis to visualise the
small DNA fragments from the EcoRI restriction digest.
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Figure 3.5 | Breeding strategy for the novel ren:LUC line Plasmid is injected into
WIK eggs at the one cell stage. To determine if the transgene has gone germline,
fish are outcrossed to the wild-type WIK. F1 progeny is selected by the transgenic
cmlc2:EGFP reporter and incrossed to generate the F2 generation of homozygous
and heterozygous fish.
3.2.3 Luciferase Assay Development
In vitro studies have shown that in the presence of high concentrations of the lu-
ciferase substrate, firefly luciferase is strongly inhibited after an initial flash, per-
sisting less than a second, due to the accumulation of inhibitory oxyluciferin. The
inhibition is also dependant on the luciferin used and the purity of the substrate.
In order to establish the ideal concentration of the luciferin to be used in in vivo
zebrafish experiments, an in vitro titration experiment with 1 µg pure recombinant
luciferase was conducted (Figure 3.6). A significant reduction of signal was seen
at luciferin concentrations of 100 mM, 50 mM and 25 mM. No significant change in
signal was observed at concentrations from 0.5 mM to 10 mM, although the highest
signal was seen at 1 mM. Physiological barriers of zebrafish will reduce the con-
centration of luciferin ultimately reaching the cells expressing luciferase, hence a
higher concentration of 10 mM was used.
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Figure 3.6 | Luciferase signal at high luciferin concentrations Measuring lu-
ciferase signal at different luciferin concentrations using 1 µg recombinant lu-
ciferase. Measurements were performed in triplicates.
3.2.4 ren:LUC Founder Selection
Cmlc2:EGFP is an ideal marker for transgenesis since the fish do not require com-
plicated mounting and high resolution microscopy for detection of the EGFP in the
zebrafish heart. The cmlc2 promoter is known to be strongly expressed, indepen-
dently of the site of integration. However, renin expression is highly dependant
on regulatory elements found upstream of the site of integration and it is essen-
tial to determine strong transgene expressing founder fish early in development of
the transgenic line. F0 injected fish were first selected for EGFP expression with
minimal mosaic expression and were subsequently screened using the luciferase
assay for luciferase signal strength, presuming a high luciferase signal indicates a
good integration site of the plasmid. Single fish were placed into a well of a 96-well
plate at 4dpf, since this was the ideal developmental stage for imaging tg(ren:RFP-
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LifeAct) larval zebrafish [47]. Luciferin was added at a final concentration of 10 mM
in the water and fish were left for 5 minutes to allow absorption of the substrate.
Measurements of luciferase expression varied significantly from very high expres-
sion (>1500 CPS 2.1%) to medium expression (>100 CPS, 19%) from one round




































Figure 3.7 | Selecting injected fish according to the luciferase signal Injected
zebrafish were selected at 24hpf by the EGFP expression driven by the the cmlc2
promoter. All strong expressing EGFP fish were placed in a single well and luciferin
was added to determine the luciferase signal strength in each individual fish. High
expressing luciferase fish (CPS>100) were selected and kept for further breeding
and establishment of the F1 line.
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3.2.5 Breeding of the F0 Founder Fish
Once the F0 fish reached sexual maturity, they were outcrossed to wild-type WIK
fish in order to determine successful transgenic germline transmission and to gen-
erate the heterozygous F1 line. In cases where a successful germline transgenic
adult was identified, the progeny were investigated for the ratio of EGFP expressing
fish to non-expressing fish. A 50/50 ratio suggests a single insertion site whereas a
higher ratio suggests multiple insertion sites. Furthermore, F1 progeny were inves-
tigated for luciferase expression in order to only take forward the highest expressing
luciferase fish. High variability in reporter signal intensity was previously also noted
in the tg(ren:RFP-LifeAct) fish, which utilised the same promoter sequence as the
ren:LUC construct. Surprisingly, no detectable luciferase signal was seen in the
progeny of any high EGFP-expressing F0 fish. By increasing the detection time,
to permit more photons to be counted, a low signal was detectable. However, a
side by side comparison between a commonly occurring high-expressing F0 and
F1 progeny showed that there was a more than a 400-fold reduction in signal in
F1 progeny (Figure 3.8). This reduction and loss of signal was seen in all progeny
of all founders, independent on their original expression level. F1 progeny were
selected according to the luciferase signal compared to background noise from
non-bioluminescent age matched wild-type control WIK fish (Figure 3.9).
3.2.6 Genotyping of ren:LUC Fish
To validate F1 transgenic progeny transgene-specific primers for EGFP and lu-
ciferase were designed (see Table 2.4). DNA extraction was performed on 5dpf
larval fish and PCR was performed using WIK fish as negative controls since nei-
ther EGFP or luciferase are expressed in wild-type zebrafish. PCR result can be
seen in Figure 3.10. The PCR results suggest that the genes coding for EGFP and



















in 4dpf F1 vs F0 larvae
F0 larvae (n=4)





Time after Luciferin administration (minutes)
F1 larvae (n=4)
Control (n=4)
Figure 3.8 | Luciferase expression comparison between F1 larvae Luciferase
expression at 4dpf in single F0 and F1 larvae over time.
3.2.7 Primary Imaging of Luciferase Expression
In order to determine the origin of the strong signal in F0 founders and whether the
weak signal in F1 progeny was stemming from the AMA, a bioluminescence imag-
ing system was required. The major limitation of bioluminescence imaging is that
the amount of photons released from the luciferase reaction is very small and highly
sensitive, supercooled detectors are required for its detection. One of these sys-
tems is the In Vivo Imaging System (IVIS). IVIS generates a brightfield image prior
to measuring bioluminescence by a long time exposure. The two separate images
were then overlaid. However, the IVIS is optimised for the imaging of rodents and
not larval zebrafish, and the spatial resolution is not ideal. 4dpf F1 and F0 larval
fish were selected using the plate detecting the luciferase signal and the highest
expressers were selected for future breeding (Figure 3.11). Fish were mounted
in agarose and 10 mM luciferin was applied to diffuse through the agarose. The
identity of each fish from the plate reader was preserved by marking the wells and
recording their mounting position in the 6-well plate. The IVIS acquired a biolumi-
nescent image via an 18 minutes exposure and overlaid the signal as a heat map
corresponding to the intensity and origin of the luciferase signal. All F0 founders
had detectable luminescence in the IVIS (A=1263, B=786, C=290, D=189, E=218,
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Figure 3.9 | Luciferase expression of F1 larvae Luciferase expression at 4dpf
in single F1 ren:LUC larvae over time from previously high expressing F0 founder
fish. Any fish with a luciferase signal below the background signal from a wild-type
control (red line) were discarded.
F=569, G=268), however the signal from F1 progeny was not strong enough to be
detected (H=35, I=39, J=19, K=24). Imaging of F0 larval fish produced a bullseye
signal, with red in the middle indicating the highest signal and blue, on the outside
most ring, indicating the lowest signal. A major limitation however, was the size
of the signal indicator produced by the IVIS and overlaid onto the black and white
image, preventing accurate localisation of the signal origin.
3.2.8 Ectopic Luciferase Expression in the Yolk Sac
To achieve higher spatial resolution, localise the source of the luciferase signal,
and investigate whether it originated from the AMA, a bioluminescence microscope
imaging system was required. The challenging issue with bioluminescence imag-
ing is the need for highly sensitive sensors that are capable of capturing the small
69
3.2. Results
Figure 3.10 | ren:LUC PCR genotyping PCR and subsequent DNA electrophore-
sis of PCR product. Genotyping of ren:LUC fish to validate the presence of the
complete transgene in F1 progeny. WIK fish were used as negative control as
EGFP and Luciferase encoding genes are not present in wild-type (WIK) zebrafish.
number of photons emitted by the 5-10 renin cells at the AMA. A supercooled
camera mounted on a microscope that was placed within a blacked out room was
utilised. Prior to the bioluminescence imaging the fish were selected by the lu-
ciferase plate reader assay and only the highest luciferase expressing fish were
chosen. The fish were mounted in 1% LMP agarose as described in Chapter 2.7
and exposed for 12 minutes. The bright-field image was acquired using a handheld
torch since no source of light was present within the blackout room. In Figure 3.12,
a WIK and tg(ren:LUC) fish are shown side-by-side. No signal was captured from
the wild-type fish however there was a clear signal from the yolk sac of the ren:LUC
fish. Furthermore, in addition to the yolk sac expression there was no expression
where the AMA would be expected (Figure 3.12). A further image was acquired of a
high expressing zebrafish to investigate the expression pattern in the yolk sac (Fig-
ure 3.13). None of the F1 fish had a signal high enough that permitted imaging.
This suggests that all the founder fish previously selected on the high luciferase
signal had had ectopic expression stemming from the yolk sac and the fish were
not selected for the renin promoter driven luciferase signal. Fish with a low signal
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Figure 3.11 | IVIS imaging luciferase expressing F0 and F1 larval zebrafish
Brightfield image of the 6-well plate containing mounted zebrafish, superimposed
with the bioluminescent luciferase signal. Bioluminescent signal strength is rep-
resented as, red=1000+ CPS, yellow=500+ CPS, blue=100+ CPS. Fish were
mounted on 1% LMP agarose. IVIS system recorded luciferase signal for 18min-
utes. Yellow arrows point to mounted zebrafish and corresponding letters to the
luciferase expression results from the plate reader. (B) Highest expressing F0 fish,
each bar represents 1 fish. Control is non luciferase expressing WIK fish. (C) F1
progeny selection for IVIS imaging.
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Figure 3.12 | Luciferase expression in the yolk sac of F0 ren:LUC zebrafish
4dpf WIK and F0, ren:LUC zebrafish mounted on 1% LMP agarose. Luciferin
was applied and left to dissolve into agarose. Images acquired with 12 minutes
exposure. 4dpf F0 larval fish were selected for high luciferase prior to imaging
using a plate reader.
3.2.9 EGFP Expression in the Yolk Sac of F0 ren:LUC
Zebrafish
Following the bioluminescence imaging, the founder F0 larval zebrafish were inves-
tigated for EGFP expression in the yolk sac. This was to determine whether the yolk
sac expression of a transgene was a characteristic phenomenon when generating
novel transgenic animals, which had not previously been noticed in F0 zebrafish.
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Upon further characterisation, cmcl2 driven EGFP expression was clearly visible
in the yolk sac zebrafish with EGFP+ hearts (Figure 3.14). The EGFP expression
intensity in the yolk sac varied suggesting that the luciferase signal strength should
also change and be directly correlated to the EGFP signal strength. Yolk sac EGFP
expression was assessed by fluorescence imaging and subsequent image analy-
sis measuring fluorescence intensity. After imaging of the yolk sacs, the luciferase
signal strength was then measured in these fish using the plate based luciferase
assay. This allowed to directly investigate the correlation between the two reporters
in individual fish (Figure 3.15).
Figure 3.13 | High magnification bioluminescent image 10x bioluminescent im-
age with 12 minutes exposure of single 4dpf ren:LUC zebrafish. No expression at
AMA and expression restricted to yolk sac.
The correlation between the luciferase signal and EGFP signal was positive
(R2=0.599). However, due to the auto-fluorescence in the zebrafish larvae yolk
sac, EGFP-negative yolk sacs appear positive in the assay. Visually the EGFP
signal in the yolk sac is very distinctive to the autofluorescent signal (Figure 3.14).
EGFP signal in the yolk sac was observable from 24hpf and up to 5dpf.
To establish whether EGFP+ yolk sac expression could be used to select against
fish expressing luciferase in the yolk sac, larval F0 zebrafish were sorted for EGFP
positive and EGFP negative yolk sacs. A luciferase assay was performed on single
fish and the data was separated accordingly (Figure 3.16). All F0 zebrafish with
positive EGFP expression in the yolk sac had a high luciferase signal. Only one F0
zebrafish with no apparent EGFP expression in the yolk sac had a high luciferase
signal (556 CPS), suggesting a potential founder with high luciferase expression
stemming from renin expressing cells.
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Figure 3.14 | Yolk sac EGFP expression in larval transgenic zebrafish Side
by side comparison of 5dpf larval F0 and F1 zebrafish. Image was acquired with
same gain and exposure settings. Top panel, F1 zebrafish with no mosaic EGFP
expression in the heart and no visible EGFP expression in the yolk sac. Bottom
panel showing mosaic expression in the heart and clear EGFP expression in the
yolk sac. Yolk sac outlined by dashed white line.
3.2.10 Luciferase Expression in Adult F1 and F0 ren:LUC Ze-
brafish Tissue
The luciferase expression in F1 progeny was low at baseline and assays such as
investigating the down regulation of renin were not possible in larval zebrafish. In
order to determine whether the luciferase expression was low due to the limited
number of renin cells during early development (<10 cells at 4dpf), a selection of
adult organs were excised, homogenised and analysed using the luciferase assay.
Heart, muscle and kidney of previously low-expressing F1 zebrafish were collected,
analysed, and compared to equivalent organs harvested from WIK fish and F0
adults (Figure 3.17). Surprisingly, highest luciferase signal was seen in the heart
of F0 fish (n=3, mean CPS=124.6) compared to F1 hearts (n=3, mean CPS=57.3)
and controls (n=3, mean CPS=4.6). Kidney expression was significantly lower in
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Correlation between yolk sac fluorescence
and total luciferase expression
R2 = 0.5985
Figure 3.15 | Luciferase expression comparison between F1 larvae Each dot
represents the measured EGFP and luciferase expression in the yolk sac of visually
EGFP+ selected zebrafish (n=63). Pearsons correlation R2=0.5985.
F0 kidney than F0 heart (n=3, CPS mean=14.6, p=<0.0001) whereas there was
no significant change in the signal between the F1 heart and F1 kidney (n=3, CPS
mean=48.6, p=0.9987). Luciferase in the muscle was not significantly higher in F0
(n=3, mean CPS=6) and F1 muscle (n=3, mean CPS=8) compared to WIK control
(n=3, mean CPS=6). Variability in expression of the same organ of the same group
was high. However, overall expression was low in all organs.
Due to the low signal in F1 progeny, which was not strong enough to be im-
aged, expression was investigated using RAS inhibiting compounds known to in-
crease renin transcription. 0.1 mM of the ACE inhibitor Captopril was administered
to a group of 24hpf fish (n=20). A further group received conditioned water (CW)
(n=20). The fish were left in the treatment until 4dpf. There was a significant in-
crease in renin expression in the Captopril treated group (Figure 3.18), suggesting
that the luciferase signal is representative of renin gene expression.
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Luciferase expression in larvae selected
according to yolk sac GFP expression
Figure 3.16 | Whole larval luciferase expression in EGFP+ yolk sac larvae Lar-
vae grouped on yolk sac EGFP expression prior to luciferase assay to determine
whether EGFP yolk sac expression can be used for selecting ectopic expression.
Yolk sac EGFP expression group n=18 and group without GFP expression in yolk
sac n=30. Data are mean ± SD. Student’s t-test, ****=p<0.0001.
3.2.11 ren:LUC-2A-mCherry
The selection of transgenic zebrafish with strong luciferase expression in renin ex-
pressing cells had proven difficult due to the ectopic luciferase and EGFP expres-
sion in the yolk sac. The yolk sac expression signal strength masked the renin cell
specific expression and prevented identification of non ectopic, strong expressing
transgenic animals. In order to overcome this problem, a new zebrafish renin re-
porter was proposed using two, reporters for the same promoter. The two reporters
were luciferase and a fluorescent reporter, to allow selection of transgenic fish us-






























Figure 3.17 | Luciferase expression in ex vivo adult organs Adult organs were
homogenised and luciferin added. 10 one second reads were recorded and the
average photon count represented. Each organ n=3 from F1 ren:LUC fish selected
for previously high luciferase expression.
plasmid was designed to have the two reporter genes separated by a 2A sequence.
The 2A sequence encodes a self-cleaving peptide, which cleaves post translation,
by a break of the peptide bond between the proline and glycine in the C-terminal
of the 2A peptide. Similarly to the ren:LUC expression described above, the 6.4kb
renin promoter published by Rider et al., was used to drive the expression of lu-
ciferase and 2A-mCherry reporters (Figure 3.19).
For the middle entry clone the same luciferase gene cassette that was utilised
in Section 3.2.2 was used. However, it was required that the stop codon was
removed to permit continuous reading into a 2A-mCherry gene cassette. The stop
codon was removed using a PCR cloning strategy as described in the methods in

























Luciferase expression in response to Captopril
treatment in F1 ren:LUC larvae (4dpf)
Figure 3.18 | Luciferase expression in response to Captopril treatment in F1
ren:LUC larvae (4dpf) F1 fish from the same founder were grouped into Captopril
treated group (n=20) and conditioned water group (n=20). Treatment was admin-
istered 24hpf and luciferase expression was measured 4dpf. Control is CW with
Captopril to ensure no bioluminescent background activity of Captopril. Data are
mean ± SD. Student’s t-test ****=p<0.0001.
codon was performed by restriction digest and subsequent DNA electrophoresis
(Figure 3.20). Only clones 1 and 5 showed correct band sizes and clone 1 was
taken forward as the final middle entry clone.
The 3’ p3E-2A-mCherrypA was acquired through Addgene. Although the pDest-
Tol2CG2 destination vector has many advantages, the intensity of the EGFP signal
from the heart can interfere with high-resolution imaging of the zebrafish kidney. A
new destination vector was chosen avoid this issue. The pDestTol2pACryCFP uses
the zebrafish crystallin beta B promoter, which is expressed in the eye of zebrafish,
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driving the ECFP as a marker for successful transgenesis. Using the 3’ entry clone
p3E-2A-mCherrypA, the 5’ 4.6kb ren promoter, and the luciferase gene cassette
as middle entry clone and the pDestTol2pACryCFP destination vector, LR recom-
bination was performed from which six resultant clones were randomly picked and
analysed by restriction digest (Figure 3.21). Only clones 1 and 4 gave the correct
fragment sizes (HindIII=12470, 2020, 789; EcoRV=10670, 4609; NCOI=13457,
1822; NOTI=15279) and clone 1 was selected to be injected, together with trans-
posase mRNA, to generate the new transgenic zebrafish line.
Despite verification of the plasmid and successful expression of the transgene-
sis marker, no mCherry expression was seen along the AMA in any fish. MCherry
and ECFP were visible in the yolk sac and luciferase expression was also de-
tectable. Despite several rounds of injections no expression could be seen at the
AMA. However, the continuous expression of mCherry and ECFP in the yolk sac
of F0 larval fish further suggest that ectopic expression in the yolk sac is a phe-
nomenon occurring when generating novel transgenic zebrafish (Figure 3.22). This
is unreported and may influence various studies performing experiments of F0 fish.
This chapter demonstrated that it is crucial to not disregard this phenomenon and






















Figure 3.19 | Plasmid map of the luciferase-2A-mCherry expression clone
Luciferase-2a-mCherry expression clone 15279bp in size. Previously published
6.64kb ren promoter driving luciferase with removed stop codon to allow contin-
uous reading over the P2A into the fluorescent mCherry reporter. The backbone




Figure 3.20 | Restriction digest analysis of the pETR-Luciferase-NoStop clone
Restriction enzyme digest and subsequen DNA gel electrophoresis of the pETR-
Luciferase-NoStop clone. 6 clones were selected and DNA extracted. Plasmid
DNA was analysed by restriction enzyme digestion using the restriction enzymes
PstI, NcoI, and BsaI.
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Figure 3.21 | Restriction digest analysis of the ren:LUC-2A-mCherry entry
clone Restriction enzyme digestion and subsequent DNA gel electrophoresis of 6
single transformed colonies post LR reaction. DNA from all colonies was digested
with the following restriction enzymes: NotI, NcoI, EcoRV, and HindIII. Expected




Figure 3.22 | Ectopic yolk sac expression of ren:LUC-2A-mCherry Ectopic ex-
pression of crystallin B and renin reporter fluorophores in the yolk sac of an F0
ren:LUC-2A-mCherry zebrafish. Crystallin blue was also expressed in the eye as




In this chapter, I describe the generation of novel zebrafish renin reporter lines. The
bioluminescent reporter, firefly luciferase was used as a surrogate marker for renin
expression. Compared to fluorescent reporters, luciferase has a short half-life al-
lowing detection of rapid changes in gene expression. Furthermore, it has a high
sensitivity, permitting for accurate quantitative studies of gene expression. The
novel transgenic lines were designed using a previously characterised renin pro-
moter sequence driving the reporter gene coding for the bioluminescent reporter,
firefly luciferase.
3.3.1 Circadian Control of Renin
Circadian rhythm studies in zebrafish have predominantly focused on the charac-
terisation of behavioural and physiological rhythms and the expression patterns of
the zebrafish homologous clock genes [153]. The genetic approach to elucidating
circadian clock mechanisms have been particularly successful in zebrafish [154].
These studies have demonstrated the presence of clock genes within the zebrafish
kidney. However, no previous attempts have been made trying to elucidate whether
zebrafish renin is controlled by a circadian rhythm. Whole kidneys were excised
from adult zebrafish at 4 different time points corresponding to early morning, mid-
day, evening and middle of the night. Subsequent RNA extraction and QPCR
analysis was performed to investigate the relative gene expression of the clock
genes and whether renin expression varied throughout 24 hours. Zebrafish un-
dergo a resting phase during the dark-cycle and if zebrafish renin is regulated by
a circadian rhythm, a similar pattern to that observed in diurnal mammals was
expected [155, 156]. Although the expression levels of the circadian clock genes
in the kidney were conformant with previous studies [125, 157], no significant dif-
ferences were seen in renin expression. However, renin expression at all time
points, apart from 3PM, had large variation. Overall, renin expression appeared
to have a negative trend with highest expression at 9AM and lowest at 5AM. The
QPCR analysis, alongside the time points were not sensitive enough to permit ob-
servation of these differences. Hence, the generation of a novel transgenic renin
zebrafish line, using a highly-sensitive, real-time time bioluminescent reporter was
proposed. Furthermore, the bioluminescent zebrafish reporter would permit in-
vestigation of renin expression dynamics and earlier temporal expression than the
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previous tg(ren:RFP-LifeAct) zebrafish line and further the research on renin and
the RAS in zebrafish.
3.3.2 Selecting F0 Founder Fish
Founder fish are commonly selected by choosing fish with the highest reporter
expression [152]. This is generally indicative that the transgene has integrated
into a permissive site in the genome. However, it is important to remember that
the transposase can continuously integrate the tol2 containing transgene causing
multiple insertion sites. Luciferase expression in F0 founders was highly variable,
which was conformant with reports previously made by Rider et al., using the same
renin promoter sequence for the generation of the tg(ren:RFP-LifeAct) transgenic
zebrafish line. 20% of all injected fish expressed EGFP and luciferase >100 CPS,
which is the expected success rate of the tol2 system. Hence, all fish with a sig-
nal higher than 100CPS were selected as founder fish. In order to identify whether
transgenic animals have multiple insertion sites, and are capable of gremline trans-
mission of the transgene, they are outcrossed to wild-type zebrafish. Progeny from
the outcross are analysed for mendelian ratio according to the cmlc2 driven EGFP
expression in the heart.
3.3.3 F1 Progeny Luciferase Expression
Luciferase screening of progeny from previously highly expressing founder demon-
strated a dramatic loss of luciferase signal, with no change in EGFP expression in
the heart. Germline transmission of the transgene was validated by PCR, demon-
strating the presence of both reporter genes in the F1 generation. As the luciferase
assay is essentially an output of photons counted over a set time, acquisition time
was increased to permit detection of low luciferase signals. Although just above
background (>10CPS), a positive signal was detectable in F1 progeny earliest at
4dpf. This was surprising as renin gene expression is reported to commence as
early as 24hpf and compared to fluorescent proteins, luciferase has been shown to
be an active enzyme after translation of its mRNA, not requiring any lengthy pro-
tein folding and should be detectable sooner. To demonstrate that the luciferase
expression was reporting for renin promoter activity in the F1 progeny, Captopril
was administered to larval zebrafish. Administration of Captopril has been previ-
ously shown to increase renin gene expression and a significant difference was
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observed when comparing luciferase signals from Captopril versus non Captopril
treated controls [47, 64]. However, the expression was still very low, potentially
limiting studying compounds that have a negative regulatory role on renin expres-
sion. In order to increase the sensitivity of the assay, Nanoluc luciferase could
have been used instead of firefly luciferase. Nanoluc luciferase recognises a struc-
turally enhanced substrate, furimazine, which produces a signal lasting for up to
two hours with a luminescence 100 fold brighter compared to the commonly used
firefly luciferase [158].
3.3.4 Yolk Sac Luciferase Expression
To determine the origin of the strong luciferase signal in the F0 founder fish and the
signal in the F1 progeny, bioluminescence imaging techniques were applied. The
bioluminescent reaction produces are very small amount of light, which requires
highly sensitive supercooled cameras to permit detection. The IVIS is specialised
for imaging rodents, by aquiring a black and white image prior to a long-time ex-
posure to detect the luciferase signal. The luciferase signal is then superimposed
on to the black and white image, permitting localisation of the signal. However,
the spatial resolution is limited. The IVIS demonstrated that the F1 progeny, with
luciferase signals ranging between 19-39 CPS, are unsuitable for bioluminescence
imaging. F0 founders however, had a strong signal but the localisation was not
possible due to the low spatial resolution. Hence, F0 with a luciferase signal higher
than 1000 CPS were selected and a house-build bioluminescent microscopy sys-
tem was utilised, permitting a higher spatial resolution. The imaging revealed lu-
ciferase expression in the yolk sac of all luciferase expressing F0 fish. Furthermore,
upon closer investigation, EGFP was also expressed in the yolk sac of zebrafish.
Cmlc2 and renin are both not expressed in the cells of the yolk sac and hence the
origin of this is believed to be ectopic. Moreover, this suggests that generation of
transgenic zebrafish leads to ectopic expression of the reporters in the yolk sac.
This phenomenon is unreported. In fact only one previous study has described
this phenomenon, by investigating whether the injection volume used for trans-
gene injection was the cause for the transient yolk sac expression [159]. Although
demonstrating that the injection volume did not affect the transgene expression in
the cells of the yolk sac, it was demonstrated that the the high transgene expres-
sion is located in the yolk syncytial layer (YSL), containing large polyploid nuclei.
The YSL is a peripheral cellular syncytium, surrounding the lipid and protein rich
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yolk sac core. The main function of the YSL is to export amino acids and hydrolyse
lipids as well as synthesise lipoproteins to transport lipids to the embryo until it is
able to feed independently [160].
3.3.5 ren:LUC-2A-mCherry
As the strong luciferase signal from the yolk sac masks potential signals stemming
from renin cells, a new transgene was generated using two reporters, driven by
the same 6.4kb renin promoter sequence. The two reporters are separated by the
’2A’ self cleaving peptide sequence. The novel transgenic zebrafish line permitted
selection of tg(ren:LUC-2A-mCherry) fish visually for the strongest mCherry signal
originating from renin expressing cells. After several rounds of breeding and estab-
lishing a homozygous, stable transgenic zebrafish line, quantitative renin gene ex-
pression analysis could then be performed without interference from ectopic trans-
gene expression. Interestingly, confirming the above mentioned observations, all
three reporters were expressed in the yolk sac of larval zebrafish. However, de-
spite crystallinB:ECFP transgene expression in the eyes of zebrafish, no transgene
expression was observed in renin expressing cells. Further DNA sequencing vali-
dated the injected plasmid as well as genotyping did not indicate any abnormalities.
Successful co-expression and functionality two reporter proteins was demonstrated
by the expression of mCherry as well as luciferase in the yolk sac of F0 founder
fish. Studies have shown that the 2A system is the ideal strategy for co-expressing
multiple reporter proteins in vivo. There have however, been reports of fluores-
cent proteins such as EGFP interfering with the 2A cleavage mechanism [161].
Although this has not been investigated with reporter proteins such as luciferase
or mCherry, if luciferase were to interfere with the 2A skipping mechanism, the
amount of fluorescent protein generated in renin expressing cells in larval fish may
not be sufficient to be detected. Unfortunately, adult tg(ren:LUC-2A-mCherry) fish
were not investigated due to the lack of signal in larval zebrafish which were sub-
sequently terminated.
3.3.6 Luciferase Expression in Adult Tissues
The chapter predominantly focuses on investigating luciferase expression in larval
zebrafish. Zebrafish commence self-feeding after 5dpf, at which point the yolk sac
has been fully metabolised. To determine whether adult zebrafish, which were
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perviously wrongfully selected for yolk sac expression had luciferase expression in
the kidney, the kidney alongside several control organs (heart and muscle) were
excised from adult zebrafish (>3 months of age) and luciferase expression was
compared to wild-type equivalent control organs. Higher luciferase expression was
observed in the F1 kidneys compared to kidneys from F0 founder fish. Founder
fish are commonly subject to mosaic expression, where not all cells contain a copy
of the transgene. This can result in not all renin expressing cells expressing the
transgene and may explain the lower, more varied luciferase expression. Most
surprisingly was the high luciferase expression measured in the heart of both, F1
and F0 tg(ren:LUC) zebrafish. Although generally low expressing, compared to the
yolk sac signal from F0 fish, a significant difference is observed compared to the
wild-type control. Studies have demonstrated that renin mRNA is expressed in the
heart at low levels, however most cardiac renin is believed have derived from the
kidney [162,163,164]. Further, highly sensitive studies are required to validate and
elucidate the luciferase signal in the heart.
Although the main aim of this chapter, to generate a luciferase renin reporter
zebrafish line was not achieved, the chapter has highlighted crucial points which
have to be regarded when generating a novel transgenic zebrafish line. Generation
of novel transgenic reporters transiently express fluorescent reporters in the yolk
sac, which can have potential misleading effects this could have on quantitative
comparative analyses. This is observation will have a crucial impact on the gener-
ation of future transgenic lines utilising quantitative reporters such as luciferase.
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The first quenched FRET probe to investigate the dynamics of enzymatic activ-
ity was a fluorescently quenched peptide substrate for ACE [165]. However, the
FRET probe showed poor sensitivity and high background fluorescence in vitro
when used on human plasma. More promising FRET probes were developed sub-
sequently by Chagas et al. which permitted the study of various endopeptidases,
including human renin in vitro [166,167]. Imaging FRET probes to study the activ-
ity of renin was performed by Peti-Peterdi et al., who have developed a dissection
and perfusion technique of glomeruli to image the real-time release of renin using
commercially available FRET probes [129,168].
The basis of designing a FRET probe for zebrafish renin is understanding the
substrate, angiotensinogen, which renin recognises and cleaves. The amino acid
sequence for zebrafish angiotensinogen is known, however there have been no
reports of measuring angiotensinogen and its derivatives, AngI and AngII in ze-
brafish tissues. By comparing the zebrafish angiotensinogen amino acid sequence
with the well annotated mammalian sequences, I was able to determine the renin
cleavage site on zebrafish angiotensinogen and the resulting amino acid sequence
for AngI resulting from the cleavage. Removal of 2 amino acids from the N-terminus
of AngI results in the 8 amino acid, AngII sequence. The amino acids sequences
for AngI and AngII are short and the peptides are known not to contain any com-
plicated secondary structures making it possible to synthesise these peptides by
SPPS.
In collaboration with Attoquant Diagnostics, which specialises in the measure-
ment of angiotensins in various species using mass spectrometry, we designed an
experiment that could measure concentrations of AngI and AngII in the zebrafish
kidney and serum. The mass spectrometry assay run by Attoquant Diagnostics
requires the mass spectrometry detectors to be primed with exogenous pure pep-
tide, which is to be measured. The assay was used to measure the AngI and AngII
concentrations in serum and kidney of zebrafish treated with Captopril against an
untreated control group. By priming the mass spectrometers with the synthesised
AngI and AngII peptides and observing a dynamic change of AngII in the zebrafish
tissues in response to Captopril, the assay would further validate the the identified
sequences for AngI and AngII.
Having identified the substrate for zebrafish renin permitted development of a
molecular probe to measure and image renin activity in the zebrafish, real-time and
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in vivo. A fluorescein derivative, namely 5(6)-carboxyfluorescein was attached to
the amino-terminus of the synthesised tetradecapeptide amino acid angiotensinon-
gen sequence. A for, 5(6)-carboxyfluorescein commonly used quencher, Methyl
Red was attached to the C-terminus of the renin substrate, inactivating fluorescent
signals from the un-cleaved probe. In this chapter I will be discussing the synthesis
of the probe, and verification of its specificity using various zebrafish models. Fur-
thermore I will be discussing the design and expression of a plasmid to produce





The zebrafish angiotensinogen sequence shares a low amino acid sequence ho-
mology to that of mouse (28.4%), rat (29%) and human (28.1%) [169]. Previous
reports have defined the mammalian tetradeca-peptide sequence and recognised
that the His-Pro-Phe motif on the N-terminal side of angiotensinogen is a crucial
determinant of renin substrate specificity [37,170]. By comparing the angiotensino-
gen protein sequences of mouse, rat and human to that of the zebrafish, the
tetradeca-peptide sequence is identifiable (Figure 4.1). The zebrafish tetradeca-
peptide sequence only shares 50% identity with that of humans, rats and mice.
Most notable are the differences of the 9th and 11th amino acid, however there
is conservation of the His-Pro-Phe sequence. In the angiotensinogen amino acid
sequence, renin cleaves angiotensinogen between the 10th (Leu) and 11th (Phe)
amino acid generating the decapeptide AngI, which is further cleaved between the
8th (The) and 9th (Asn) amino acid by ACE. From the sequence alignment, the
10 amino acids on the N-terminus of the tetradecapeptide form AngI and the 8










Figure 4.1 | Renin substrate sequence homology Comparison of the tetradeca
angiotensinogen sequence recognised and cleaved by renin with highlighted, AngI
and AngII sequence homology renin cleavage and ACE cleavage site of AngI in




AngI was synthesised using the 10 amino acid sequence defined in Section 4.2.1.
AngI is the product of the renin cleavage of the N-terminus of angiotensinogen.
AngI is biologically inactive and acts as a substrate for ACE. The peptide was syn-
thesised using SPPS on a Chloro-(2’-chloro)trityl polystyrene resin (Figure 4.2).
The AngI peptide was purified using reverse phase HPLC and analysed using an-
alytical HPLC and MALDI-TOF MS (Figure 4.3 & 4.4). Calculated mass for the
peptide was 1258.45 Da and after reverse phase HPLC a single peptide was de-
tected using the ELS detector by analytical HPLC, indicating a pure compound.
Figure 4.2 | AngI structure Structure of the synthesised AngI peptide.
4.2.3 AngII Synthesis
AngII was synthesised from the identified 8 amino acid sequence in Section 4.2.1.
AngI is the product of the ACE cleavage of the N-terminus of AngII. The peptide
was synthesised on a Chloro-(2’-chloro)trityl polystyrene resin (Figure 4.5). The
AngII peptide was purified using reverse phase HPLC and analysed using analyti-
cal HPLC and MALDI-TOF MS (Figure 4.6 & 4.7).
4.2.4 Mass Spectrometry Calibration
The synthesis of AngI and AngII permitted calibration of mass spectrometers to
identify and measure the concentration of the endogenous AngI and AngII in ze-
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Figure 4.3 | AngI Peptide Synthesis MALDI MS trace and mass calculated for
C59H87N17O14 1258.5, found 1258.56.
brafish tissues. Attoquant Diagnostics GmbH provides a service to measure an-
giotensins within tissues using a mass spectrometry assay. To ensure specific
detection of the compounds of interest, the synthesised peptides are titrated in the
mass spectrometry buffer and subsequently measured (Figures 4.8 & 4.9) (Mass
Spectrometry Data Provided by Attoquant Diagnostics).
4.2.5 AngI and AngII Measurement in Zebrafish Kidney Tissue
375 adult fish were treated with 0.05 mM Captopril over 7 days to block the ACE
mediated conversion of AngI to AngII. As a control 300 fish were housed in con-
ditioned water (CW) for 7 days without Captopril. After 7 days of treatment, fish
kidneys and serum were extracted. The mass spectrometry assay required 100 µl
of serum and 50 mg tissue to permit accurate measurements. The number of fish
used, allowed for 5 AngI and AngII measurements in kidney tissue and 3 measure-
ments in serum. The mean AngI concentration in kidney tissue of CW fish was
17.4 ng/g (n=5) and was non-significantly reduced (p=0.0768) in Captopril treated
fish (6.996 ng/g, n=5), which was surprising as commonly an increase in AngI is
observed in response to ACE inhibition (Figure 4.10). However, a dramatic de-
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Figure 4.4 | Analytical HPLC of AngI Analytical HPLC trace of AngI with a single
signal at 3.1 minutes.
Figure 4.5 | AngII structure Structure of the by solid phase peptide synthesis
synthesised AngII peptide.
crease of AngII concentration was seen in zebrafish kidney tissue from 330.62 pg/g
to 5.56 pg/g in the Captopril treated group (p<0.0001), suggesting Captopril being
highly effective in inhibiting zebrafish ACE.
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Figure 4.6 | AngII Peptide Synthesis MALDI MS trace for AngI, mass calculated
for C49H70N14O11 1031.2, found 1031.46.

















Figure 4.7 | Analytical HPLC of AngII Analytical HPLC trace of AngII with a single
signal at 2.9 minutes.
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AngI - MS Calibration
R2 = 0.9999
Figure 4.8 | AngI mass spectrometry calibration Calibration of mass spectrom-
eter using synthesised AngI in mass spectrometry assay buffer. R2=0.9999.
















AngII - MS Calibration
R2 = 0.9994
Figure 4.9 | AngII mass spectrometry calibration Calibration of mass spectrom-
eter using synthesised AngII in mass spectrometry assay buffer. R2=0.9994.
4.2.6 AngI and AngII Measurement in Zebrafish Serum
In serum, contrary to the kidney tissue results, a non significant increase (p=0.1271)










































Figure 4.10 | Measurment of Ang I and Ang II in whole adult mesonephric
kidney tissue Concentrations of Ang I and Ang II were measured in adult whole
zebrafish kidney tissue in response to a 7 day 0.05 mM Captopril treatment. Ang I
n=5, p=0.0768; Ang II n=5, p<0.0001. Each point represents a mass spectrometry
measurement of a collective 75 mesonephric zebrafish kidneys. Data are mean ±
SD. Student’s t-test, ****=p<0.0001.
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(n=5, mean=195.2 pg/g) compared to control group without Captopril treatment
(n=5, mean=93.7 pg/g) (Figure 4.11). AngII was reduced in the Captopril treated
group (n=5, mean=87.77 pg/g) compared to the untreated group (mean=182.6 pg/g),
however, the difference was not significant (p=0.4670).
4.2.7 Synthesis of RenP1
There is a lack of tools that permit investigation of active zebrafish renin. Various
tools have been developed that allow investigation of mammalian renin. Most in-
terestingly is the use of FRET probes which can be designed to fluoresce upon
interaction with renin. Thus FRET probes were designed using the tetradecapep-
tide sequence discussed in Section 4.2.1. The RenP1 FRET probe was devel-
oped using the zebrafish tetradecapeptide sequence (NRVYVHPFNLFSSE) and
the 5(6)-carboxyfluorescein to allow simple quantification and visualisation. The
peptide sequence was synthesised using SPPS on a polystyrene resin. On the
N-terminus, 5(6)-carboxyfluorescein was attached, which was quenched by the
addition of Methyl Red on the C-terminus of the peptide sequence (Figure 4.12).
Quenching of 5(6)-carboxyfluorescein by Methyl Red has been commonly used
and has also been visualised using a spectrometer (Figure 4.13). Furthermore,
successful quenching was demonstrated by measuring the fluorescence intensity
of 5(6)-carboxyfluorescein attached to the tetradecapepeptide sequence with and
without Methyl Red (Figure 4.14). The probe was purified using semi-preparative
HPLC and structure was verified using MALDI-TOF MS (Figure 4.15) and analytical
HPLC (Figure 4.25). The presence of 5(6)-carboxyfluorescein permitted analytical
HPLC analysis by ELS and detection at 490 nm.
4.2.8 RenP1 Activity at Different Stages of Development
RenP1 activity was assessed in homogenate from 3dpf (n=5), 4dpf (n=5) and 5dpf
(n=5) zebrafish using a micro-plate fluorescence assay. All larval zebrafish used in
this experiment originated from the same cutch and were measured on the same
plate. Briefly, 25 fish were collected at 3-, 4- and 5dpf. For each measurement,
5 fish were homogenised and the homogenate was placed in a well of a 96-well
plate. RenP1 (10 µl) was added to the homogenate and fluorescence intensity
was measured at 520 nm after 0.1 second excitation at 480 nm. An increase in








































Figure 4.11 | Measurment of Ang I and Ang II in adult zebrafish serum Concen-
trations of Ang I and Ang II were measured in adult zebrafish serum of zebrafish
after 7 day 0.05 mM Captopril treatment or conditioned water (CW) control. Ang
I n=3, p=0.1271; Ang II n=3, p=0.4670. Each point on the graph represents one
mass spectrometry assay from serum from 120 adult zebrafish. Data are mean ±





































































































































Figure 4.13 | Emission spectra of 5(6)-carboxyfluorescein Green: Emission
spectra of 5(6)-carboxyfluorescein by excitation at 480 nm and emission curve peak
at 520 nm. Red: Emission spectra of 5(6)-carboxyfluorescein in the presence of
Methyl Red, by excitation at 480 nm and no detectable emission peak.
to 5dpf (p<0.0001) (Figure 4.17). However, no significant increase was observed
between 4dpf and 5dpf (p<0.0001).
4.2.9 RenP1 Activity in Captopril Treated Larval Zebrafish
The ACE inhibitor Captopril, which has been demonstrated to be highly effective in
zebrafish in Section 4.2.5, upregulates renin mRNA and ultimately circulating renin
concentration [64,171]. In order to have a better understanding of the specificity of
renin on the FRET probe, larval zebrafish were treated with Captopril and RenP1
activity was compared to untreated (CW), age matched larval zebrafish. Five fish
were collected and homogenised for each measurement. RenP1 was added to the
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Figure 4.14 | Emission spectra of RenP1 Green: Emission spectra of RenP1
without queching by Methyl Red by excitation at 480 nm and emission curve peak
at 520 nm. Red: Emission spectra of quenched RenP1 by Methyl Red, by excitation
at 480 nm
homogenate and fluorescence intensity at was measured at 520 nm by excitation at
480 nm over 1 hour. (Figure 4.18). A significant difference in fluorescence intensity
was observed at all time points between the Captopril treated and CW group.
4.2.10 RenP1 Activity in Adult Zebrafish Plasma
Captopril was also used to assess the RenP1 activity in adult zebrafish serum from
zebrafish treated with 0.05 mM Captopril (n=3) or left in CW (n=3) for 7 days prior
to serum extraction. Blood was collected and serum extracted. Each measurement
required pooled blood from 125 fish. The RenP1 FRET probe was directly added
to the serum and fluorescence intensity was measured over 2 hours (Figure 4.19).
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Figure 4.15 | RenP1 MALDI analysis MALDI MS of RenP1, mass calculated for
C121H149N27O29 2445.68, found 2446.21.
HPLC – RenP1






































Figure 4.16 | Analytical HPLC - RenP1 Analytical HPLC trace after semi-
preparative HPLC column. (a) HPLC ELSD trace of RenP1 (b) HPLC trace with


























RenP1 activity in larval zebrafish homogenate
at different stages of development
Figure 4.17 | RenP1 fluorescence intensity in homogenate of larval zebrafish
RenP1 fluorescence intensity measured in homogenate of larval zebrafish at 3dpf
(n=5), 4dpf (n=5), 5dpf (n=5). Every biological replicate constitutes of the ho-
mogenate of 5 age matched zebrafish. Fluorescence intensity was measured after
1 hour of adding the RenP1 Fret probe to the homogenate. Data are mean ± SD.
ANOVA, ****=p<0.0001.
Fluorescence intensity only increased slowly, suggesting a low concentration of
enzymes activating the FRET probe. Higher fluorescence intensity was measured
over 1 hour in plasma from Captopril treated fish.
4.2.11 RenP1 Activity in Mibta52b(−/−) Zebrafish Mutants
RenP1 activity was assessed in Notch signalling impaired mibta52b mutants. Mibta52b
zebrafish mutants do not express Notch 3 due to lack of the ubiquitin ligase mib,
which is required for the delta-mediated activation of the Notch receptor in target
cells. Mibta52b(−/−) zebrafish mutants do not to express renin mRNA at any stage
of development [47, 172]. Fluorescence intensity was compared to age matched
wild-type zebrafish. There was a significant decrease in fluorescence intensity in
mibta52b mutants compared to wild-type zebrafish at 5dpf (p=<0.0001) at every 5
minutes measurement over 1 hour (Figure 4.20).
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RenP1 Activity in Captopril
Treated Larval Zebrafish
CW
CW + 0.05mM Captopril
Control
Figure 4.18 | RenP1 Activity in 0.05 mM Captopril treated 5dpf larval Ze-
brafish RenP1 fluorescence intensity was measured every minute for 1 hour in
homogenate of 5dpf larval zebrafish. Fish were either left to develop in normal wa-
ter (CW) or conditioned water with 0.05 mM Captopril (CW + 0.05 mM Captopril).
Each biological replicate consisted of 10 homogenised larval zebrafish. Control
is probe with CW. Data are ± SD. ANOVA with Bonferroni’s multiple comparisons
test, ****=p<0.0001.
4.2.12 RenP1 Activity in ren−/− Larval Zebrafish
The specificity of the probe was assessed using CRISPR/Cas9 mediated ren−/−
zebrafish, developed in our laboratory and characterised in chapter 5. Change in
RenP1 fluorescence intensity was assessed in 5dpf ren−/− larval zebrafish (n=5)
against age matched ren+/+ (n=5) whole zebrafish. The fish were left to develop
in conditioned system water for 5dpf. For each assay measurement, 5 fish were
pooled together, homogenised and placed in a well of a 96-well plate and RenP1
was added. The plate was left for 24 hours and fluorescence intensity was mea-
sured using a fluorescent microplate reader. No difference in fluorescence intensity
was observed in ren−/− zebrafish (p=0.4972) (Figure 4.21).
4.2.13 RenP1 Activity in ren−/− Adult Zebrafish
RenP1 fluorescence activity was measured in homogenised kidney and muscle tis-
sue excised from ren−/− and ren+/+ adult zebrafish. The muscle tissue was used
as a control tissue. A significantly higher fluorescence intensity was measured in
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RenP1 Activity in Adult Zebrafish Plasma
CW
0.05 µM Captopril
Figure 4.19 | RenP1 Activity in Adult Plasma of Captopril Treated Zebrafish
RenP1 fluorescence intensity was measured in plasma collected from adult ze-
brafish after 7 days in conditioned water (CW) (n=3) and 0.05 mM Captopril (n=3).
Each biological replicate is the plasma from 120 adult zebrafish. Fluorescence in-
tensity was measured every 5 minutes over 2 hours. Data are mean ± SD. ANOVA
(p=0.056) with Bonferroni’s multiple comparisons test *=p<0.05.
homogenate from kidneys excised from ren+/+ (n=5) compared to and ren−/− ze-
brafish (p=.0.0052) (Figure 4.22). No significant difference in fluorescence inten-
sity could be observed in the muscle tissue between ren+/+ and ren−/− zebrafish
(p=0.6561). The fluorescence intensity of ren+/+ and ren−/− muscle to kidney tis-
sue was significantly higher, respectively (p<0.0001).
Breeding the ren−/− zebrafish with tg(ren:RFP-LifeAct) and tg(acta2:EGFP) ze-
brafish lines and the development of a FAC sorting protocol, allowed FAC sorting for
renin expressing cells and vascular renal cells from ren+/+ and ren−/− zebrafish.
The sorted cells were seeded onto fibronectin coated plates and cultured. Cell
media was collected after 2 days of cell culture and assessed using the FRET
probe plate based assay. The experiment was repeated 3 times from culture me-
dia from the same cells (Figure 4.23). A significant difference in fluorescence in-
tensity was observed in cell media from ren+/+ and ren−/− RFP-LifeAct positive
cells (p<0.0001). No difference in fluorescence intensity was observed between
































Figure 4.20 | RenP1 cleavage by homogenised larval Mibta52b(−/−) and
Mibta52b(+/+) zebrafish RenP1 cleavage by homogenised larval Mibta52b(−/−) n=8
and Mibta52b(+/+) n=8 zebrafish. Each biological replicate constitutes of the ho-
mogenate of 10, 5dpf larval zebrafish. Fluorescence intensity of the 5(6)-
carboxyfluoresein was measured every minute for 1 hour. Control is the RenP1
FRET probe without any homogenate. Data are mean ± SD. ANOVA with Bonfer-
roni’s multiple comparisons test ****=p<0.0001.
4.2.14 Probe Specificity
Proteinase K has been identified as a protease that can cleave the FRET probe.
Proteinase K is a serine protease and has a broad cleave specificity [173]. The
protease predominantly cleaves peptides at peptide bonds adjacent to the carboxyl
group of aromatic amino acids with a blocked amino group.
A further non-renin cleavage of the probe was assessed using trypsin. Trypsin,
similarly to proteinase K is also a serine protease and is commonly found in the
digestive system of many vertebrates [174]. Trypsin is known to cleave peptide
chains predominantly at the carboxyl site of the amino acids lysine and arginine
[175]. In the RenP1 FRET probe such sites are Arg2 and Lysine15.
4.2.15 Synthesis of RenP1-D
In order to increase the specificity of the probe, single amino acids in the FRET























RenP1 Activity in Larval
Zebrafish Tissue
Figure 4.21 | Fluorescence intensity of RenP1 in ren+/+ and ren−/− larval tis-
sue Fluorescence intensity increase of RenP1 was assessed 24 hours after adding
RenP1 to homogenised, ren+/+ or ren−/− larval fish (n=5). Each biological repli-
cate consists of 5 homogenised larval fish. Data are mean ± SD. Student’s t-test,
ns=not significant.
ing the probe. However, changes in amino acids may affect the enzyme substrate
interaction. Due to lack of pure renin, testing the affinity of zebrafish renin to the
substrate was not possible. A new probe was designed to prevent cleavage by
trypsin and proteinase K. Proteases are chiral and can distinguish between L- and
D-enantiomeric substrates and D-peptides are capable of resisting cleavage by
many proteases [176, 177] The new RenP1-D FRET probe design was based on
the tetradeca-peptide sequenced synthesied for RenP1. Amino acids Glu2-Ser3
and Phe8-Asn15 were exchanged for D-amino acids which should reduce back-
ground activity by becoming unsuitable for enzymatic degradation by trypsin and
proteinase K without influencing renin. The FRET probe was also synthesised by
solid phase peptide synthesis. A C-terminus Lysine-Dde amino acid was used
for elective deprotection and attachment of the MR quenching the N-terminus at-
tached 5(6)-carboxyfluoroscein. The peptide was analysed using analytical HPLC


































RenP1 Activity in Adult
Zebrafish Kidney Tissue
Figure 4.22 | Fluorescence intensity of RenP1 in ren+/+ and ren−/− zebrafish
kidney and muscle tissue Fluorescence intensity increase of RenP1 was as-
sessed 24 hours after adding RenP1 to homogenised, ren+/+ or ren−/− muscle
(n=5) and kidney tissue (n=5). Data are mean ± SD. ANOVA (p<0.0001) with Bon-
ferroni’s multiple comparisons test, **=p<0.01, ***=p<0.001, ****=p<0.0001.
4.2.16 Testing RenP1-D
Trypsin cleavage of RenP1-D was assessed and compared to RenP1. Fluores-
cence intensity was measured every minute over 1 hour (Figure 4.26). No differ-
ence of fluorescence was observed between RenP1 and RenP1-D, suggesting no
difference of trypsin cleavage of RenP1-D compared to RenP1.
Cleavage kinetics of RenP1-D by proteinase K were assessed and fluores-
cence was measured every 5 minutes over 1 hour and compared to RenP1-D.
(Figure 4.27). There was an increase in fluorescence compared to RenP1-D sug-
gesting that the D-amino acids hinder proteinase K cleavage of RenP1-D.
To investigate whether RenP1-D influenced the ability of renin cleavage and
whether the reduced activity of proteinase K reduced background activity several
assays in adult and larval fish were performed. Fluorescence activity was mea-
sured in homogenised kidney and muscle tissue excised from ren−/− and ren+/+
zebrafish. The muscle tissue was used as a control tissue as zebrafish muscula-
ture contains no renin expressing cells. A significantly higher fluorescence intensity
was measured in homogenate from kidneys excised from ren+/+ (n=5) compared
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Figure 4.23 | Fluorescence intensity of RenP1 in cell media from cultured ze-
brafish ren and acta2 expressing cells from ren+/+ and ren−/− zebrafish Fluo-
rescence intensity increase of RenP1 was assessed 24 hours after adding RenP1
to cell media from cultured RFP-LifeAct and EGFP expressing cells collected
from tg(ren:RFP-LifeAct; acta2:EGFP) ren+/+ or tg(ren:RFP-LifeAct; acta2:EGFP)
ren−/− zebrafish fish (n=3). Data are mean ± SD. ANOVA (p<0.0001) with Bonfer-
roni’s multiple comparisons test ****=p<0.0001.
to and ren−/− zebrafish (p=0.0052) (Figure 4.22). No significant difference in flu-
orescence intensity could be observed in the muscle tissue between ren+/+ and
ren−/− zebrafish (p=0.6561). However, the fluorescence intensity of ren+/+ and
ren−/− muscle to kidney tissue was significantly higher, respectively (p<0.0001,
p<0.0001). The results did not differ or improve the assay compared to the results
seen in Section 4.2.13.
Change in RenP1-D fluorescence intensity was assessed in 5dpf ren−/− larval
zebrafish (n=5) against age matched ren+/+ (n=5) whole zebrafish. The fish were
left to develop in conditioned system water for 5 days. For each assay measure-
ment, 5 fish were pooled together, homogenised and placed in a well of a 96-well
plate and RenP1-D was added. The plate was left for 24 hours and fluorescence
intensity was measured using a fluorescent microplate reader. No difference in
fluorescence intensity was observed between ren+/+ and ren−/− larval zebrafish
(p=0.4972) (Figure 4.21).
RenP1-D activity was assessed in cell media from ren+/+ and ren−/− RFP-
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Figure 4.24 | RenP1-D MALDI analysis MALDI MS of RenP1-D, mass calculated
for C121H149N27O29 2445.68, found 2446.21.
LifeAct positive was cells, collected after 2 days of cell culture The experiment was
repeated 3 times from culture media from the same cells (Figure 4.23). No dif-
ference in fluorescence intensity was observed of the FRET probe in media from
ren+/+ and ren−/− RFP-LifeAct positive cells (p=0.1500). Furthermore, No differ-
ence in fluorescence intensity was observed between fresh culture media and me-
dia taken from ren+/+ cells RFP-LifeAct positive cells (p=0.8545).
4.2.17 Recombinant Prorenin Synthesis
Throughout this chapter the probe was tested on various different zebrafish mod-
els that either have an increase or decrease in active zebrafish renin. However,
the specificity and enzyme kinetics of renin cleavage of RenP1 has not been as-
sessed. There is no commercially available recombinant zebrafish renin. Recom-







































Figure 4.25 | Analytical HPLC - RenP1-D Analytical HPLC trace after semi-
preparative HPLC column. (a) HPLC ELSD trace of RenP1-D (b) HPLC trace with
detection at 490 nm.
























Figure 4.26 | Cleavage kinetics of Trypsin on RenP1R Cleavage kinetics of
trypsin on RenP1R were measured and assessed versus RenP1. Fluorescence
intensity was measured every minute for 1 hour. Control is average of both FRET
probes background fluorescence.
systems, as prorenin and subsequently activated by removal of the pro-segment
by partial trypsin digestion [178]. To express recombinant prorenin, the coding se-
quence for prorenin was synthesised by DC BIOSCIENCES Ltd.. The sequence
113
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Figure 4.27 | Cleavage kinetics of Proteinase K on RenP1R Cleavage kinetics
of Proteinase K on RenP1R were measured and assessed versus RenP1. Fluo-
rescence intensity was measured every minute for 1 hour. Control is average of
both FRET probes background fluorescence.
was designed to incorporate a 5’ EcoRI and a 3’ XhoI restriction enzyme cut site
(see Appendix A). These permit for simple restriction digest and subsequent lig-
ation for plasmid cloning. The synthesised prorenin coding sequence, shipped in
a cloning vector, was excised by restriction digest by EcoRI and XhoI alongside
the destination vector (psec2c). The different sized bands were separated by gel
electrophoresis (Figure 4.31). The prorenin coding sequence band (1160bp) was
extracted from the agarose gel alongside the digested psec2c vector and ligated.
The resulting plasmid was analysed by restriction digest with APAL1 and MSC1 re-
striction enzymes and gel electrophoresis (Figure 4.33). The plasmid was further
verified by DNA sequencing.
4.2.18 Recombinant Renin Synthesis
Prorenin is the inactive from of renin. The endogenous enzyme responsible for
renin activation is still unknown. Commonly trypsin has been shown to cleave the
43 amino acid pro-segment and is able to activate renin in vitro. Using trypsin
to activate the recombinant zebrafish renin, could lead to trypsin contamination


































RenP1-D Activity in Adult
Zebrafish Kidney Tissue
Figure 4.28 | Fluorescence intensity of RenP1 in ren+/+ and ren−/− zebrafish
kidney and muscle tissue Fluorescence intensity increase of RenP1 was as-
sessed 24hrs after adding RenP1 to homogenised, ren+/+ or ren−/− muscle (n=5)
and kidney tissue (n=5). Data are mean ± SD. ANOVA (p<0.0001) with Bonfer-
roni’s multiple comparisons test**=p<0.01, ***=p<0.001, ****=p<0.0001.
quence for renin, without the coding sequence for the pro-segment was synthe-
sised by DC BIOSCIENCES Ltd.. However, renin has been commonly synthesised
as prorenin and activity of renin by synthesis without the pro-signal has not been
previously demonstrated. The sequence, similarly to the prorenin sequence, was
designed to incorporate a 5’ EcoRI and a 3’ XhoI restriction enzyme cut site (see
Appendix B). These permit for simple restriction digest and subsequent ligation for
plasmid cloning. The synthesised renin coding sequence, shipped in a cloning vec-
tor, was excised by restriction digest by EcoRI and XhoI alongside the destination
vector (psec2c) the different sized bands were separated by DNA gel electrophore-
sis (Figure 4.31). The renin coding sequence band (1060bp) was extracted from
the agarose gel alongside the digested psec2c vector and ligated. The resulting
plasmid was analysed by restriction digest with APAL1 and MSC1 restriction en-
zymes and gel electrophoresis (Figure 4.35). From 6 selected plasmid clones all


























RenP1-D Activity in Larval
Zebrafish Tissue
Figure 4.29 | Fluorescence intensity of RenP1-D in ren+/+ and ren−/− larval
tissue Fluorescence intensity increase of RenP1-D was assessed 24 hours after
adding RenP1-D to homogenised, ren+/+ or ren−/− larval fish (n=5). Each biologi-
cal replicate consists of 5 homogenised larval fish. Data are mean ± SD. Student’s
t-test, ns=not significant.
4.2.19 Recombinant Renin Cell Expression
The renin-psec2c and prorenin-psec2c plasmids were transfected to Chinese Ovar-
ian Hamster (CHO) cells using the Expi-system, and left for 5 days. The ExpiCHO
system plasmids are designed to secrete the protein of interest into the cells media
due to the secretion signal from the V-J20C region of the mouse lg kappa chain. Af-
ter 5 days of culture, cells transfected with renin-psec2c and cells transfected with
prorenin-psec2c were harvested alongside the cell media. Expression of the pro-
tein was verified by western blot, using a mouse anti 6×His antibody. The protein
was visualised by Alexa 488 goat anti mouse secondary antibody and scanning of
the protein containing membrane (Figure 4.36). No protein expression could be
seen in the cell media and cell lysate from cells transfected with the renin-psec2c
plasmid. Furthermore, there was no secretion of recombinant prorenin from cells
transfected with prorenin-psec2c. Only the cell lysate contained a His-tagged pro-
tein that was over expressed (Figure 4.36).
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RenP1-D Activity in Cell Media
Figure 4.30 | Fluorescence intensity of RenP1-D in cell media from cul-
tured zebrafish ren and acta2 expressing cells from ren+/+ and ren−/− ze-
brafish Fluorescence intensity increase of RenP1-D was assessed 24 hours after
adding RenP1-D to cell media from cultured LifeActRFP and EGFP expressing
cells collected from tg(ren:RFP-LifeAct; acta2:EGFP) ren+/+ or tg(ren:RFP-LifeAct;
acta2:EGFP) ren−/− zebrafish (n=3). Data are mean ± SD. ANOVA (p=0.5593)
with Bonferroni’s multiple comparisons test, ns=p>0.05.
Figure 4.31 | Gel electrophoresis of restriction enzyme digest of psectag2c
vector and prorenin and renin carrier vectors Gel electrophoresis of restriction
enzyme digest of psectag2c vector and prorenin and renin carrier vectors by EcoRI















Figure 4.32 | Prorenin Psec2c Plasmid Map Plasmid map of the PSec2C vector
containing the zebrafish prorenin coding sequence placed downstream of the CMV
promoter. Plasmid contains the AmpR casette for antibiotic plasmid selectivity.
Downstream of the prorenin coding sequence is a TEV restriction site and a 6×His
signal for purification and identification purposes.
4.2.20 Prorenin Activation
The protein collected from the cell lysate was purified by using His-tag captur-
ing columns. Activation by removal of the pro segment from the prorenin was
performed using immobilised trypsin, to prevent trypsin contamination in the final
product. Trypsin was left to cleave prorenin for 15 minutes before washing and
eluting the product. The eluted, trypsin activated protein was identified by western
blot (Figure 4.37). No protein was detected using western blot analysis and subse-
quent visualisation of the protein using fluorescent tagged antibodies. The partial
trypsin digest caused dilution of the protein. The product was too dilute for west-
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Figure 4.33 | Gel electrophoresis of restriction enzyme digest of prorenin
psectag2c vector Gel electrophoresis of restriction enzyme digest of prorenin
psectag2c by APAL1 and MSC1. First lane contains 10kb ladder followed by 6
selected clones and their DNA analysed by restriction digest by APAL1 and MSC1
and gel electrophoresis.
ern blotting analysis to identify the protein. RenP1 activity was determined in the
elution media containing the activated prorenin. No difference in cleavage kinetics
of RenP1 was observed between prorenin and activated prorenin (Figure 4.38).
Further attempts at recombinant renin expression were made by the
Max-Delbrück-Centrum (MDC) for Molecular Medicine. Similar expression plas-
mids were designed for protein expression in HEK293 cells and for bacterial pro-
tein expression. However, no protein expression could be observed after multiple
over-expression attempts, suggesting that the higher temperature of mammalian
















Figure 4.34 | Renin Psec2c Plasmid Map Plasmid map of the PSec2C vector
containing the zebrafish renin coding sequence placed downstream of the CMV
promoter. Plasmid contains the AmpR cassette for antibiotic plasmid selectivity.
Downstream of the renin coding sequence is a TEV restriction site and a 6×His
signal for purification and identification purposes.
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Figure 4.35 | DNA gel electrophoresis of restriction enzyme digest of prorenin
psectag2c vector Gel electrophoresis of restriction enzyme digest of renin psec-
tag2c by APAL1 and MSC1. First lane contains 10kb ladder followed by 6 selected
clones and their DNA analysed by restriction digest by APAL1 and MSC1 and gel
electrophoresis.
Figure 4.36 | Western Blot analysis of the recombinant renin and prorenin ex-
pression from CHO cells Cell media and cell lysate were run on a 4-12% gradient
gel under non denaturing conditions. After transfer to 0.45 µm nitrocellulose the
blotted bands were immunodetected with a specific mouse anti 6×His and sub-
sequently visualized with Alexa 488 goat anti-mouse IgG antibodies. Lane: MW
marker, lane 1: Renin cell media 2: Renin Cell lystate 3: Prorenin cell media 4:
Prorenin cell Lysate 5: His-tagged positive control protein.
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Figure 4.37 | Western Blot analysis of the trypsin activation of recombinant
zebrafish prorenin Cell media and cell lysate were run on 4-12% gradient gels un-
der non-denaturating conditions. After transfer to 0.45 µm nitrocellulose the blotted
bands were immunodetected with a specific mouse anti 6×His and subsequently
visualized with alexa 488 goat anti-mouse IgG antibodies. L: MW marker, lane 1:
5 µg His-tagged positive control protein 2: 10 µg His-tagged positive control protein
3: 5 µg Recombinant Prorenin 4: 10 µg Recombinant Prorenin 5: 5 µg Recombi-
nant Renin 6: 10 µg Recombinant Renin.






















Figure 4.38 | Testing activity of recombinant zebrafish prorenin Testing activity




In this chapter I synthesised zebrafish AngI and AngII by SPPS. In collaboration
with Attoquant diagnostics, we were able to use the synthetic AngI and AngII to
calibrate an MS assay to detect AngI and AngII concentrations in kidneys of adult
zebrafish. The AngI and AngI concentrations were measured in kidneys from ze-
brafish treated with the ACE inhibitor Captopril and the measurements were com-
pared to untreated controls. Furthermore, this chapter describes the synthesis and
validation of the first renin zebrafish FRET probe. Although, lacking recombinant
renin to investigate enzyme kinetics, first results suggest successful cleavage of
the probe in larval and adult zebrafish assays.
Lastly, several attempts have been made in expressing recombinant renin. Al-
though these have been unsuccessful they gave an understanding of the possible
difficulties of expressing zebrafish proteins in mammalian protein expression sys-
tems.
4.3.1 Zebrafish Angiotensinogen Tetradecapeptide Sequence
The sequences for AngI and AngII were identified by comparison of the zebrafish
angiotensinogen amino acid sequence to its mammalian counterparts. Structural
and biochemical studies on the interaction of renin and angiotensinogen have
shown that renin recognises a tetradecapeptide amino acid sequence at the N-
terminal of angiotensinogen and is the only known substrate [179]. The well an-
notated mammalian sequences permit identification of the tetradeca-peptide se-
quence in the zebrafish sequence and the potential renin cleavage site. The
renin cleavage of angiotensinogen has been shown to exhibit species specificity by
demonstrating that human angiotensinogen cannot be readily cleaved by mouse
renin [180]. Although only 50% sequence homology between zebrafish and its
mammalian counterparts can be seen, the eight amino acids encoding AngII are
highly conserved across a wide range of species. Paritcularly striking is the preser-
vation of the His-Pro-Phe amino acid sequence which is crucial for the cleavage of
the substrate by renin [37].
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4.3.2 AngI and AngII Synthesis
Both peptides were synthesised using SPPS, which showed promising yields of
product. Peptide concentration was 120 mg and 114 mg, for AngI and AngII, re-
spectively after purification by HPLC column. Purification of the compound sug-
gested 99% purity and should permit using the peptides for injecting into zebrafish
for further experiments. Using SPPS many simple zebrafish peptides can be syn-
thesised.
4.3.3 AngI and AngII measurement in Zebrafish Tissues
The synthesis of Zebrafish AngI and AngII permitted identification and measure-
ment of AngI and AngII concentrations in the zebrafish kidney and serum. In order
to provoke a dynamic change of expression of AngII and possibly AngI, zebrafish
were treated with the ACE inhibitor Captopril. ACE is a metalloenzyme that cleaves
a dipeptide from the C-terminus of the decapeptide AngI to form the vasopressor
Ang II [181]. Captopril has been previously shown to be effective in zebrafish by
studies investigating the zebrafish responsiveness to different salt concentrations.
The measurement of AngII in the zebrafish tissue showed that Captopril is highly
effective in the zebrafish as there was a complete lack of renal AngII in adult ze-
brafish that were Captopril treated for 7 days. Surprisingly there was no decrease
in the AngI concentration measured in the kidney tissue. Previous in vitro and in
vivo studies have shown that ACE inhibitors increase AngI [182, 183]. A possible
explanation for the decrease seen in the zebrafish renal tissue is that the renal
renin stores might be exhausted following the increased secretion in order to com-
pensate for the complete lack of AngII. The serum results showed high variability
for both the AngI and AngII measurements and suggest low reproducibility. A pos-
sibly cause for this might be the serum preparation and the half life of AngI and
AngII.
The MS assay is highly accurate in measuring AngI and AngII concentrations,
however, requires a large number of fish to have sufficient material to permit the
measurement. An increased sensitivity and optimisation of the assay would hope-




4.3.4 Reduced Activity in Mib Mutants
The notch signalling pathway is a highly evolutionary conserved signalling path-
way involved in the the pattern formation and cell fate determination by cell to cell
interactions [184]. Mind Bomb is a ubiquitin ligase required for the activation of
the Notch receptor in target cells [172]. Zebrafish mind bomb (mib) mutants have a
compromised notch signalling pathway which leads to the premature differentiation
of neural progenitors causing severe neurogenic phenotypes and a range of devel-
opmental defects due to the failure to develop proper somites, neural crest and
vasculature. Interestingly it has been shown that renin cells express high levels of
Notch3 and that mibta52b mutant fish do not express renin mRNA at any stage of de-
velopment suggesting that a proper notch signalling pathway is required for larval
ren expression [47,185]. Prior to the generation of the first renin knockout-fish the
mibta52b mutant presented the best opportunity of a renin like knockout zebrafish
mutant in order to test the specificity of the RenP1 FRET probe. Although a signifi-
cant difference can be observed in the RenP1 fluorescence activity, suggesting the
lack of renin causes a reduction in the fluorescence signal. However, the mibta52b
mutant has been characterised with many major developmental phenotypes which
may also lead to an impaired development of the digestive system. This could ulti-
mately lead to the lack of development of digestive enzymes and lead to a decrease
in cleavage kinetics of the probe observer with the mibta52b mutants.
4.3.5 RenP1 in Larval Zebrafish
Due to the lack of recombinant renin the RenP1 probe specificity was assessed by
RAS altered zebrafish. Renin is first expressed in the zebrafish at 24hpf. Renin
cell area at the AMA was previously assessed using a transgenic zebrafish line ex-
pressing RFP-LifeAct under a renin promoter, expressing RFP in renin expressing
cells [47]. Investigating the fluorescent signal stemming from the renin cells at the
AMA suggested an increased renin cell area. If zebrafish secret functional renin at
this stage of development and the probe is renin specific a steady increase should
be seen in the RenP1 activity at different days of development. RenP1 activity in
homogenate larval fish at 3dpf, 4dpf and 5dpf suggested that there was increased
activity of RenP1 from 3dpf to 4- and 5dpf however, not between 4- and 5dpf. This
suggests that at 3dpf, with the commencement of the pronephric filtration, there
is an increase in active renin. RenP1 activity was not assessed prior to 3dpf. At
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2dpf the larval zebrafish are still enveloped in their protective chorion and express
chorion digesting enzymes that might interfere with RenP1 activity. It would be
interesting to investigate RenP1 activity throughout the first 2 weeks of zebrafish
development and investigate whether an increase of renin can be observed with
the formation of mesonephros which occurs at 14dpf.
RenP1 activity was also assed in zebrafish treated with the ACE inhibitor Capto-
pril. Fish were left in Captopril from 24hpf to 5dpf, washed and homogenised prior
to the RenP1 micro-plate assay. A clear increase in RenP1 fluorescence intensity
was observed in fish treated with Captopril. This observation concours with previ-
ous studies showing that animals treated with Captopril show renin cell recruitment
along renal arterioles, and have a higher PRA. [47,79,186].
4.3.6 RenP1 in Adult Zebrafish
RenP1 activity was also assessed in adult zebrafish. Similarly as in larval ze-
brafish, RenP1 activity was assessed in RAS modulated adult zebrafish treated
with the ACE inhibitor Captopril. Furthermore, the previously discussed MS assay
revealed high effectiveness of Captopril on zebrafish ACE, which should diminish
the AngII mediated negative feedback and an increase in renin transcription and
secretion. RenP1 activity in zebrafish plasma of Captopril treated fish revealed
higher cleavage kinetic activity within the first hour of the assay. Although this
change is not as dramatic as observed in the larval fish, the assaying of zebrafish
plasma has proven difficult in the MS assay. ReninP1 activity in the kidneys of
Captopril treated adult zebrafish was not assessed. It would be interesting to see
whether RenP1 activity would complement the MS data.
4.3.7 ren−/− Larval Zebrafish
The ren−/− zebrafish, developed in our laboratory is the ideal model to test the
probe on zebrafish lacking active renin. This model was developed after the testing
with the mibta52b mutants, showing a decrease of probe activity in homogenised
larval zebrafish. RenP1 activity was assessed in 5dpf homogenised ren−/− lar-
val zebrafish and compared to age matched wild-type zebrafish. Surprisingly, no
change change in RenP1 activity was observed. However, previously data has
suggested that there was a difference in RenP1 activity between Captopril and
non-Captopril treated fish. The data suggests that the effectiveness of Captopril
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might cause a dramatic increase in active renin present, which is identifiable using
the RenP1 probe. However, potentially the early larval renin activity is low and the
difference between ren−/− and ren+/+ larval zebrafish requires a more sensitive
assay, with a more specific probe.
4.3.8 ren−/− Adult Fish
Despite the lack of change in RenP1 activity in the larval zebrafish, RenP1 activ-
ity was assessed in the adult kidney of ren−/− zebrafish and compared to ren+/+,
wild-type controls. Furthermore, zebrafish muscle tissue was used as a control as
no renin activity is expected in muscle tissues. There was a significant increase
in fluorescence intensity measured in ren+/+ compared to ren−/− zebrafish. Fur-
thermore, there was no difference in the muscle tissue. This experiment suggests
successful cleavage of the probe, however the lack of dramatic difference suggests
that the lack of specificity and high background activity interferes with the probe.
Due to the lack of sensitivity of the probe in larval ren−/− and ren+/+ zebrafish,
it would be interesting to assess at what time point during zebrafish development,
enough renin is present to detect a significant difference.
4.3.9 Probe Specificity
Due to lack of recombinant renin, the Km value of zebrafish renin and the probe
specificity could not be assessed. However, the above mentioned assays were
able to show dynamic changes in the cleavage kinetics of RenP1 in models that
are expected to have higher or lower concentrations of renin. A further difficulty
is the lack of a zebrafish renin inhibitor. Despite a long history of development of
renin inhibitors, the only successful renin inhibitor currently available is Aliskiren,
Aliskiren is a non-peptide renin inhibitor as is currently successfully used as a hy-
pertension mono-therapy. Aliskiren is highly specific to human renin and has not
been tested in this project. Despite the evidence that renin activity is measurable in
larval and adult zebrafish, it would be interesting to investigate whether a dynamic
change as well as a dose response could be measured using Aliskiren in zebrafish.
However, aliskiren effectiveness would have to be assessed first as-well as a drug
repose curve.
To increase the probe sensitivity, a new RenP1-D FRET probe was successfully
synthesised. RenP1-D was identified to be cleaved by trypsin and proteinase K.
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Studies have shown that most proteases are chiral and that they can distinguish
between L- and D-enantiomeric substrates and that D-peptides are capable of re-
sisting cleavage by many proteases [176, 177]. Despite successful synthesis no
difference could be seen in cleaving kinetics between RenP1-D and RenP1 when
exposed to trypsin. Although not significant, there was an ultimately higher fluores-
cent signal from the RenP1 probe compared to the RenP1-D probe when exposed
to proteinase K. Assays to test the probe were designed to test whether the probe
specificity was increased and whether potential cleavage by renin was influenced.
No differences in the assays could be observed, apart from when measuring ac-
tivity in the cell media from ren−/− and ren+/+ cells from tg(ren:RFP-LifeAct) and
tg(acta2:EGFP) zebrafish.
Further testing would have to be conducted. It is crucial to assess a possible
change in affinity of renin to the substrate containing D-amino acids. Although the
4 amino acids directly at the peptide cleavage were not changed (Ser9-Asn12), the
amino acids crucial for renin cleavage (His6, Pro7, Phe8) were replaced with their
enantiomeric form,
4.3.10 Recombinant Renin
The FRET probe specificity was a major issue during the development of the ze-
brafish renin FRET probe. In order to increase the specificity, the pure enzyme is
required. The development of an recombinant protein turned out to be difficult due
to the different temperatures at which zebrafish proteins are folded. If there was
a pure protein this would allow to develop various new probes with single amino
acids changed that would inhibit trypsin from cleaving the probe however the re-
combinant renin would be required to be able to assess how the single amino acid
change effected renin from cleaving the probe.
Several different methods were employed to develop recombinant renin; how-
ever, most were unsuccessful. Mammalian renin was previously successfully ex-
pressed as the inactive renin form, prorenin, in CHO and HEK293 cells [187,188].
In this thesis, zebrafish renin was attempted to be expressed in CHO cells and
HEK293 cells. HEK293 yielded no protein and CHO cells protein over expression
was observed, however the protein was trapped within inclusion bodies and re-
quired additional purification steps. Western blot analysis demonstrated that the




In collaboration to the work performed in the thesis, attempts were made by
the MDC in Berlin, which specialises in the expression of recombinant proteins, to
express zebrafish renin in bacterial and mammalian cells, which were also unsuc-
cessful. Expression of zebrafish proteins has previously been performed in bac-
terial cells [189]. The temperature at which the mammalian cells are maintained











To deepen our understanding of the role of renin and the RAS in zebrafish, a
CRISPR/CAS9 induced renin knockout zebrafish was generated. Zebrafish renin
specific gRNAs were designed to target CRISPR-Cas9 to renin exon 2, resulting in
an 8bp deletion. The targeted knockout was identified by sequencing.
This chapter focuses on the phenotypic characterisation of the ren−/− zebrafish
line using different methodologies, including the high-throughput VAST system.
The VAST system allowed for a large number of age matched fish to be imaged and
downstream image analysis identified morphological differences between ren−/−
and ren+/+ fish. During early development a noticeable delay in swim bladder infla-
tion and body length was observed and was suggestive of renin playing an impor-
tant role during early zebrafish development.
To assess morphological differences at a cellular level, the ren−/− knockout
fish were crossed to existing transgenic lines to assess kidney development, renal
vasculature and morphology of juxtaglomerular cells in the absence of renin. A
cross of the ren−/− fish to the tg(wt1b:EGFP) transgenic fish, enabled the visual-
isation of glomerular and tubular structures of the pronephros during early kidney
development. For a better understanding of JG cell morphology, the ren−/− fish
were crossed to the tg(ren:RFP; acta2:EGFP) double transgenic line. Although no
difference in cell morphology, between the ren−/− and ren+/+ was noticeable in the
pronephric kidney, high resolution imaging of ex vivo zebrafish mesonephric kid-
neys revealed a dramatic increase of renin-expressing cells along the renal arteri-
oles. This phenotype was further quantified using FACS to sort for red (ren:LifeAct-
RFP) and green (acta2:EGFP) positive cells. In this chapter I will characterise the
various phenotypes of the first renin knockout zebrafish and discuss possible roles





The ren−/− zebrafish strain, was generated in our laboratory by Linda Mullins and
Sebastien Rider and has a deletion of 8 bp in renin exon 2, causing a truncation of
the mRNA between nucleotides 1388 and 1380, resulting in a frameshift mutation
and premature truncation of the normal open reading frame after codon 75 (Fig-
ure 5.1). I was given the opportunity to phenotypically characterise the breeding
ren−/− zebrafish line using different molecular techniques.
5.2.1 Viability
Phenotypic observations were performed on PCR-validated ren−/− larval fish and
compared to age-matched ren+/+ (WIK) fish. Ren−/− showed no loss in viability
during the first 5dpf in an normal salt environment (CW) (Figure 5.2). A previous
study showed that zebrafish exposed to Captopril in combination with low salt (1/20
CW) results in a 97% loss of viability at 4dpf [47]. The lack of renin in ren−/− fish
will result in the loss of production of AngI, and therefore the absence of AngII,
leading to an inability to handle low a salt concentration environment. Viability was
not reduced in ren−/− fish exposed to 1/20 CW. Exposing ren−/− fish to 0.05 mM
Captopril in CW, which has previously been demonstrated to be the highest con-
centration without any toxic effect [47], reduced viability by only 5% (n=42) and
had no effect on viability in ren+/+ fish during early development. The combination
of Captopril with dilute medium (1/20 CW) resulted in 0% viability in ren−/− and
12.5% in ren+/+ fish, however surviving wild type fish showed severe pericardial
and yolk sac oedema at 5dpf.
5.2.2 Hatching
A delay in hatching of the ren−/− fish larval fish from the protective chorion was ob-
served. The hatching period in zebrafish occurs between 48-72hpf and individual
fish from the same clutch will hatch sporadically throughout the third day [190]. The
number of hatched fish was assessed at the end of the third day of development in
ren−/− and age matched ren+/+ control (Figure 5.3). Only 43.75% of ren−/− had
hatched by the end of the third day compared to 73.33% of ren+/+ fish (p=0.0207).
Exposing the fish to 1/20 CW caused a even more dramatic decrease of hatched




































































































































Figure 5.2 | Viability of ren−/− fish Viability of ren+/+ (n=48) versus ren−/− (n=48)
fish was assessed at 5dpf. 100% viability was seen in ren+/+ and ren−/− in normal
salinity (CW) and dilute medium (1/20 CW). Addition of 0.05 mM of the angiotensin-
converting enzyme inhibitor Captopril to CW reduced the viability of ren−/− fish by
5% (n=42). Addition of Captopril to 1/20 CW reduced viability of ren+/+ fish by
87.5% (n=48) and no ren−/− fish survived to 5dpf (n=48).
To determine if a functional RAS was required for hatching of fish, Captopril
was administered to fish in CW and 1/20 CW. Administration of Captopril, similarly
to 1/20 CW without Captopril, reduced the number of hatched ren−/− fish by 91.7%
and ren+/+ by 30.75% (p=0.0024). Combination 1/20 CW and Captopril reduced
the number of hatched ren+/+ and ren−/− fish by 43.75% and 84.25%, respectively
(p=0.0225). However, the final number of hatched fish was strongly influenced by
the low viability of these fish in the Captopril and 1/20 CW.
5.2.3 Oedema During Early Larval Development
Oedema is suggestive of the inability of proper osmoregulation and specifically
pericardial and yolk sac oedema is a sign of developmental toxicity in the larval ze-
brafish [191]. To assess at which stage of development the phenotypic differences
arise between the ren−/− and ren+/+ larvae, larval ren−/− and ren+/+ zebrafish
were placed in CW or 1/20 CW and oedema occurrences were recorded (0-5dpf).
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Figure 5.3 | Quantity of ren+/+ and ren−/− zebrafish hatched at 3dpf The num-
ber of hatched ren+/+ versus ren−/− fish was assessed at 72hpf. In normal salin-
ity (CW) 73.3% of ren+/+ (n=3) and only 43.48% of ren−/− (n=3, p=0.0207) had
hatched. Low salinity (1/20 CW) reduced number of hatched ren+/+ to 68.8% (n=3)
and ren−/− fish to 7.6% of (n=3, p=0.0003). Addition of 0.05 mM Captopril to CW
reduced the number of ren+/+ fish hatched to 68.8% (n=3) and 8.3% in ren−/− fish
(n=3, p=0.0024). 1/20CW and Captopril reduced hatching to 56.3% and 15.9%
of ren+/+ (n=3) and ren−/− fish (n=3), respectively (p=0.0225). Data are mean ±
SD.*=p<0.05, **=p<0.01, ***=p<0.001.
Oedema was defined as the presence of any pericardial effusion and or a cranial
haemorrhage. In CW, ren+/+ fish did not develop any oedema (Figure 5.4). A small
subset of ren−/− fish developed oedemas at 5dpf (8.7%). In 1/20 CW, 12.5% of
ren−/− fish developed pericardial oedema and 4% of ren+/+ developed oedemas.
No oedema were noted prior to 2dpf and there was also no increase after 3dpf
suggesting normal salinity is crucial between 2 and 3dpf of development, the time
at which filtration in the zebrafish pronephros is first observed [103].
5.2.4 Oedema in Response to Captopril
Although viability did not significantly decrease in ren−/− fish exposed to 0.05 mM
Captopril (Figure 5.2), 30% of the fish developed oedema by 4dpf (Figure 5.5). No
oedema was seen in ren+/+ fish during the first 5 days of development. In 1/20
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Figure 5.4 | Occurrence of oedema during early development Occurrences of
pericardial and yolk sac oedemas during the first 5 days of ren+/+ and ren−/− fish
during development in normal salinity (CW) and low salt (1/20 CW). Data are mean
± SD. ****=p<0.0001.
CW and Captopril, oedemas were noted as early as 24hpf in ren+/+ and 48hpf in
ren−/−. No ren−/− and ren+/+ fish survived past 3dpf and 4dpf, respectively. This
was suggests that despite the lack of renin in ren−/− fish, inhibition of ACE reduces
viability suggesting that ACE might be implicated in other pathways.
5.2.5 Delay in Swim Bladder Inflation
In zebrafish the swim bladder develops at 4-5dpf and is directly correlated to the
fish length, an indicator of overall fish development. A preliminary experiment in-
vestigated the swim bladder size in ren−/− at 5dpf against age-matched ren+/+ fish
(Figure 5.6). There was a significant difference in swim bladder size in ren−/− fish
at 5dpf (p=<0.0001, n=9). Interestingly, when fish were grown in 1/20 CW, no sig-
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Figure 5.5 | Occurrence of oedema during early development of zebrafish
exposed to 0.05 mM Captopril Incidence of pericardial and yolk sac oedema
in ren+/+ and ren−/− fish during first 5 days of development, when exposed to
0.05 mM Captopril in normal salt (CW) and low salt (1/20 CW). Data are mean ±
SD.*=p<0.05.
nificant difference in swim bladder size was observed (p=0.5705, n=9). In line with
previous observations, there was a reduction of swim bladder size of ren+/+ fish in
CW compared to ren+/+ in 1/20 CW (p<0.0001) [43]. The high variability in ren+/+
fish in 1/20 CW suggests that not all fish are capable of handling low salt equally.
5.2.6 Swim Bladder and Length Measurement up to 5 Days of
Development
The VAST system allows a large number of fish to be imaged with highly repro-
ducible accuracy. Furthermore, the fish are anaesthetised and collected from a

























Figure 5.6 | Swim bladder size of ren+/+ and ren−/− at 5dpf Swim bladder area
was assessed at 5dpf in ren+/+ (n=9) and ren−/− (n=9) zebrafish, from acquired
lateral brightfield images. Swim bladder size was reduced in ren−/− fish in nor-
mal salt water (CW) (p<0.0001). No significant difference in swim bladder size
was observed in low salt water (1/20 CW), ren+/+ (n=9) ren−/− (n=8), p=0.5705).
Swim bladder size of ren+/+ fish was reduced in 1/20 CW. Data are mean ± SD.
****=p<0.0001.
absence of mounting medium and minimal exposure to anaesthetic enables the
same fish to be tracked for several days during development. However, during the
imaging and transfer of the fish, approximately 10% of the fish are injured and lost
after every imaging session. To reduce the number of fish lost and allow statis-
tically significant and reproducible data to be collected, the measurements were
restricted to 3 time points. The preliminary data for swim bladder inflation sug-
gested delayed development in ren−/− fish at 5dpf. The VAST was used to image
fish at 3dpf, 4dpf and 5dpf to determine whether the delay in development occurs
before 5dpf. Lateral images were acquired and the size of the swim bladder as
well as the length of the fish were assessed (Figure 5.7). Fish with no visible
swim bladder were recorded to have a swim bladder area of 0 mm2. Although the
VAST imaging systems ensures reproducible images, the tail region is commonly
excluded from the image. In these instances the length was not recorded. There
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was no difference in fish length at 3dpf between ren−/− (n=38, length=3.43 mm)
and ren+/+ (n=37, length=3.36 mm) fish and a lack of inflated swim bladders in both
ren−/− (n=47, area=0 mm2) and ren+/+ (n=48, area=0 mm2) fish (Figure 5.8). An
increased size and more fish with inflated swim bladders were observed at 4dpf
in ren+/+ (n=20, length=3.7 mm; n=46, area=29.26 mm2) fish compared to ren−/−
(n=30, length=3.54 mm; n=43, area=7.87 mm2) fish, and the latter had a significant
reduction in length (p=0.0156). This phenotype was more dramatic at 5dpf with
all ren+/+ (n=44, area=117.46 mm2) having inflated swim bladders of various sizes
however, many ren−/− (n=41, area=48.26 mm2) fish lacked or had small swim blad-
ders. Furthermore, there was a significant difference in fish length (ren+/+: n=15,
length=3.89 mm; ren−/−: n=28, length=3.69 mm) at 5dpf between the two geno-
types (p=0.0063).
Figure 5.7 | VAST system measurements Lateral larval zebrafish image acquired
using the VAST system. The fish is held in place in a rotatable capillary. Yel-
low dotted circular line indicates the area determined for the swim bladder area
measurements. Red lines and dotted yellow line in-between indicate an example
measurement of the length of a zebrafish.
5.2.7 Swim Bladder and Length Measurement up to 8 Days of
Development
The VAST is optimised for larval zebrafish and the width of the capillary transport-
ing the fish to the imaging system limits the fish to a maximum age of 8dpf. Since
the most significant phenotype in developmental delay appears to be at 5dpf, I
was interested to determine whether the phenotype persisted past 5 days of de-
velopment. New images using the VAST brightfield system were acquired at 3
different time points (4dpf, 5dpf, and 8dpf) (Figure 5.9). Surprsingly, swim bladder
size was not significantly different in size at 4dpf (ren+/+: n=46, area=0.046 mm2;









































Figure 5.8 | Swim bladder area and fish length during early development
Ren+/+ and ren−/− zebrafish larvae were imaged at 3dpf, 4dpf and 5dpf using
the VAST brightfield imaging system and fish length and swim bladder size were
assessed. Swim bladder size was reduced in ren−/− at 4dpf (p=0.0358, n=47),
and 5dpf (p=<0.0001, n=44). Significant differences in fish length were seen at
4dpf (p<0.0156, n=30) and 5dpf (p=0.063, n=28) although no significant differ-
ences were observed at 3dpf (p=0.2970, n=37). Data are mean ± SD. *=p<0.05,
**=p<0.01, ****=p<0.0001.
occurring earlier in than in the previous experiment. However, swim bladder was
significantly different at 5dpf (ren+/+: n=38, area=0.115 mm2; ren−/−: n=40,
area=0.0574 mm2; p<0.0001). Interestingly no significant difference of swim blad-
der area was observable at 8dpf (ren+/+: n=40, area=0.255 mm2; ren−/−: n=41,
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area=0.224 mm2; p=0.1594). The growth retardation at 4dpf (ren+/+: n=40,
length=3.79 mm; ren−/−: n=38, length=3.58 mm; p<0.0001) and 5dpf (ren+/+: n=30,
length=3.88 mm; ren−/−: n=29, length=3.76 mm; p=0.0107), was no longer evident
by 8dpf (ren+/+: n=19, length=3.9 mm; ren−/−: n=21, length=3.87 mm; p=0.8653)
suggesting that the fish were capable of reversing the phenotype seen during early
development with pathways overcoming the lack of renin from 5dpf.
5.2.8 Pronephric Development
Many components of the RAS are expressed in the developing kidney suggesting
an involvement in renal development [192]. The translucent nature of the larval ze-
brafish allows for renal development to be investigated in-vivo, by using transgenic
zebrafish lines such as the tg(wt1b:EGFP). Wt1b is localised in the pronephric
proximal tubule and glomerulus in the developing nephron [98]. Confocal imag-
ing of the tg(wt1b:EGFP) permits visualisation of the pronephric kidney structures
and downstream image analysis allows for measurement of the pronephric struc-
tures. Unpublished work in our laboratory showed that fish with an impaired RAS
develop asymmetrically sized glomeruli at the pronephric stage and experience a
delay in glomerular fusion. I measured the glomerular distance, neck width and
glomerular area in 3dpf, 4dpf and 5dpf ren−/− and aged matched ren+/+ zebrafish
(Figure 5.10). No difference between the left and right glomerulus was observed
in ren−/− and ren+/+ fish at any of the 3 stages of development (Figure 5.11).
However, when measuring the anterior and posterior distance between the fus-
ing glomeruli in the pronephric zebrafish kidney, there was a significant delay in
fusion of the glomerulus at all stages of development (Figure 5.12). Pronephric
neck length was decreased at 3dpf and 4dpf in both the left and right neck regions
(Figure 1.13). At 5dpf neck width of the left tubule was significantly different (Fig-
ure 5.14). This suggests that renin renin is required for proper development of the
zebrafish pronephros and the lack of renin leads to delay of pronephric glomerular
fusion.
5.2.9 Renin Cell Morphology in the Pronephric Kidney
In normal salinity RAS blockade in the zebrafish has been shown to increase mural
ren:LifeAct-RFP expression at the AMA [47] and this is consistent with the RAS-



































Figure 5.9 | Swim bladder size and length of ren−/− fish ren+/+ and ren−/− ze-
brafish larvae were imaged at 3 developmental time points (4dpf, 5dpf and 8dpf)
using the VAST birghtfield imaging system and fish length and swim bladder size
were assessed. Swim bladder development is was delayed in ren−/− at 5dpf
(p<0.0001, n=37), however no difference was seen at 8dpf. Significant differences
in fish length were seen at 4dpf (p<0.0001, n=29) and 5dpf (p=0.0119, n=29) al-
though no significant difference was observed at 8dpf (p=0.8478, n=22). Data are
mean ± SD. **=p<0.01, ****=p<0.0001.
mechanism existed in the ren−/− fish, the extent of mural cell ren:LifeAct-RFP ex-
pression at the AMA was determined in ren+/+ and ren−/− carrying the ren:LifeAct-
RFP transgene using the SPIM microscopy system. No significant change at 5dpf
in the ren:LifeAct-RFP cell expressing coverage at the AMA could be observed
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Figure 5.10 | Fluorescent dorsal image of the pronephros of the
tg(wt1b:EGFP) transgenic line Fluorescent image of the pronephros of a
Tg(wt1b:EGFP) on a ren−/− background acquired using the VAST confocal sys-
tem. The VAST imaging system ensured accurate reproducible orientation of ev-
ery imaged fish. Yellow oval indicates the measurement for the left glomerular area
(LGA), yellow double sided arrow indicates the left neck width (LNW), dotted line
with double sided yellow arrows indicates the anterior glomerular distance (AGD),
yellow arrow indicates left neck length (LNL). Red oval is an example measure-
ment for the right glomerular area (RGA), red double sided arrow the right neck
width (RNW) and the red dotted line with double sided arrow indicates the poste-
rior glomerular distance (PGD), and red arrow indicates right neck length (RNL).
Scale bar=50 µm.
(Figure 5.15). The lack of increase of ren:LifeAct-RFP expressing cells suggest
























Figure 5.11 | Comparison of glomerular area between ren+/+ and ren−/−
zebrafish at 3dpf, 4dpf and 5dpf Measurements of glomerular area during
pronephric development. Images were acquired using the VAST system to en-
sure reproducibility. Area of right and left glomerulus were measured using dorsal
images of the larval zebrafish (ren+/+: 3dpf n=43, 4dpf=35, 5dpf=33; ren−/−: 3dpf
n=39, 4dpf=30, 5dpf=29). Data are mean ± SD.
5.2.10 Renin Cell Morphology in the Mesonephric Kidney
The role of renin in the pronephric kidney might be different to that in the meso-
nephric kidney, and to investigate this I crossed ren−/− and ren+/+ fish with
tg(ren:LifeAct-RFP, acta2:EGFP) double reporter fish. Renin cells are specialised
smooth muscle cells, expressing the smooth muscle marker acta2. The double
transgenic would visualise smooth muscle cells, renin cells expressing ren:LifeAct-
RFP, acta2:EGFP and potentially permit capture of smooth muscle cells assuming
a renin phenotype. Confocal imaging of ex vivo mesonephric kidneys of
tg(ren:LifeAct-RFP, acta2:EGFP) revealed a substantial increase of ren:LifeAct-
RFP expressing cells in the ren−/− and fish compared to the ren+/+ control fish
(Figure 5.16). In ren+/+ mesonephric kidneys, renin expressing cells are located
along afferent arterioles but not efferent arterioles [67]. The cells appear in a inter-
changing pattern with acta2 expressing smooth muscle cells. In the mesonephric
ren−/− kidney, smooth muscle cells appear to lose acta2:EGFP expression which
is replaced by expression of ren:LifeAct-RFP, giving the vessels an appearance of
continuous renin cell covering the vessel (Figure 5.16).
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Figure 5.12 | Comparison of glomerular distance in ren+/+ and ren−/− ze-
brafish at 3dpf, 4dpf and 5dpf Measurements of the anterior and posterior
glomerular distance to investigate a possible delay in glomerular fusion in ren−/−
zebrafish. The pronephric images were from age matched ren+/+ (3dpf n=43,
4dpf=35, 5dpf=33) and ren−/− (3dpf n=39, 4dpf=30, 5dpf=29) fish crossed with the
transgenic tg(wt1b:EGFP), acquired using the spinning disk confocal microscope
mounted to the VAST system. Data are mean ± SD. **=p<0.01, ****=p<0.0001.
5.2.11 Mesonephric Kidney Histology
Coronal plane sections of adult ren+/+ and ren−/− zebrafish were taken in a dorsal
to ventral orientation. This permitted nearly fully intact 5 µm thick sections of the
adult mesonephric zebrafish kidney to be prepared. H&E staining visualised major
renal structures (Figure 5.17). Kidneys of ren−/− fish showed vacuolation of the
proximal tubule (n=3). No vacuolation was observed in the distal tubule and the
number of glomeruli appeared unchanged between ren+/+ and ren−/− zebrafish
kidneys.
5.2.12 Verification of RFP and EGFP Expression in FAC Sorted
Renin and Smooth Muscle Actin Cells
EGFP- and RFP- positive cells were sorted by FACS from kidneys of adult ren−/−
and ren+/+ tg(ren:LifeAct-RFP, acta2:EGFP) fish. The FACS and cell dissociation
protocols were carefully optimised to ensure the capture of live cells and to max-
imise the recovery of the small number of renin expressing cells. The FACS gating
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Figure 5.13 | Comparison of the lateral neck length of the pronephros in
ren+/+ and ren−/− zebrafish at 3dpf, 4dpf and 5dpf Measurements of the lat-
eral neck length to investigate a delay in pronephric development in ren−/− fish.
The tg(wt1b:EGFP) zebrafish on a ren+/+ and ren−/− background were imaged
using the VAST confocal system. Downstream image analysis permitted the mea-
surement of the left and right neck length (ren+/+: 3dpf n=43, 4dpf=35, 5dpf=33;
ren−/−: 3dpf n=39, 4dpf=30, 5dpf=29). Data are mean ± SD.*=p<0.05, **=p<0.01.
was optimised to capture, separately, RFP- and EGFP-expressing cells, to quantify
the number of ren and acta2 expressing cells respectively (Figure 5.18). Further
gating of the sorted GFP-positive cells was performed to detect LifeAct-RFP and
EGFP double positive cells. The gating also permitted the quantification of EGFP-
positive cells with varying LifeAct-RFP brightness allowing me to determine the
number of cells transitioning from a smooth muscle to renin expressing cell pheno-
type.
Following previous experiences in our laboratory, the cells were seeded onto
fibronectin-coated, glass-bottom culture dishes. The fibronectin is ideal for JG cell
attachment to glass-bottom dishes, which permit light penetration for confocal mi-
croscopy imaging. Confocal microscopy was used to image EGFP and RFP ex-
pression. The cells fully adhered to the fibronectin-coated dishes and expressed
LifeAct-RFP and EGFP (Figure 5.19). The images were acquired using high res-
olution microscopy to enable visualisation of the cytoskeleton which is revealed
by the binding of LifeAct-RFP to intracellular actin. Although the cells settled, no
changes in cell morphology or evidence for cell proliferation was observed, and
LifeAct-RFP and EGFP fluorescence were no longer visible in cells after 5 days in
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Figure 5.14 | Comparison of the lateral neck width of the pronephros in ze-
brafish at 3dpf, 4dpf and 5dpf. Measurements of the lateral neck width in ren+/+:
3dpf n=43, 4dpf=35, 5dpf=33; ren−/−: 3dpf n=39, 4dpf=30, 5dpf=29) to investigate
a delay in pronephric development in ren−/− fish. The tg(wt1b:EGFP) zebrafish on
a ren+/+ and ren−/− background were imaged using the VAST system. Data are
mean ± SD. **=p<0.01.
culture, indicating cell de-differentiation or cell death. However, this first demon-
strated successful sorting and culturing of renin cells, expressing both ren:LifeAct-
RFP, acta2:EGFP, in line with previous observations by Rider et al. [67].
5.2.13 FAC sorting ren and acta2 Expressing Cells from
Mesonephric ren+/+ and ren−/− Zebrafish Kidneys.
FAC sorted EGFP- and LifeAct-RFP-positive cells from the transgenic
tg(ren:LifeAct-RFP; acta2:EGFP) fish on ren−/− and ren+/+ backgrounds were quan-
tified by analysis of the FACS data (Figure 5.18). LifeAct-RFP and EGFP expres-
sion were confirmed by high resolution imaging of cells plated on fibronectin-coated
culture dishes. The cell sorting quantified the phenotype of the increased num-
ber of renin expressing cells observed in Section 5.2.10. The FACS data show
that in ren+/+ fish kidneys, the sorted cells comprised of 78% EGFP-positive cells,
1.5% LifeAct-RFP-positive cells and 20.23% double-positive cells expressing both














RFP-LifeAct AMA Area Analysis
(a) (b)
Figure 5.15 | Evaluation of ren:RFP-LifeAct signal at the AMA in tg(ren:RFP-
LifeAct, acta2:EGFP) on a ren+/+ and ren−/− background (a) Pronephric AMA
with red being RFP-LifeAct in ren expressing cells and green being EGFP in acta2
expressing cells. (b) representative greyscale image for mean area analysis .
There was no significant difference in the area of RFP-LifeAct along the AMA in
ren+/+ and ren−/− 5dpf larval zebrafish.
3% LifeAct-RFP-positive cells and 32% double-positive cells. This suggests that
ren−/− fish possess twice the number of ren-expressing cells, only expressing
ren:LifeAct-RFP, in the adult mesonephric kidney, and a 60% increase in cells ex-
pressing both reporters. This is suggestive of a higher number of cells transitioning
from a smooth muscle cell phenotype to a renin-expressing cell.
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Figure 5.16 | Expression of renin and smooth muscle markers in the
mesonephric kidney in zebrafish on a ren+/+ and ren−/− background Fluores-
cent image of tg(ren:LifeAct-RFP, acta2:EGFP), ren+/+ and ren−/− mesospheric
kidney squash. Images of ren−/− mesonephros revealed increase of renin ex-
pressing cells along renal arterioles. Ren−/− renal vasculature looses intermittent
pattern of renin and smooth muscle cells. Scale bar=50 µm.
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Figure 5.17 | H&E stain of a ren+/+ and a ren−/− zebrafish mesonephric kidney
section Comparison of H&E stained adult mesonephric kidneys from ren−/− and
ren+/+ fish revealed excessive vacuolation of proximal tubule cells (yellow arrows)
in the kidney of ren−/− fish. Cells of the distal tubule (green arrows) appeared
unchanged. G shows the glomeruli in the kidney sections. Scale bar=100 µm.
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Figure 5.18 | Gating used for FACS of ren and acta2 expressing cells Using
cells from adult ren+/+ and ren−/− tg(ren:RFP; acta2:EGFP) kidney digests, gating
strategy was optimised on non fluorescent WIK mesonephric kidneys. P1, sin-
glet cells were gated on by plotting the side scatter area (SSC-A) against forward
scatter height (FSC-H). P2, the population of live, single cells were gated by plot-
ting the FSC-H of the singlet cells against the forward scatter area (FSC-A). P3,
Following the previous gating, cells negative for the ’live-dead’ marker DAPI were
selected. P4 and P5 were gated on the FSC-A against the green (525 nm) or red
(582 nm) laser to discriminate between autofluorescence and true signal. P6, P7




Figure 5.19 | Confirmation of RFP and EGFP expression in ren and acta2
expressing cells isolated from adult metanephric kidneys ren and acta2
expressing cells from metanephric tg(ren:LifeAct-RFP; acta2:EGFP) ren+/+ and
ren−/− kidneys were FAC sorted on their RFP and EGFP expression and plated
on fibronectin-coated (50 µg/ml) dishes. Images were acquired after 48 hours of
culture with a confocal microscope and a 60× objective lens. Green: EGFP ex-
pression in acta2 expressing cells, red: LifeAct-RFP expression in ren expressing












































Figure 5.20 | Quantification of cell sorting data from FAC sorting of adult
metanephric tg(ren:LifeAct-RFP; acta2:EGFP) ren+/+ and ren−/− zebrafish
kidneys Quantified data on ren- (LifeAct-RFP) and acta2- (EGFP) expressing






This chapter focuses on the characterisation of the first renin null zebrafish strain.
Homozygous renin knockout fish were genotyped by PCR amplification of the
knockout region with subsequent sequencing of the PCR product verifying the 8bp
deletion in renin exon 2. The 8bp deletion causes a frameshift mutation resulting in
early termination of renin translation. Knockout animals are commonly validated by
confirming the absence of the protein using western blotting. Unfortunately, there
is a general lack of zebrafish-specific antibodies and, critically, there is no antibody
available that recognises zebrafish renin. Due to the low protein homology between
zebrafish and mammalian renin [40], it is highly unlikely that mammalian renin an-
tibodies recognise and bind to the zebrafish renin epitope. Furthermore, mRNA
levels were not confirmed in the knockout and compared to wild-type zebrafish.
Lack of detectable renin mRNA would suggest a successful knockout, however,
previous reports have indicated that not all transcripts with a frameshift mutation
are directed to the Nonsense Mediated Decay pathway and might be detectable.
Hence, measurement of the renin protein is crucial to fully verify this knockout [193].
AngI and AngII is virtually undetectable in the plasma of Ren-1c mice [62]. It
would be interesting to validate this by measuring the absence of AngI and AngII in
the plasma and kidney tissue of ren−/− zebrafish. The mass spectrometry assay
described in chapter 2.0 was shown to be highly accurate and specific to zebrafish
AngI and AngII. However, a disadvantage of the mass spectrometry assay is the
large quantity of animals required for a single measurement, making it unaffordable
for routine analysis.
5.3.2 Viability
Phenotypic observations were carried out during the early stages of development
of ren−/− zebrafish larvae. There were no obvious behavioural differences, such
as swimming action, between ren−/− and wild type zebrafish during early devel-
opment and adulthood. A loss of viability was reported in homozygous Ren-1c
mice [62] which require daily administration of saline solution in order to prevent
neonatal death, and are polyuric due to their inability to concentrate their urine [62].
In contrast, there was also no reduction in viability in ren−/− fish under normal salt
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concentrations. The survival of ren−/− fish might be due to the differences in en-
vironment and water handling, since zebrafish are obviously surrounded by water
and dehydration is not an issue. To test the requirement for renin in salt handling in
zebrafish, larval ren−/− fish were placed in a low salt environment and showed no
evidence of reduced viability. The survival of ren−/− fish in a low salt environment
suggests that alternative pathways can compensate for the lack of renin. Loss of
viability of ren−/− fish was only observed when the fish were placed in low salt
and treated with Captopril and this was in keeping with a previous study by Rider
et al., which reported only 3% survival when fish were treated with Captopril and
exposed to a low salt environment [47].
In addition to the advantages of their aqueous environment, zebrafish have ion-
icytes in their gills and their skin during early development, providing alternative
routes for salt homeostasis. Salt regulation in fish is performed by a variety of or-
gans, including the kidneys, gills and skin. However, these structures are not fully
developed in early embryos. Larval zebrafish rely predominantly on ion pump ac-
tivity of the ionocytes, which cover the larval fish skin [194]. Furthermore, it has
been shown that larval fish become more tolerant of salinity from the blastula and
gastrula stages compared to the cleavage stage due advanced osmoregulatory
capacities [194]. It would be interesting to see whether the other salt handling
mechanisms are upregulated in ren−/− zebrafish, in comparison to ren−/− con-
trols.
5.3.3 Salt Handling
The physiologically relevance of the RAS in fish, and its involvement in volume
control, was first shown by Smith et al. [195]. AngII is recognised as the major reg-
ulatory hormone for controlling salt reabsorption in the mammalian kidney [7]. Salt
and blood pressure regulation by AngII is enabled predominantly through the AT1
receptor, which is expressed significantly higher in adult mammalian tissues com-
pared to the AT2 receptor [196]. Tucker et al., first identified the presence of AT1
receptors in zebrafish [46]. The mechanisms underlying the blood pressure regula-
tion through AngII activity are different across species, however, plasma AngII and
renin have both been shown to be transiently or chronically elevated when transfer-
ring euryhaline fish species into salt water [195,197]. Furthermore, Hoshijima and
Hirose reported an increase of renin mRNA when exposing zebrafish to 1/20 salt
water [43]. The 1/20 salt water concentration used in this chapter is based on that
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initial experiment [43]. However, whether the RAS is the major mechanism involved
in the salt uptake in fresh water fish is still undetermined. Two studies recently sug-
gested that the RAS is crucial for the salt handling in zebrafish in ion poor water,
however further studies are required to assess if AngII receptors are expressed in
the larval pronephric, as well as the adult mesonephric, kidney [44,47]. It would be
interesting to assess the ion channels in the gills and determine whether there is
an increased expression of these in repose to the lack of renin in ren−/− zebrafish.
5.3.4 Swim Bladder
Phenotypic observations between ren+/+ and ren−/− fish during early development,
showed a delay in swim bladder development and in some fish no obvious swim
bladder could be seen. Furthermore, ren+/+ fish maintained in 1/20CW showed a
similar phenotype. A previous study has suggested that lower ionic concentrations
have an effect on zebrafish development, however no differences in morphology
were reported when fish were placed in high ionic concentrations [43]. The obser-
vation that ren−/− fish exhibit a similar developmental delay when grown in CW as
ren+/+ fish do in 1/20 CW suggests that ren−/− fish appear to struggle with proper
salt regulation. Since no significant differences in swim behaviour can be seen in
adult ren−/−, suggesting swim bladder development normalises at a certain time
point, swim bladder inflation was traced from 3dpf up to 8dpf. Interestingly, fish
length, which is directly correlated to the inflation of the swim bladder, and swim
bladder inflation, were most significantly reduced at 5dpf. However, at later stages
the phenotype appeared to be normalised since no differences were observed be-
tween ren+/+ and ren−/− fish. It would be valuable to understand what mechanisms
these fish use between 5- and 8- dpf, which allow them to revert the oedema phe-
notype caused by the lack of renin.
5.3.5 Mesonephric Kidney Morphology
The lack of a functional renin gene leads to profound changes in kidney morphol-
ogy. Especially dramatic is the vacuolation of the proximal tubular cells within the
mesonephric kidney. Cytoplasmic vacuolation is characterised by the appearance
of vacuoles in renal tubules with the lack of any further morphological changes
such as renal degeneration [198]. The proximal tubule can be identified by the
presence of a brush border which is not present in the distal tubule. Vacuolation
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of cells is indicative of an osmotic imbalance and suggests that increased solute
transport across these cells increases the internal osmotic pressure. However, at
the present time it is not possible to tell whether the morphological changes in the
kidney structure are due to the absence of functional renin or whether they are due
to the lack of AngII. In mammalian studies it has been shown that blockade of AngII
causes changes to the number of glomeruli. It is difficult to assess the number of
glomeruli in the zebrafish since the adult kidney, unlike its mammalian counterpart,
is not structurally solid compared to the mammalian metanephric kidney. Further-
more the mesonephric zebrafish kidney is known to exhibit age-dependent nephro-
genesis, continually growing as the fish increases in length- age- matched control
would have to be carefully selected.
5.3.6 Renal Function
In mice and rats the lack of renin has shown to lead to a reduction in blood pres-
sure. As a result it is argued that this also causes the reduction of renal function
and a decrease in proteinuria is observed. Glomerular function in the zebrafish can
be assessed via the use of dextran-based compounds [103]. Dextrans are com-
plex polysaccharides, consisting of a mixture of glucose polymers [199]. A major
advantage of using dextran for assessing the glomerular filtration is the availability
of dextran of variable molecular sizes. Dextrans have been shown to be inert and
are commonly labelled with fluorescent tags and can be visually detected within
the vasculature of zebrafish larvae [104, 105]. By tracing dextran in the zebrafish
pronephros, the filtration activity of the pronephros as been shown to commence
after 3dpf. In a healthy pronephric kidney a dextran smaller than 10 kDa is filtered
by the glomerulus, however dextran of larger molecular weight (>70 kDa) are fil-
tered less efficiently. Hence, the filtration rate and also the glomerular function
can be assessed using the injection of low to high molecular weight fluorescent
dextran and measurement of the fluorescent intensity in the blood vessels, re-
spectively [104, 105, 200, 201]. Future studies on the ren−/− fish should include
renal function. Glomerular filtration could be assessed in adult ren−/− fish bred
on the ’casper’ background, allowing the imaging of blood vessels and fluorescent
intensity measurements of injected dextran. Alternatively, Rider et al., developed a
clearance assay in which they measured excreted dextran rather than residual dex-
tran remaining in the fish, and this method could be adopted [201]. Such studies
remain to be undertaken.
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5.3.7 Renin Cell Morphology
During early kidney development renin cells are expressed throughout the mam-
malian renal vasculature, gradually becoming more restricted in their vascular loca-
tion. Only after birth, do the renin cells become spatially defined to the JGA [202].
However, mammalian renal smooth muscle cells retain the ability to switch to an
endocrine renin phenotype in response to a physiological challenge [185,203,204,
205]. It is expected that the lack of a functional renin gene would simulate a se-
vere physiological challenge. To assess whether more renin cells are present in
the pronephric zebrafish kidney, ren+/+ fish were crossed to the renin and perivas-
cular double transgenic reporter line tg(ren:LifeAct-RFP, acta2:EGFP). The RFP-
positive area of renin-expressing cells along the AMA in the zebrafish pronephric
kidney was not found to be statistically different to that of ren+/+ fish, suggesting
that renin might not exert a crucial regulatory function during early stages of de-
velopment. However, imaging of the excised mesonephric kidney of the double
transgenic line tg(ren:LifeAct-RFP, acta2:EGFP) on a ren−/− background showed
a dramatic phenotype and increase of renin cells along the renal vasculature. This
was further quantified by the use of FACS, showing double the number of renin
expressing cells in the adult mesonephric kidney. Furthermore, there was an in-
crease in cells expressing both, smooth muscle marker acta2 and ren. However,
as shown in Figure 5.16, there is a reduction of smooth muscle cells, suggesting
that these cells change their phenotype from a smooth muscle phenotype to a renin
expressing cell phenotype. This would emphasise that the physiological function
of these perivascular renal cells appears to be conserved.
A subset of mammalian metanephric renin cells are granulated [49]. Rider et
al., used immuno-gold staining and electron microscopy to visualise granulation
in renin-expressing cells in the of the adult kidney zebrafish. There have been
no reports of the granulation of renin-expressing cells in the pronephric zebrafish
kidney despite EM being used to image glomerular pronephric structures [64].
5.3.8 Investigation of ren+/− Zebrafish
Although heterozygous Ren-1c+/− mice showed no phenotype (i.e. no difference
in kidney development, blood pressure or renin mRNA) compared to WT animals
[64], it should not be assumed that heterozygous fish would be entirely normal.
Therefore whilst this chapter focused on the phenotypic characterisation of ren−/−,
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it would be of interest in future work to determine whether heterozygous ren+/−
zebrafish have any detectable phenotype.
5.3.9 Transcriptional Adaptation
Several adverse ren−/− phenotypes have been reported in this chapter. However,
compared to mouse and rat renin null models the zebrafish appeared to be able
to cope with low salt concentrations and did not show signs of significant architec-
tural kidney abnormalities. An interesting study by Rossi et al., studied the reason
for the lack of obvious phenotypes in some gene knockout experiments and pro-
posed ’transcriptional adaptation’ as a possible mechanism [206]. According to
the concept of transcriptional adaption, transcripts arising from a targeted gene
can cause altered transcription of genes, the products of which can compensate
for the original loss of gene function. Studies show that the compensatory mech-
anism is not seen in cases of complete knockout of an entire gene locus, or a
promoter region both of which result in the complete loss of gene transcripts [207].
The ren−/− knockout fish have a 8bp deletion in exon 2, causing a frameshift mu-
tation and early termination of translation, however the promoter region of gene
remains intact. Therefore transcription of the mutated mRNA could, in theory, ac-
tivate transcriptional adaptation. Although no specific genes are known to be able
to complement for the loss of renin, scRNA sequencing data might suggest com-








In this thesis, I aimed to develop tools to study the function and activity of the RAS
and its rate-limiting enzyme renin, in zebrafish.
During the development of a novel renin reporter zebrafish line, using a biolu-
minescent reporter to permit studying the dynamics of renin expression in vivo, I
was able to visualise and report on a previously poorly studied phenomenon [159].
During the development of transgenic zebrafish reporter lines using fluorescence
or bioluminescence, reporter proteins are transiently expressed in the yolk sac of
larval zebrafish. The ectopic expression is not observable in adult zebrafish and
subsequent generations. Although the ectopic signal has prevented the establish-
ment of a new renin bioluminescent reporter fish, it has advanced the understand-
ing of generating new transgenic zebrafish lines in our department. It is crucial
to have an understanding of this phenomenon since it may influence quantitative
studies using genetic reporters due to the expression from the yolk sac and the
possibility of masking bone fide transgene expression.
This project also aimed to overcome the limitation of investigating RAS compo-
nents in the zebrafish due to the lack of tools to study zebrafish RAS proteins. Pre-
vious studies enabled the determination of the AngI and AngII peptide sequences,
which subsequently were synthesised using SPPS [169]. The synthetic AngI and
AngII peptides were then employed to calibrate an MS assay, in collaboration with
Attoquant Diagnostics, which enabled the measurement of endogenous zebrafish
AngI and AngII in mesonephric kidneys of zebrafish treated with Captopril and
compare the results against untreated controls. There was a dramatic lack of
AngII in kidneys of Captopril treated fish, suggesting Captopril is highly effective
in inhibiting ACE in zebrafish. Furthermore, a zebrafish renin FRET probe was
developed by synthesising the 14-amino acid sequence recognised and cleaved
by zebrafish renin. Attachment of a non-toxic fluorophore to the N-terminus and a
quencher of that fluorophore, to the C-terminus of the peptide sequence, success-
fully quenched the fluorescent signal. A plate-based assay was designed to as-
sess and validate that cleavage of the peptide resulted in a quantifiable fluorescent
signal. Despite several unsuccessful attempts to produce recombinant zebrafish
renin, to fully validate and increase the specificity of the probe, an assay was de-
signed that permitted measuring activity of the FRET probe in vivo, using larval
zebrafish homogenates and tissues from adult zebrafish. Experiments provided
evidence that the probe was successfully cleaved by zebrafish renin by using the
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probe at different stages of larval development, and the application of pharmaco-
logical strategies (i.e. Captopril) and zebrafish mutant lines.
Lastly, chapter 5 describes an extensive characterisation of the first renin knock-
out zebrafish. Ren KO zebrafish do not show reduced viability unlike renin KO
mice which require post-natal injections of saline for survival [62]. However, high-
throughput imaging using the VAST system revealed a delay in development, ob-
servable by the delay of an inflated swim bladder and reduced fish length when
comparing them to age-matched wild-type controls. Furthermore, crossing the
ren−/− zebrafish line to existing fluorescent reporter lines such as the tg(wt1b:EGFP)
and subsequent confocal microscopy imaging, suggested a delay in the glomerular
fusion of the pronephros. Crossing the ren−/− zebrafish to the renin reporter line
tg(ren:RFP-LifeAct) and the smooth muscle reporter tg(acta2:EGFP), revealed a
dramatic increase of renin cells in the mesonephros. The high-resolution imaging
visualised the change in renin cell morphology compared to ren−/− fish. Further-
more, the crossing of ren−/− fish to tg(ren:RFP-LifeAct) and tg(acta2:EGFP) fish
facilitated the development of a FAC-sorting protocol which allowed the purifica-
tion of renin-expressing and smooth muscle actin-expressing cells from ren−/−
and ren−/− zebrafish for imaging, co-culture and the preparation of scRNAseq li-
braries. Pathological examination of the zebrafish mesonephros revealed vacuola-
tion of cells of the proximal tubule of ren−/− zebrafish. Lastly, the FACS protocol
has allowed sorting for renin expressing cells of ren−/− and ren−/− zebrafish and
perform scRNAseq and generate a gene expression profile of these cells. Although
the first attempts were only partially successful, a gene expression profile for cells
deriving from ren−/− fish was possible. The preliminary data gave insight into the
genes highly expressed in renin expressing cells from ren−/− fish, which have been
previously reported to be essential for the recruitment of renin cells in response to
physiological stresses on the RAS [185, 203, 208]. Although not in the scope of
the timeline of this thesis, a successful FACS and subsequent scRNAseq analysis





6.2.1 Renin FRET Probe
The site of angiotensinogen cleavage by renin has not been directly identified in ze-
brafish. Mass spectrometry analysis of the cleavage products from the FRET probe
designed in this thesis would demonstrate this. The sizes of the cleavage products
can be predicted and are identifiable by the N-terminal 5(6)-carboxyfluorescein and
the C-terminal Methyl Red. Although attempts have been made in recovering the
products from the cleavage reaction of in vitro experiments, the zebrafish tissue
homogenates have made it difficult to detect the products through the background
noise. Pure zebrafish renin would be required to perform this experiment success-
fully.
Although the FRET probe has shown activity in zebrafish tissues and whole
embryo homogenates, only initial attempts have been made to inject the probe into
live zebrafish. The main limitation was, predicatably, the mobility of the probe once
injected. The development of a membrane-bound FRET probe would potentially
allow the detection and localisation of renin activity in real-time. Membrane-bound
FRET probes have previously been developed [209, 210, 211]. The addition of
a lipid tail to the N-terminus of the FRET probe could lead to the integration of
the FRET probe into the cell membranes of endothelial cells when injected. The
N-terminal fluorophore would remain anchored within the cell membrane after re-
moval of the N-terminus, containing the quencher, after renin interaction with the
FRET probe. An in vitro assay to permit imaging of single cells to demonstrate the
successful integration of the probe into the cell membrane as well as using renin to
demonstrate that the probe can still be cleaved would be required.
Attempts were made to design a probe using a combination of L- and D-peptides.
Previous studies have suggested that most proteases are chiral and that they can
distinguish between L- and D-enantiomeric substrates and that D-peptides are ca-
pable of resisting cleavage by many proteases [176,177]. Although no change was
observed, a panel Ang1-14 peptides with single L-amino acids exchanged for D-
amino acids, and subsequent kinematic assays should be performed. This could
lead to higher specificity and resistance of the peptide to other proteases without
changing the renin cleavage capability of its substrate.
Throughout this project, it has been shown that larval zebrafish are highly auto-
fluorescent. Previous work in our laboratory has described the synthesis of FRET
164
6.2. Future Directions
probes using fluorophore-quencher pairs which emit at near-infrared or ultraviolet.
Although these probes do not allow for qualitative imaging of the FRET probe ac-
tivity, they may enhance the quantitative read-out generated by renin activity on the
FRET probe in vivo.
6.2.2 Recombinant Renin
Several different methods were employed to develop recombinant renin; however,
most were unsuccessful. Mammalian renin was previously successfully expressed
as the inactive renin form, pro-renin, in CHO and HEK293 cells [187, 188]. In this
thesis, the production and purification of zebrafish renin was attempted using CHO
cells and HEK293 cells. HEK293 yielded no protein and although over expression
was observed in CHO cells the protein was trapped within inclusion bodies and
required additional purification steps. Western blot analysis demonstrated that the
protein was of the wrong molecular size to the expected zebrafish pro-renin or renin
and inactive.
In collaboration, reseachers at the recombinant protein core facility at the Max-
Delbrück-Centrum (MDC) in Berlin attempted to express zebrafish renin in bacterial
and mammalian cells, however their efforts were also unsuccessful. Expression of
other zebrafish proteins has previously been reported in bacterial cells [189]. The
temperature at which the mammalian cells are maintained (37 ◦C) might be the
problem causing factor of the expression of more complex zebrafish proteins.
Recombinant zebrafish renin would allow the assessment of the enzyme kinet-
ics between renin and its substrate without the interference of activity from other
proteolytic enzymes. Furthermore, using recombinant renin in in vivo FRET probe
assays would also allow to accurately assess changes of the ability of renin to
cleave the peptide sequence when substituting single bases of the renin FRET
probe.
Recombinant renin would also permit the development of a zebrafish renin anti-
body. There have been reports of using human renin antibodies for the detection of
zebrafish renin [44], however, it is not clear how specifically these anti-mammalian
renin antibodies recognise the zebrafish renin due to the low amino acid sequence
homology between mammalian and zebrafish renins.
The renin knockout zebrafish has revealed some dramatic morphological
changes in the mesonephric kidney. However, several questions remain unan-
swered, such as at what stage does the lack of renin induce these morphological
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changes. Recombinant renin would permit administer renin at different stages of
zebrafish development and potential observe a reversal of the renin knockout phe-
notype.
6.2.3 Measuring RAS Peptides
In the FRET probe development chapter, extensive work has gone into the synthe-
sis of zebrafish AngI and AngII. Both peptides were required for the calibration of
MS instruments and led to the development of an assay, in collaboration with At-
toquant Diagnostics, which permitted the accurate measurements of endogenous
AngI and AngII concentrations in zebrafish tissues. The assay demonstrated the
effectiveness of Captopril in blocking the conversion of AngI to AngII. Further as-
says could be designed to validate the renin knockout zebrafish by demonstrating
the complete absence of AngI and AngII. However, more interestingly would be
to demonstrate the presence, and measure the concentration, of the smaller RAS
peptides such as Ang1-7 or Ang1-9. Although studies have failed to identify an
analogous protein for the mammalian MAS receptor in zebrafish, there have been
reports of an analogue for ACE2, despite no studies further verifying this [41].
6.2.4 Ren−/−
The majority of physiological phenotypes were assessed in larval ren−/− zebrafish.
Larval zebrafish, compared to adults have various additional strategies that permit
handling of salt, which may explain the loss of viability when exposing larval ren−/−
zebrafish to water containing 1/20th of the normal concentration of salt [194]. It
would be particularly interesting to investigate the physiological effects of low salt
on adult zebrafish lacking renin and determine whether zebrafish have other mech-
anisms permitting salt handling. Furthermore, the pathological and subsequent im-
munohistochemical examination of the fish gills using ionicyte specific antibodies
could reveal possible changes to the fish gills. A possible phenotype could be the
increased expression of sodium ion transporters in the gills to overcome the lack
of salt handling performed by the kidney of adult zebrafish.
The morphology of the mesonephric zebrafish kidney revealed that the proxi-
mal tubules were vacuolated. The vacuolation is comparable to the ’moth eaten’
appearance seen in renin null rats [63, 198]. The vacuolation is suggestive of the
inability of proper osmoregulation. It would be of interest to perform immunohis-
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tochemistry in combination with antibodies specific for sodium transporters in the
kidney, to investigate any changes in the density of sodium transporters expressed.
Ren−/− adult zebrafish displayed a dramatic increase in the number of renin
cells along the arterioles of the mesonephros, suggesting an increase in renin cell
recruitment to overcome the lack of renin. It would be interesting to see if this phe-
notype could be recreated by using the ACE inhibitor Captopril. Captopril is highly
effective in inhibiting zebrafish ACE, causing a lack of AngII and increasing renin
transcription [47, 64]. However, the effects of Captopril on renin cell morphology
has not been assessed.
Lastly, EM studies have shown that zebrafish renin cells contain large electron-
dense granules. Furthermore, using LysoTracker staining, these granules are
highly acidic, suggestive of renin processing. Electron microscopy of ren−/− trans-
genic zebrafish would hopefully show the absence of these storage granules in
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Size: 386 Amino Acids (42.2 kDa)
Restriction sites:EcoRI/Xhol (EF/TR)
Destination vector: pSECTAG2C
C-terminal TEV protease site (YFQG)
EFLWRVKLKK MPSIRETLKE MSVTPAQVLS EIMPKYQEPS PTNGTAPTPL INYLDTQYFG
EISIGSPAQM FNVVFDTGSA NLWVPSHSCS PLYTACFTHN RYDASKSLTH IFNGTGFSIQ
YASGNVRGFL SEDVVVVGGI PVVQVFAEAT ALPAIPFIFA KFDGVLGMGY PDVAIDGITP
VFDRIMSQHV LKENVFSVYY SRDPTHIPGG ELVLGGTDPN YHTGPFHYIN TKEQGKWEVI
MKGVSVGADI LFCKDGCTAV IDTGSSYITG PASSISILMK TIGAVELAEG GYTVSCNVVR



























Size: 353 Amino Acids (38.32 kDa)
Restriction sites:EcoRI/Xhol (EF/TR)
Destination vector: pSECTAG2C
C-terminal TEV protease site (YFQG)
EFYQEPSPTN GTAPTPLINY LDTQYFGEIS IGSPAQMFNV VFDTGSANLW VPSHSCSPLY
TACFTHNRYD ASKSLTHIFN GTGFSIQYAS GNVRGFLSED VVVVGGIPVV QVFAEATALP
AIPFIFAKFD GVLGMGYPDV AIDGITPVFD RIMSQHVLKE NVFSVYYSRD PTHIPGGELV
LGGTDPNYHT GPFHYINTKE QGKWEVIMKG VSVGADILFC KDGCTAVIDT GSSYITGPAS
SISILMKTIG AVELAEGGYT VSCNVVRLLP TVAFHLGGQE YSLTDEDYIL WQSEFGEDIC
TVTFKALDVP PPTGPVWILG ANFIARYYTE FDRGNNRIGF ARAVENLYFQ GTR
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